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General introduction and scope of the thesis
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Chapter 1
1.1 Current cardiovascular disease burden and intervention strategies in
brief
Despite improvements in surgical and drug treatment, cardiovascular diseases (CVD)
remain the leading cause of death in modern societies. CVDs account for 3.9 million death
or 45% of all death in Europe with cost of €210 billion on economy per year [1]. A major
part of CVD is attributable to atherosclerosis. Correcting dyslipidemia (mostly lowering
blood low density lipoprotein (LDL) cholesterol levels) and mitigating immune response are
the 2 main strategies to attenuate risk for vascular mortality caused by atherosclerosis [2,
3]. The most successful and widely used intervention is inhibition of endogenous cholesterol
synthesis by targeting HMGCoA (β-hydroxy β-methylglutaryl-coenzyme A) reductase using
statins. Monoclonal antibody for PCSK9 can further decrease LDL levels [4]. However,
there is still substantial risk after LDL levels are corrected, prompting the need for managing
inflammatory response in atherosclerosis.
Comparing to LDL cholesterol lowering strategy, evidence of efficacy of interventions
targeting immune response is still emerging. IL-1β antibody canakinumab was shown to
reduce cardiovascular disease endpoint by 16% [5]. Nonetheless, there was the side-effect
of increasing lethal infection episodes, resulted from impaired host defense. On the other
hand, patients with atherosclerosis could display normal blood cholesterol levels [6]. More-
over, it is well-known that atherosclerosis lesions profoundly affect vascular bifurcations and
areas with low wall shear stress, despite universal exposure to the one’s blood lipid levels,
suggesting an independent role of endothelial dysfunction in atherogenesis [7]. The above
evidence has motivated research efforts to gain deeper insights in endothelial dysfunction
and inflammatory responses in pathogenesis of atherosclerosis to further tackle the residual
risk after correction of dyslipidemia. A series of recent research has identified novel functions
of neuronal guidance cues in atherogenesis and related pathophysiological process (reviewed
in detail in Chapter 2).
1.2 Pathogenesis of atherosclerosis: a brief recall
Atherosclerosis, literally meaning “artery hardening” from Greek, is the complex pathol-
ogy of formation of plaques on the artery walls. The pathological process starts as early as
teenage with forming of initial lesion, featured by continued exposure of the endothelium to
metabolic and hemodynamic risk factors leading to a state of chronic systemic activation
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of the endothelial cells [8]. Endothelial dysfunction results in enhanced macrovascular en-
dothelial permeability, an event that augments low-density lipoprotein (LDL) accumulation
in the subendothelial space. Oxidation of LDL leads to further activation of the endothelium
and potentiation of pro-inflammatory responses, including upregulation of various adhesion
molecules and chemokines that actively recruit inflammatory cells like monocytes [9]. Re-
cruited monocytes can differentiate to macrophages with stimulation of various inflammatory
cytokines and other regulatory factors. The monocytes and macrophages can endocytose the
pro-inflammatory oxidized lipids, leading to lipid-laden cells called “foam cells” (initial le-
sion – fatty streak). Following the years, the lesions grow mainly by thickening of intima
by deposition of lipoprotein by formation of “foam cells” and later proliferation of vascular
smooth muscle cells. The foam cells in the plaques can eventually die via apoptosis or necro-
sis process, allowing forming of extracellular lipid core (intermediate lesion - fibroatheroma).
The plaques can further growth in size, fibrosis content and histological compositions into
fibrous plaques and complicated lesions. Atherosclerosis remains largely asymptotic before
the size of atherosclerotic lesion causes significant stenosis, formation of atherothrombosis
or plaque rapture, causing decrease or sudden loss of perfusion to the organs. Stenosis in
coronary artery leads to angina due to the restrict blood supply, while occlusion of coronary
artery or arteries in brain causes myocardial infarction or stroke, respectively. Essentially,
pathways involved in endothelial function and dysfunction, monocyte-macrophage biology
are likely to be involved in development of atherosclerosis.
1.3 What are neuronal guidance cues?
Neuronal guidance cues (NGCs) are proteins originally identified in the nervous system
for their ability to directing growth of axons to the correct targets. Depending on the
context, they are also called neuronal guidance proteins (to specify the molecular property),
axonal guidance cues (to specify the original function) or even neuroimmune guidance cues
(to emphasize on their later-found roles in immunology). It is generally accepted that NGCs
consist of 4 families of ligands, namely netrin, semaphorin, slit and ephrin (Reviewed in
[10]). The ligands bind to their various receptors with different specifies and affinities,
exerting complex downstream signals to the target cells (See Table 1 for a list of NGC
ligands and receptors). A large part of the downstream signals results in altered activities
of small-GTPases, which in turn regulates organizations of cytoskeletons: the underlying






























Table 1. List of NGC ligands and receptors
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1.4 Scope of this thesis
The nervous and vascular systems of vertebrates share many similarities and often
overlap in anatomy. These notions led to one of the major recent insights in developmental
vascular biology being that the coordinated patterning of nerves and vessels is achieved by
each system separately using the same cues and signals [9]. Next to roles of NGCs during de-
velopment, functions of NGCs have been described in both mature endothelium and immune
cells, which is the focus in this thesis. With the knowledge in this thesis, I demonstrate the
relevance of NGCs in vascular biology from bench to bedside. Previous knowledge on NGCs
showed that NGCs are regulated by hemodynamic conditions and inflammations, thereby
affecting endothelial cell function. In Chapter 2, a detailed literature review of functions
of semaphorins and netrins in mature endothelial cells is given as the background of NGC
research in endothelial cells. Next, in Chapter 3 and Chapter 4 are the studies describing
the regulation and function of SEMA3F and NTN4 in mature endothelial cells, 2 of most
abundantly expressed NGCs in endothelial cells. We tried to push the boundary by under-
standing the mechanism underlying the function of SEMA3F and NTN4. We describe a role
for both SEMA3F and NTN4 in preventing endothelium dysfunction and trans-endothelial
migration of monocytes, 2 critical mechanisms in development of early atherosclerotic le-
sions. NGCs have also been found to play a role in monocyte biology. In this regard, I
move on to a comprehensive analysis of NGC gene expression and change of NGC pathway
during monocyte to macrophage differentiation in Chapter 5. I first quantified regulation
of NGC expression during monocyte to macrophage differentiation. And secondly, the role
of the RNA-binding protein quaking, a regulator of monocyte-macrophage function, in regu-
lation of NGC expression was investigated and discussed. In Chapter 6, I seek to prove the
clinical relevance of NGCs by building predictive modeling models using NGC expression in
circulating monocytes to infer the health status of CVD patients. Finally, in Chapter 7, I
discuss the results from my studies in relevance to the current knowledge and give directions
for future research.
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Chapter 2
Review: Understanding Netrins and Semaphorins in Mature
Endothelial Cell Biology





Netrins and semaphorins are known as neuronal guidance molecules that are important
to the facilitate patterning of the nervous system in embryonic development. In recent
years, their function has been broadened to guide development in other systems, including
the vascular system, where netrins and semaphorins critically contribute to the development
of the vascular system. Evidence is accumulating that these guidance cues are also of critical
importance in the biology of the mature endothelium by regulating the maintenance of
endothelial quiescence. Here we review our current insights into the roles of netrins and
semaphorins in endothelial cell survival, self-renewing, barrier function, response to wall
shear stress, and control of the vascular tone. We also provide suggestions for future research
into the functions of netrins and semaphorins in mature endothelial cell biology.
Keywords




The vascular system involves an extensive network of arteries, capillaries and veins,
lined by endothelial cells. While the endothelial monolayer was first thought to be an inert
layer between blood and tissue, a range of discoveries has led to better understanding of the
complex active homeostatic functions of the endothelium including the controlling vascular
tone, blood fluidity, and vascular inflammation [1]. The observation that the anatomy and
gene expression patterns of the vascular system of vertebrates often overlap with that of the
nervous system has led to the growing awareness that the coordinated patterning of nerves
and vessels is achieved by each system separately using the same cues and signals [2, 3]. These
conserved patterning factors, together called the “neuronal guidance cues” (NGCs), were first
identified in neural development and involve 4 major families of conserved ligands netrins,
slits, semaphorins, and ephrins. NGCs act together through a complex interplay of short and
long-range signals that can either repel or attract the cells of the developing network [4]. The
effects of NGCs on the developing vascular network, especially with respect to angiogenesis,
have been well characterized and received some excellent reviews [5-9]. However, next to their
function in development, evidence is accumulating that a selective group of the NGCs, the
netrins and semaphorins, have important homeostatic functions in the mature established
endothelial monolayer. Here, we review the novel insights into the regulatory roles of netrins
and semaphorins in endothelial cells in the mature endothelium.
2.2 Role of netrins and semaphorins in the survival of endothelial cells
The integrity of the vascular endothelium depends on the continued replacement of
injured or senescent cells. Conditions that “stress” endothelial cells, such as an adverse
hemodynamic or metabolic environment, or local and systemic inflammation, are associated
with a faster turnover of endothelial cells [10, 11]. This concept of endothelial cell turnover
naturally raises two questions: (1) what contributes to preservation or survival of endothelial
cells, and (2) what regulates the renewal activity of endothelial cells? Recent evidence points
at roles for netrins and semaphorins in both phenomena. Besides acting as a directional
signal for angiogenic sprouting, vascular endothelial growth factor (VEGF) is a survival
factor that plays a major role in the shaping of the vascular networks. Hypoxic tissues in
need of (neo-)vascularization express VEGF that supports the generation and survival of
the endothelial cells that makeup the new angiogenic network. However, this also relives the
hypoxia in the tissue and, therefore, other mechanisms have to kick in to replace the pro-
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survival signals previously provided by VEGF. These stabilization signals include, amongst
others, angiopoietin1/TIE2 signaling, platelet-derived growth factor (receptor signaling),
and signaling generated by the interaction of endothelial cells and extracellular matrix, more
specifically the endothelial basement membrane, via integrins. Integrin activity has been
shown to be important in stabilization and survival of mature vascular networks [12]. These
stabilization signals within a functional network rely heavily on stimulation of endothelial
cells by laminar shear stress. Below we discuss recent studies that demonstrate prominent
roles for the netrins and semaphorins in the regulation of endothelial cell survival.
2.2.1 NTN4 promotes endothelial cell survival by activating integrin α6β1
The first vertebrate netrin was discovered in 1994 as a guidance cue for the embryonic
development of commissural axons in the spinal cord [13, 14]. Up until today, expression
of six different netrins has been described in mammals. Netrin-1, 3, 4, and 5 (NTN1,
3, 4, 5) are secreted proteins, while netrin-G1 and G2 (NTNG1 and G2) are membrane-
bound proteins tethered by glycosyl-phosphatidylinostitol tails [15, 16]. Netrins can bind to
the classical “deleted in colorectal cancer” (DCC), neogenin (NEO1) and uncoordinated-5
(UNC-5) receptors. Beside the classical ligand receptor interactions also interactions with
other receptors, such as integrins [17] and adenosine A2b receptors (ADORA2B) [18], have
been described (Figure 2). In human endothelial cells, NTN4 is the highest expressed
netrin class member [19-21] (Figure 1) and can be upregulated by laminar shear stress [22].
Interestingly, NTN4 can serve as an activator of integrins, including endothelial integrin
α6β1, a binding partner of laminin [23-25]. In human microvascular endothelial cells, NTN4
directly interacts with the integrin α6β1 complex, leading to more activated integrin β1.
Functionally, a NTN4 coating indeed increases adhesion of endothelial cells in vitro to culture
plate [23]. Studies from multiple groups also show that the presence of NTN4 increases
activity of Akt and ERK1/2, suggesting that NTN4 is able to induce survival signaling in
endothelial cells [26, 27]. In line with this, less caspase3 activity was detected when human
umbilical vein endothelial cells (HUVECs) were treated with NTN4 [21, 26]. Together,
these results suggest that NTN4 may provide endothelial cells with pro-survival signaling
especially in stable functional vascular networks. It is important to note that NTN4 knockout
mice, under normal conditions, do not have any defects in retina vascular networks [28,
29]. Therefore, to fully understand the in vivo function of NTN4, further investigation is
needed. Intriguingly, NTN4 is itself a component of the basement membrane [30]; this is not
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surprising as the netrin family is structurally related to the laminin superfamily which has
an important role in the structure of the extracellular matrix [31]. As a component of the
basement membrane, NTN4 has been shown to regulate the assembly of laminin networks,
thus altering the structure of the basement membrane and thereby affecting the survival of
endothelial cells [32]. A report by Reuten et al. demonstrated that NTN4 competitively
binds to the laminin γ chain, causing disassembly of the laminin network and disruption
of the endothelial basement membrane [32]. Adding NTN4 to capillary networks in chick
embryo chorioallantoic membranes disrupted formation of stable capillary networks [32]. It
was then suggested that NTN4 causes destabilization of blood vessels. This suggestion is at
first glance contradictory to the pro-survival role of NTN4. However, in order to function as
a laminin network disassembling agent, a concentration of 2.1 μM NTN4 was needed, which
is probably hardly reached in physiological conditions. Generally, a concentration of around
1.7 pM NTN4 can be found in endothelial cell culture [21]. Therefore, the consequences of
regulation of the basement membrane structure by NTN4 in the physiological concentration
range are not fully elucidated yet.
2.2.2 NTN1 has an anti-apoptotic effect on endothelial cells
Next to NTN4, NTN1 was found to be expressed by various types of endothelial cells.
In general, NTN1 is believed to have moderate expression in endothelial cells [19, 33, 34].
Co-localization of NTN1 with endothelium was observed in both large blood vessels and
capillaries [26, 35]. There is a lack of agreement in the serum concentration NTN1. In healthy
humans, several picograms to several hundred picograms per milliliter NTN1 were detected in
serum using enzyme-linked immunosorbent assays, depending on the lab and reagents used.
[36-41] More expression of NTN1 was found in endothelial cells cultured under shear stress
and in aortic regions with higher shear stress [34]. In tumor cells and neurons, NTN1 has been
shown to be a survival factor in cells expressing the netrin receptors DCC and UNC5H [42,
43]. In endothelial cells, NTN1 also acts as a survival factor as NTN1 blocked the apoptotic
effect of serum starvation in HUVECs and human umbilical artery endothelial cells [44]. This
anti-apoptotic effect was proven to be an antagonistic effect of NTN1 binding to UNC5B,
as blocking UNC5B with siRNA also reduced apoptosis while abolishing the anti-apoptotic
effect of NTN1 [44]. Further evidence also demonstrated that NTN1 promotes endothelial
cell survival by blocking the UNC5B-induced inhibition of death-associated protein kinase 1
(DAPK1) [44]. Similar mechanisms were described before in DCC and UNC5B expressing
19
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Figure 1. Expression heatmap of netrin family proteins (left) and their receptors (right)
Values are the average normalized expression signals from all published data on the Affymetrix
Human Genome U133 Plus 2.0 Array (HG-U133 Plus 2.0/GPL570) platform obtained using the
Genevestigator software [100]. Lighter colors indicate higher expression. Expression levels within
the top quantile on GPL570 platform are recognized as “high”; levels within the inter-quantile range
(IQR) are recognized as “moderate”; levels within the bottom quantile are recognized as “low”.
These notions are used consistently throughout this article. For comparison, we include CDH5




Figure 2. Ligand-receptor binding map of netrin family proteins and their receptors
Red circles represent ligands, blue circles represent receptors.
neurons, where binding of NTN1 to its receptors is essential to maintain survival of these
neurons [42, 43]. Under high glucose condition, NTN1 was shown to prevent bovine aortic
endothelial from high glucose induced apoptosis by activating ERK1/2 and eNOS [45]. The
effect of NTN1 on increasing nitrous oxide production is discussed in Section 6.
2.2.3 Ligands of PLXND1 decrease endothelial cell survival via regulation of integrin
activity
The semaphorins are a large family of secreted (Class-3 semaphorins/SEMA3s) or
membrane-associated proteins (Class-4-7 semaphorins/SEMA4-7). Almost all types of en-
dothelial cells express high levels of SEMA3F. SEMA3C and SEMA3G have varied expres-
sion levels among different endothelial cells. SEMA3A has moderate expression. Class 4-7
semaphorins generally have moderate to high expression levels (Figure 3). The main recep-
tors of semaphorins comprise two groups, namely neuropilins (NRP1 and NRP2) and plexins
(PLXNA1-4, PLXNB1-3, PLXNC1, and PLXND1) [46-48]. In endothelial cells, high expres-
sion levels of PLXNA1, PLXNA2, PLXNB2 and PLXND1 can be found. NRP1 and NRP2
in general also have high expression levels. PLXNA3, PLXNA4, PLXNB1 and PLXNB3
21
Chapter 2
have moderate expression levels (Figure 3). Class-4-7 semaphorins can directly bind to
plexins. Class-3 semaphorins, except SEMA3E, require neuropilins as obligate co-receptors
to interact with plexins, while SEMA3E can independently bind to PLXND1 (Figure 4).
Next to SEMA3E, SEMA3C and SEMA4A are also ligands for PLXND1 [49], and similar
functional consequences have been found when endothelial cells are stimulated with these
ligands [50, 51]. Looking at a more functional level, the SEMA3E-PLXND1 axis has been
shown to be able to abrogate β1 integrin catch bonds, thus negatively regulating activity
of the integrin. PLXND1 itself is required for the normal cluster pattern of β1 integrin on
cells [52]. Since PLXND1 is widely expressed in various types of endothelial cells [50, 51,
53, 54], this observation is highly relevant also in endothelial cells. Sakurai et al. [55] have
established that, in immortalized mouse endothelial cells, exogenous SEMA3E led to a de-
crease of β1 integrin activity and reduced focal adhesions, as demonstrated by a decrease of
paxillin immunostaining. As a result, adhesion of these cells to collagen but not to poly-
L-lysine reduced after SEMA3E treatment. Knockdown of PLXND1, on the other hand,
almost completely abolished focal adhesion with or without SEMA3E, supporting a similar
role of PLXND1 in endothelial cells on integrin patterning. Interestingly, they also found
that SEMA3E induced internalization of β1 integrin, via PLXND1-dependent activation of
Arf6 [55]. Together with the observations that integrins, as mentioned before, are important
stabilization and survival signals, these mechanisms suggest that SEMA3E-PLXND1 inter-
action should reduce survival signals and induce apoptosis. Similar functional consequences
were observed when endothelial cells were treated with other ligands of PLXND1 [56]: con-
ditioning a medium with SEMA3C increased caspase3/7 activity of HUVECs possibly via
inhibition of Akt activity; SEMA3C also decreased focal adhesions and the activity of focal
adhesion kinase. Soluble SEMA4A, which is another direct ligand of PLXND1, similarly de-
creased adhesion of HUVEC to fibronectin and collagen IV. The effect could be rescued by
activation of β1 integrin, indicating that binding of SEMA4A to PLXND1 also affects inte-
grin activity. As a result of SEMA4A/PLXND1 interaction, phosphorylation of Akt was also
decreased, confirming the lack of integrin activity [50]. Overall, ligands of PLXND1 are able




2.2.4 SEMA3C promotes endothelial cell survival via integrin α5β1 and αvβ3
Using a different mechanism, an opposite function of SEMA3C on endothelial cells has
also been observed. SEMA3C is found to be expressed in mouse glomerular endothelial cells,
in which SEMA3C was able to directly activate integrin β1, while activity of focal adhesion
kinase was not affected [51]. With exogenous SEMA3C, adhesion of mouse glomerular en-
dothelial cells to collagen and fibronectin could be increased, but not to gelatin [51]. Indeed,
blocking antibody against α5β1 and αvβ3 integrin blocked the increase of adhesion to fi-
bronectin induced by SEMA3C [51]. This is consistent with the fact that fibronectin is a
Arg-Gly-Asp-containing ligand, to which α5β1 and αvβ3 integrins can bind [57]. The differ-
ence in the extracellular matrix coating is one possible explanation why an opposite role of
SEMA3C was seen here. In a similar experiment using only gelatin coating, no pro-survival
function could be detected [56].
2.3 Role of netrins and semaphorins in the renewal potential of endothelial
cells
The second phase in endothelial cell turnover is to replace the damaged endothelium
with healthy endothelial cells, which requires endothelial renewal capability. This ability
is often assessed in vitro with proliferation assays and/or wound-healing assays, mimicking
the endothelial self-renewal and repairing capability, respectively. To be noted is that the
mechanisms underlying the renewal potential are sometimes similar to what we have dis-
cussed in in Section 2 for endothelial survival, resulting from versatile pathways regulating
both functions. In addition, interpretation of proliferative capability should be done with
caution, since quiescent endothelial cells do not proliferate but make up the actual functional
endothelium in stable vasculature.
2.3.1 NTN1 dose-dependently affects endothelial cell renewal
In vitro studies demonstrated that lower concentrations of NTN1 ( 100 ng/ml) promote
proliferation of endothelial cells [58-62], while an extremely high concentration of NTN1
inhibits [60-62] or has no effect [63] on the proliferation of endothelial cells. Considering that
the typical concentration of NTN1 in human plasma is only several picograms to several
hundred picograms per milliliter NTN1[33], the physiological concentration in plasma is far
from reaching the threshold for an inhibitory effect on proliferation. NTN1 has been found
to play dual roles on the wound-healing capacity of endothelial cells. A low concentration
23
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Figure 3. Expression heatmap of semaphorin family proteins (left) and their receptors
(right)
Values are the average normalized expression signal from all published data on the Affymetrix Human
Genome U133 Plus 2.0 Array (HG-U133 Plus 2.0/GPL570) platform obtained using the Geneves-
tigator software [100]. Lighter colors indicate higher expression. Expression levels within the top
quantile on GPL570 platform are recognized as “high”; levels within the inter-quantile range (IQR)
are recognized as “moderate”; levels within the bottom quantile are recognized as “low”. These no-
tions are used consistently throughout this article. For comparison, we include CDH5 (VE-Cadherin)
as a high-expression reference, and CDH1 (E-Cadherin) as a low-expression reference (bottom right).
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Figure 4. The ligand-receptor binding map of semaphorin family proteins and their
receptors
Red circles represent ligands, blue circles represent receptors.
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of NTN1 increased the rate with which the gap in a monolayer of endothelial cells was
closed in culture [64-67], while a high concentration of NTN1 decreased that [65]. Multiple
studies confirmed that the canonical receptor of NTN1, UNC5B, mediated the inhibitory
effect of NTN1, since siRNA knockdown of UNC5B abolished this inhibitory effect [60, 62].
Interestingly, UNC5B-knockout mice displayed excessive development of blood vessels, while
the same phenotype was not observed in NTN1-knockout mouse, further confirming that
NTN1 in physiological concentrations does not primarily regulate the downstream signaling
of UNC5B [64, 68]. In 2015, Tu et al. [62] identified the melanoma cell adhesion molecule
(MCAM) or CD146 as a novel NTN1 receptor that could mediate the stimulatory effect
of NTN1 on proliferation. MCAM co-immunoprecipitated with NTN1 in endothelial cells
and had a better binding affinity compared to UNC5B (dissociation constant Kd = 1.33
nM vs 5.10 nM), which is consistent with the finding that MCAM is responsible for NTN1
function in lower concentration ranges. Blocking MCAM expression using siRNA indeed
abolished the effect of NTN1 on the proliferation of endothelial cells [62]. Therefore, the
NTN1/MCAM pathway most likely mediates the stimulatory effect of (low levels of) NTN1
on proliferation, while UNC5B mediates the NTN1-induced decrease in proliferation when
high levels of NTN1 are present.
2.3.2 The effect of NTN4 on endothelial cell renewal is ambiguous
The effect of NTN4 on the endothelial cell renewal capacity is still a matter of on-going
debate. Wilson et al. [59] found that NTN4, similar to NTN1, promoted proliferation of
various types of endothelial cells at lower concentrations. For very high concentrations of
NTN4, Nacht et al. [20] found an inhibitory effect of NTN4 on the proliferation of HMVECs.
In contrast to NTN1, Dakouane-Giudicelli et al. [69] showed that a lower concentration of
NTN4 also had an inhibitory effect on both proliferation and wound-healing capacity of
human placenta endothelial cells. It is very likely that different mechanisms are involved
in the effect of NTN4 on endothelial cells, as both structural biology analysis and kinetic
binding analysis revealed that NTN4 is not able to bind to several canonical receptors of
netrin family, namely DCC, Neogenin and UNC5B [32]. Instead, NTN4 could bind to laminin
γ chain to regulate laminin network formation and, potentially, stiffness of the endothelial
basement membrane [32]. Since stiffness of extracellular matrix also has an influence on
endothelial cell function, more investigation is needed to fully understand the mechanism of
NTN4 and its effect on endothelial cell proliferation [70].
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2.3.3 SEMA3 family members have dual roles in endothelial cell proliferation
Multiple mechanisms have been proposed to explain the involvement of SEMA3 family
members in proliferation of endothelial cells. Class-3 semaphorins except SEMA3E share
neuropilins as co-receptor with the VEGF165 isoform ,although evidences showed that
VEGF121 isoform can also bind NRP. Neuropillins serve to augment downstream signal-
ing of VEGF165 in endothelial cells by forming a receptor complex with VEGFR2 [71, 72].
Survival signaling by VEGF is especially important during development but can still be of
significance in a stabilized vascular network [73]. Loss of VEGF signaling after development
decreases vascular integrity, causing symptoms like brain hemorrhage and heart fibrosis in
endothelial conditional VEGF-knockout mice [73]. Because of the competition for NRPs
between VEGF and SEMA3s, SEMA3s were found to be endogenous inhibitors of VEGF
[74-76]. SEMA3A, SEMA3B, SEMA3C and SEMA3F can all reduce endothelial prolifera-
tion in the presence of VEGF, which can be blocked by NRP antibody or silencing NRP [56,
77-80]. SEMA3E, on the other hand, binds directly to PLXND1 and the binding of SEMA3E
and PLXND1 could also cause upregulation of soluble VEGFR1 in endothelial cells, which
serves as endogenous VEGF decoy [81]. Similar to its effect on survival of endothelial cells,
SEMA3C plays dual roles on endothelial cell proliferation as well. The increase of prolifera-
tion and decrease of apoptosis was attributed to the ability of SEMA3C to induce activation
of integrin β1 [51]. This effect could be blocked by NRP1 antibodies, confirming the necessity
of NRP1 as a co-receptor of SEMA3C [51].
2.4 Roles of netrins and semaphorins in the response to vessel wall shear
stress
Endothelial cells sense shear stress via mechanosensors and trigger a variety of down-
stream signals that are necessary for the survival of endothelial cells after initial angiogenic
stimuli. Unidirectional laminar wall shear stress is a critical hemodynamic factor for en-
dothelial cell maturation and quiescence. An unfavorable hemodynamic environment can
disturb quiescent signaling and lead to endothelial cell activation and inflammation, often
leading to the development of atherosclerotic lesions. Several studies have proposed roles for
neuronal guidance cues as mediators of effects of shear stress.
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2.4.1 NTN1 and SEMA3A repel leukocytes in response to laminar shear stress
Expression of both netrins and semaphorins is regulated by wall shear stress. In LDL
receptor knockout mice, lower expression of NTN1 could be detected in the inner curva-
ture of the aorta compared to the outer curvature [34]. Given that the endothelium in
the inner curvature of mouse aorta experiences lower wall shear stress than in the outer
curvature, NTN1 is positively regulated by shear stress. This regulation was confirmed in
vitro using human coronary artery endothelial cells cultured under unidirectional laminar
flow [34]. In addition, NTN1 was shown to have a repellent role on both migration and
adhesion of leukocytes [18, 34, 35, 82]. Neutralizing NTN1 using a blocking antibody abol-
ished the inhibitory effect of NTN1 on leukocyte adhesion to endothelial cells both in vitro
and in cremaster capillaries in mice [34]. UNC5B, the receptor of NTN1 involved in its
inhibitory proliferative effects, is expressed in peripheral blood leukocytes [35]. Blocking
UNC5B using an inhibitory antibody abolished the effect of NTN1 on monocyte migration,
confirming the canonical NTN1-UNC5B pathway as the underlying mechanism for the in-
hibition of leukocyte adhesion and migration [34]. As we discussed above, NTN1 also has
a pro-survival function for endothelial cells under physiological concentrations. These ob-
servations suggest that NTN1 is one of the mediators for the adaptation of endothelial cells
to their hemodynamic environment, to promote survival of endothelial cells, and to inhibit
leukocyte adhesion to quiescent endothelium under laminar shear stress. Similar regulation
of expression by wall shear stress applies to SEMA3A. Higher expression of SEMA3A was
found both in the outer curvature of the aorta of LDL receptor knockout mice and in human
coronary artery endothelial cells cultured under laminar flow. SEMA3A also inhibits adhe-
sion of RAW264.7 cells (a macrophage-like cell line) and transwell migration of THP-1 cells
(a monocyte-like cell line) in vitro. In addition, a blocking peptide of SEMA3A increases
leukocyte adhesion to endothelium in cremaster capillaries [34]. These observations implicate
SEMA3A as another mediator for the adaptation of endothelial cells to their hemodynamic
environment. However, the mechanism how SEMA3A has this effect needs to be further
elucidated.
2.4.2 SEMA7A enhances atherosclerosis in response to disturbed blood flow
In contrast to NTN1 and SEMA3A, SEMA7A is upregulated in the left carotid artery of
ApoE -/- mice upon disturbed flow induced by a partial carotid artery ligation procedure [83].
This positive regulation was confirmed by the elevated expression of SEMA7A in HUVECs
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cultured under oscillatory shear stress. The upregulation was mediated by downregulation
of CREB phosphorylation, while CREB is known as a downstream effector of laminar shear
stress. The disturbed flow in the left carotid artery of ApoE -/- mice with partial ligation
promoted atherogenesis in this region, but much less atherosclerotic lesions could be seen
in the same region in ApoE -/- SEMA7A -/- double knockout mice. Further studies found
that SEMA7A overexpressing HUVECs also expressed more ICAM and VCAM, and allowed
more monocyte adhesion [83]. The reason for such changes is yet to be determined, but
these observations make SEMA7A a possible mediator of the effects of adverse hemodynamic
environment on endothelial cells and even renders it a potential therapeutic target.
2.4.3 Downregulation of SEMA6A/6D by shear stress induced miR-27b promote per-
icyte recruitment
In the case of SEMA6A and SEMA6D, shear stress regulates their expression indirectly
via upregulation of microRNA miR-27b. Downregulation of SEMA6A and SEMA6D by such
mechanism in HUVECs was found to increase adhesion of human brain vascular pericytes
to HUVECs. Inhibition of miR-27b in mice by intraperitoneally injection of locked nucleic
acid (LNA) reduce pericyte to endothelial ratio in the uterus. Since pericyte recruitment is
a key step in vascular maturation, these experiments provide one of the mechanisms how
semaphorins are regulated downstream of shear stress via microRNA to allow endothelium-
pericytes interaction [84].
2.5 Roles of netrins and semaphorins in the endothelial barrier function
Vascular endothelium provides a crucial selective barrier for molecule exchange between
blood and tissue fluid and for controlled blood cell infiltration. A well-maintained endothelial
barrier function relies on correct cytoskeleton arrangements and formation of endothelial cell-
cell junctions. Quiescent endothelial cells have abundant cortical filamentous actin (F-actin)
network and few stress fibers. Such a cytoskeletal structure limits centripetal tension in
endothelial cells and keeps them in a spread morphology. The intercellular connections of
endothelial cells are made possible by the formation of both tight junctions and adherens
junctions. On the molecular level, tight junctions and adherens junctions ‘seal’ adjacent
endothelial cells by a hemophilic interaction of claudin and occludin proteins, and vascular
endothelial cadherin (VE-cadherin or CDH5) proteins, respectively. The cytoplasmic tails
of CDH5 interact with several intracellular components resulting in actin filament binding.
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Factors that have influence on either cytoskeletal networks or directly on endothelial cell-cell
junctions can alter the endothelial barrier function. Through these mechanisms, netrins and
semaphorins are identified as regulators of the barrier function of the endothelium.
2.5.1 NTN1 is necessary for tight junctions in the blood-brain barrier
Intact tight junctions are critical in the blood-brain barrier to ensure more selective
exchange of molecules between cerebrospinal fluid and blood. Neonatal mice with a NTN1
knockout genotype displayed impaired function of the blood-brain barrier, as the permeabil-
ity for macromolecules increased [19]. The effect was due to disrupted tight junctions, as
evidenced by a decrease of occludin and JAM-A (tight junction proteins) expression that
was observed in the endothelium of brain blood vessels of NTN1 knockout mice [19]. It is
possible that NTN1 in wild type conditions is presented to endothelial cells by astrocytes
in the brain, since conditioned medium from astrocytes, similar to recombinant NTN1, up-
regulates several tight junction components including ZO-1, p120 and α-catenin in human
brain-derived endothelial cells [19, 85]. The therapeutic potential of NTN1 has been ex-
amined in experimental autoimmune encephalomyelitis and middle cerebral artery occlusion
models [19, 86]. In both cases, mice treated with NTN1 showed improved barrier function of
the blood-brain barrier [19, 86]. However, the exact mechanism on how NTN1 contributes
to formation or maintenance of the tight junctions is not known yet. It is interesting to
note that MCAM is part of the endothelial cell-cell junction alongside tight junctions and
adherent junctions [87]. Previously, we discussed the involvement of MCAM as a receptor
for NTN1 in endothelial cell survival. Whether the NTN1/MCAM signaling pathway can
play a role in endothelial junction formation remains an interesting topic for future research.
2.5.2 SEMA3A induces endothelial permeability
Multiple studies demonstrated SEMA3A as a factor inducing permeability [88-91]. In-
jection of SEMA3A led to increased vessel permeability in mouse retro-orbital venous sinus
[88], mouse ear vessels [89], mouse retina [90], and mouse subcutaneous capillaries [91]. This
effect was confirmed in vitro with human brain endothelial cells [88], rat brain capillary
endothelial cells [89], and HUVECs [90, 91]. Increase in phosphorylation of CDH5 was ob-
served in endothelial cells after SEMA3A treatment, resulting in internalization of CDH5
and destabilization of adherent junctions [88, 90, 91]. The effects were dependent on NRP1
expressed by endothelial cells [90, 91]. As one of the underlying mechanisms, Le Guelte et
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al. [88] suggested that SEMA3A/NRP1/PLXNA2 signaling leads to phosphorylation of Src
kinase, which causes dissociation of PP2A from CDH5, thereby exposing a phosphorylation
site on CDH5. SEMA3A has also been found to increase association of VEGFR1 to Mi-
cal2, with Mical2 being an enhancer of F-actin depolymerization [89]. Indeed, SEMA3A was
found to induce a collapse in F-actin fibers [54, 80]. In addition, in SEMA3A-knockout mice
ischemia-reperfusion in the brain caused less leakage from brain blood vessels compared to
wild-type mice [89]. Altogether this implies that SEMA3A increase endothelial permeability
by disrupting adherens junction and collapsing cytoskeleton. However, controversy remains
on the source of SEMA3A as endothelial cells express significant but low levels of SEMA3A
and endothelial cell-specific knockout of SEMA3A did not cause a change in permeability of
skin vessels [92].
2.6 Role of netrin-1 in controlling of the vascular tone
One of the important functions of endothelial cells is to control vascular tone. This
function is realized by production of both vasodilators and vasoconstrictors by endothelial
cells. Nitric oxide (NO), a soluble gas, is an important endogenous vasodilator. Besides
vasodilation, NO also serves as an anti-inflammatory and anti-oxidative factor for endothelial
cells (see the review by Tousoulis et al. [93]). Limited data is available to elucidate the role
of NGCs in the regulation of vascular tone. To our knowledge, no role for semaphorins in
controlling vascular tone has been described. For the netrins however, an interesting role for
NTN1 in this process is described in several studies.
2.6.1 NTN1 controls vascular tone by stimulating release of nitric oxide via DCC
receptors
In 2006, Nguyen and Cai [67] found that NTN1 increased activity of endothelial nitric
oxide synthase (eNOS) via phosphorylation of extracellular signal-regulated kinase (ERK1/2).
Phosphorylation of ERK1/2 led to an increased activity of eNOS, which then catalyzed the
oxidation of L-arginine to produce NO [67, 94]. This effect could be blocked by a DCC an-
tibody, suggesting involvement of DCC as the responsible receptor [45, 67, 95-97]. Despite
low expression of DCC on endothelial cells, it was shown that NO itself preserves DCC from
degradation in endothelial cells via inhibition of the E3 ubiquitin ligase “seven in absentia
homolog” (SIAH) [98]. The ability of NTN1 to activate NO production gives it a protective
function in organ ischemia reperfusion. Infusion of NTN1 following ischemia reperfusion of
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mouse hearts decreases infarct size and improves mitochondrial dysfunction, resulting from
the increased bio-availability of NO [96, 97, 99]. Very recently, induction of NO production
by NTN1 was confirmed in vivo in NTN1 transgenic mice. Compared to WT mice, NTN1
transgenic mice showed increased level of NO in aortic ring assessed by 4,5-diaminofluorescein
(DAF-2) staining. Under normal condition, response of aortas to acetylcholine (relaxation),
nitroprusside (relaxation) and phenylephrine (contraction) did not change by NTN1 trans-
gene. In diabetic condition, NTN1 overexpression transgene could protect the mice from
dampened response to relaxation agents and exaggerated response to contraction agent. [45]
2.7 Concluding remarks
In this review, we summarized relevant studies about the involvement of netrins (Figure
5) and semaphorins (Figure 6) in the function of mature endothelial cells. Netrins and
semaphorins were originally identified to have axonal guidance function in the nervous sys-
tem. Given the striking similarity in anatomy of the peripheral nervous and vascular systems,
it is not surprising that the vascular system uses the same group of molecules in development.
A lesson learned in recent years is that the function of mature and quiescent endothelial cells
is of great importance and requires active regulation. Besides other well-known mechanisms,
evidence accumulates suggesting that netrins and semaphorins continue to serve as intercel-
lular and extracellular cues for endothelial cells to maintain their quiescent state and related
functions as described in this review. These functions also give both netrins and semaphorins
implications in the development of several diseases. Despite the fact that more and more
attention is being paid to the regulation of endothelial cell function by NGCs, most research
has been performed in vitro. More in vivo evidence is required to fully confirm the neces-
sity of semaphorins and netrins. As research into this aspect is ongoing, we expect new
insights in the near future. For example, it has already been shown that NTN1 promotes
endothelial tight junctions in the blood-brain barrier in a model of experimental autoim-
mune encephalomyelitis (which is a mouse model for brain inflammation caused by loss of
blood-brain barrier function) and middle cerebral artery occlusion models (mouse models
for stroke). Moreover, SEMA7A can elevate monocyte adhesion in regions with disturbed
flow and thereby promote atherosclerosis. Taken together, NGCs are intrinsically involved in
endothelial pathophysiology and there is no doubt that further investigations of NGCs will
reveal novel insights in and disease targets towards sustaining vascular health and integrity.
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Figure 5. Schematic representation of mature endothelial cell biology, indicating the
roles of netrin family proteins
(1) Moderate secretion of NTN1. (2) Saturated concentration of NTN1. (3) High affinity binding.
(4) Basolateral secretion. (5) Activation of integrin α6β1. (6) Physiological concentration of NTN4
possibly changes the stiffness of the laminin matrix. (7) Saturating concentration of NTN4 dissociates
the laminin network. (8) Low stiffness of extracellular matrix promotes endothelial cell quiescence.
(9) NTN1 is necessary for tight junction stability in the blood-brain barrier. (10) NTN1 binds to
MCAM; this could have an influence on endothelial barrier. (11) Laminar shear stress increases the
expression of NTN1, while disturbed flow decreases it. (12) NTN1 increases NO production via DCC




Figure 6. Schematic representation of mature endothelial cell biology, indicating the
roles of semaphorin family proteins
(1) Laminar shear stress upregulates the flow-dependent transcription factor KLF2. Translocation
of KLF2 into the nucleus increases the expression of its target gene SEMA3A. (2) SEMA3A secreted
by endothelial cells reduce adhesion of leukocytes and repel leukocyte migration. (3) Competition
on co-receptor neuropillin between Class-3 semaphorin and VEGF decreases VEGF signaling, thus
decreasing endothelial cell proliferation. (4) SEMA7A, upregulated by turbulent flow on endothelial
cells, increases expression of adhesion molecules ICAM-1 and VCAM-1, thereby increasing mono-
cyte adhesion to endothelial cells. (5) PLXND1 itself patterns integrin β1 on the endothelial cell
surface. (6) Binding of ligands to PLXND1 causes loss of integrin catch bond, thus decreasing
integrin activity. (7) Binding of ligands to PLXND1 inactivate integrin activity and induce inte-
grin internalization. (8) Binding of SEMA3A to its receptor complex increases phosphorylation of
Src kinase, which causes dissociation of PP2A from CDH5, resulting in phosphorylation of CDH5
and thereby its internalization. This disturbs the adherent junction between endothelial cells. (9)
Binding of SEMA3A to its receptor complex induces association of Mical2 to VEGFR1, which leads
to depolymerization of cortical F-actin. Loss of cortical actin filaments undermines the ability of
endothelial cells to counteract centripetal tension, thus destabilizing the endothelial barrier. (10)
Laminar shear stress increases expression of miR-27b, which represses expression of SEMA6A and
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Endothelial Semaphorin 3F Maintains Endothelial Barrier
Function and Inhibits Monocyte Migration
Zhang, H., Vreeken, D., Junaid, A., Wang, G., Sol, W., de Bruin, R. G., van Zonneveld, A.
J. and van Gils, J. M.




In normal physiology, endothelial cells (ECs) form a vital barrier between the blood
and underlying tissue controlling leukocyte diapedesis and vascular inflammation. Emerging
data suggest that neuronal guidance cues, typically expressed during development, have
roles outside the nervous system in vascular biology and immune responses. In particular,
Class III semaphorins have been reported to affect EC migration and angiogenesis. While
ECs express high levels of semaphorin 3F (SEMA3F), little is known about its function in
mature ECs. Here we show that SEMA3F expression is reduced by inflammatory stimuli
and increased by laminar flow. Endothelial cells exposed to laminar flow secrete SEMA3F,
which subsequently binds to heparan sulfates on the surface of ECs. However, under pro-
inflammatory conditions, reduced levels of SEMA3F make ECs more prone to monocyte
diapedesis and display impaired barrier function as measured with an electric cell–substrate
impedance sensing system and a microfluidic system. In addition, we demonstrate that
SEMA3F can directly inhibit the migration of activated monocytes. Taken together, our
data suggest an important homeostatic function for EC-expressed SEMA3F, serving as a
mediator of endothelial quiescence.
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Endothelial cells (ECs) form a vital barrier between the blood and underlying tis-
sue, and are crucial for maintaining vessel homeostasis by controlling vascular tone, blood
fluidity, endothelial permeability and the regulation of plasma constituents and leukocyte
transendothelial migration [1]. The observation that the anatomy and the cellular transcrip-
tomes of the vascular systems of vertebrates often overlap with that of their nervous systems
has led to one of the major recent insights in developmental vascular biology, i.e., that the
coordinated patterning of nerves and vessels is achieved by each system separately using the
same cues and signals [2, 3]. These conserved patterning factors, together called the neuronal
guidance cues, were first identified in neural development and involve four major families
of conserved ligands being the semaphorins (SEMAs), netrins, ephrins and slits. Neuronal
guidance cues act together through a complex interplay of short and long-range signals that
can either repel or attract the cells of the developing network [4]. More recently, their critical
roles in physiological and pathological regulation of vascular biology and immune responses
have been increasingly recognized. In particular, members of the Class III SEMA family
have been reported to affect endothelial biology [5-7]. Class III SEMAs are secreted proteins
typically composed of a signal peptide for cellular secretion, a SEMA domain (involved in
dimerization and receptor binding to plexins/neuropilins), an Immunoglobulin (Ig) domain,
a PSI domain (domain found in Plexins, Semaphorins and Integrins necessary for receptor
binding to neuropilins) and a basic tail [8]. Class III SEMA protein molecules form homo-
dimers by disulfide bonds and bind to its canonical receptors Plexin (PLXN) A1-4 or D1
with the help of neuropilin (NRP) 1 or 2, which increases ligand binding affinity [9]. The
intracellular regions of these PLXN receptors have a Rho-GTPase binding domains and an
R-Ras GTPase activating protein domain, allowing the interaction with small GTPases [10,
11]. Of the Class III SEMAs the function of SEMA3A has been investigated the most in
endothelial biology. Less is known about the necessity of SEMA3F in EC biology, though
SEMA3A has only moderate expression and almost all types of ECs express high levels of
SEMA3F [6]. In this article, we confirmed the high expression of SEMA3F in ECs and
demonstrated its modulation by shear stress and inflammatory factors. We further investi-
gated the functional importance of SEMA3F and propose the involvement of SEMA3F in
endothelial barrier function and monocyte migration.
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3.2 Materials and Methods
3.2.1 Access of Gene Expression Omnibus Data
Curated gene expression data of all human cell types that were profiled on Affymetrix
Human Genome U133 Plus 2.0 Array platform (Accession: GPL570/HG-U133 Plus 2) were
obtained using Genevestigator software [12]. For each cell type, average expression value
and the standard deviation were calculated. Graphs were created with R package ggplot2
[13].
3.2.2 Cell Culture
HEK293T cells (ATCC, CRL-3216) were cultured in DMEM (Gibco) supplemented
with 10% FCS (v/v) and antibiotics. THP-1 cells (ATCC, TIB-202) were cultured in RPMI
1640 (Gibco, Paisley, UK) supplemented with 10% FCS (v/v), antibiotics and 0.05 mM
2-mercaptoethanol. Primary HUVECs were isolated from in house human umbilical cords
and were cultured in EGM2 medium (Lonza, Walkersville, MD, USA) supplemented with
antibiotics. Gelatin (0.5% w/v in water) coated plates or flasks were used for HUVECs. All
experiments using HUVECs were repeated at least 3 times using cells from different donors.
All cells were maintained in a 37 °C incubator with 5% CO2.
3.2.3 Laminar or Oscillatory Shear Stress Culture Conditions
Culturing cells under laminar or oscillatory flow was performed using an iBiDi flow
system according to the manufacture’s instruction. Briefly, HUVECs were seeded into closed
perfusion chambers (IbidiTreat 0.4 μ-Slide I, Luer, Ibidi, Martinsried, Germany) and allowed
to adhere for 15 minutes. The 2 inlets of the slide were then connected to 2 syringes, which
acts as the reservoir for medium. The tops of the 2 syringes were connected to an iBiDi
pump, which introduces pressure on one of the syringes in alternate manner. A central valve
was placed on the tube, which allowed alternation of the flow direction. For the laminar
flow condition, the alternation of pressure introduction was synchronized with the valve-
controlled alternation of flow direction, resulting in unidirectional flow over the cells with
constant shear stress. For oscillatory flow, the pump still alternated similar to laminar flow,
while the valve alternated every 1 second, creating oscillatory flow over the cells. The pump
setup allowed perfusion of culture medium over the monolayer of ECs at a shear stress of 10
dyn/cm2, both laminar and oscillatory. The chamber and reservoirs containing the medium
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were kept in an incubator at 37 °C and 5% CO2. Medium was refreshed after 1 and 4 days of
culture. After 1 day or 7 days of flow, tubing connections were removed. Trizol (Invitrogen,
15596026, Carlsbad, CA, USA) or RIPA (Cell Signaling Technology, #9806, Danvers, MA,
USA) buffer were added for RNA analysis or protein analysis, respectively.
3.2.4 Lentiviral Vector for KLF2 Overexpression or SEMA3F or KLF2 Knockdown
Second generation lentiviral system was used for delivery of a plasmid containing
the KLF2 gene or a plasmid containing short hairpin RNA (shRNA) construct targeting
SEMA3F mRNA (SEMA3F KD) or KLF2 mRNA (KLF2 KD). Plasmids without the KLF2
gene (mock) or with a scrambled shRNA (scrambled) were used as controls. Briefly, pack-
aging plasmids (pPAX), envelope plasmids (pVSVG) and plasmids containing shRNA con-
structs were transfected into HEK293T cells using the polyethylenimine transfection method.
The culture medium containing lentivirus particles was harvested 2 days and 3 days after
transfection and was filtered with 0.45 μM filters to exclude cell remnants. The lentiviral
particle containing medium was then used to transduce HUVECs with dilution ratio of 1:10
in EGM2 medium. The inoculum was removed after 1 day. Puromycin (2 μg/mL, Thermo
Fisher, Grand Island, NY, USA) selection was done 2 days after the lentiviral transduction.
Cells that were resistant to puromycin for 24 hours were subcultured and used in subsequent
experiments.
3.2.5 Quantitative Polymerase Chain Reaction
For quantification of mRNA expression, cells were lysed in Trizol (Invitrogen, 15596026,
Carlsbad, CA, USA) and total RNA was isolated using RNeasy miniKit (Qiagen, 74106,
Hilden, Germany) according to the manufacturer’s instructions. First strand complementary
DNA synthesis was done using M-MLV reverse transcriptase kit (Promega, M1701, Madison,
WI, USA) with oligodT as primer. Quantitative polymerase chain reactions (qPCR) were
done using SYBR green/polymerase mix (Applied Biosystems, 4472903, Vilnius, Lithuania)
on a Biorad CFX384 system. GAPDH served as the reference gene. List of primers used in
qPCR is provided in Table 1.
3.2.6 Western Blot Analysis
For Western blot analysis, cells were lysed with the ice cold RIPA buffer (Cell Signaling
Technology, #9806, Danvers, MA, USA) supplemented with a Complete Protease Inhibitor
Cocktail (Roche, 11836153001, Mannheim, Germany). The cell debris was precipitated by
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Table 1. List of primers
centrifuging at 14,000 rpm for 20 min and supernatant was harvested. Protein concentration
in samples was measured using Pierce BCA Protein Assay Kit (ThermoFisher Scientific,
23225, Rockford, IL, USA). For electrophoresis, 10 μg samples in 20 μL were prepared with
loading buffer (Cell Signaling Technology, #7722, Danvers, MA, USA) with or without
DTT, depending on whether the reductive environment was needed. After electrophoresis
separation on a 4%–15% polyacrylamide gel (BioRad, 4561084, Temse, Belgium), proteins
on gels were transferred onto PVDF membranes (BioRad, 1704156, Temse, Belgium) using
BioRad turbo transfer system (BioRad, 1704150). The membranes were blocked using 5%
BSA solution (w/v in TBST). The primary antibodies were prepared in 5% BSA solution:
rabbit anti-human SEMA3F (Abcam, ab135880 1:500, Cambridge, UK) and rabbit anti-
human GAPDH (Cell Signaling Technology, #2118, 1:5000, Danvers, MA, USA). After
overnight incubation of primary antibody at 4 °C, secondary antibody (Dako, P044801-2,
1:5000, Glostrup, Denmark) was added and incubated for 1 hour. HPR signal was detected
with a Pierce™ ECL Western Blotting Substrate (ThermoFisher Scientific, 34095, Rockford,
IL, USA) and captured by the Chemidoc system (BioRad, 17001401). The images were




For immunofluorescence staining, HUVECs were cultured on μ-Slide 8 well (Ibidi,
C80826, Martinsried, Germandy) and fixated with 4% formaldehyde (v/v in HBSS sup-
plemented with calcium and magnesium (HBSS+), Gibco, Paisley, UK) for 10 minutes.
Cells were then permeabilized with 0.1% triton-X100 for 2 minutes for F-actin and blocked
by 5% BSA (w/w in HBSS) for 30 minutes. Except when staining for heparan sulfate and
SEMA3F, then cells were not permeabilized and directly incubated with blocking solution.
The primary antibody was prepared in 0.5% BSA (w/v in HBSS+): CDH5 mouse anti-
human antibody (BD Biosciences, 555661, 1:200, San Jose, CA, USA), SEMA3F rabbit
anti-human antibody (Abcam, ab77760, 1:50, Cambridge, UK) and heparan sulfate (JM403;
1.1 mg/mL, gift from Dr. van der Vlag and Dr. Kuppevelt (Nijmegen Center for Molecu-
lar Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands), 1:110).
Overnight incubation of the primary antibody was done at 4 °C. The secondary antibody
was also prepared in 0.5% BSA (goat anti-mouse IgG alexa 488, goat anti-rabbit IgG alexa
568 or goat anti-mouse alexa 488, Invitrogen, 1:250, Eugene, OR, USA), together with Rho-
damine Phalloidin (Invitrogen, 1:200, Eugene, OR, USA) and Hoechst (Invitrogen, 1:2000,
Eugene, OR, USA) to stain F-actin and cell nuclei. Fluorescence images were captured by
the Leica sp5 confocal microscopic system and analyzed using ImageJ software.
3.2.8 Electric Cell–Substrate Impedance Sensing
Electric cell–substrate impedance sensing (ECIS) assays were done using the ECIS
Ztheta (Applied BioPhysics, Troy, NY, USA) device with the standard 8 well arrays (Applied
BioPhysics, 8W10E) or 96 wells array (Applied BioPhysics, 96W20idf), which measures the
change in the EC monolayer barrier function in real time [14]. The plate was treated with
10 mM L-cysteine for 10 minutes to prepare the surface of gold electrodes and washed twice
with water. We then coated the plate with 0.5% gelatin solution for 30 minutes at 37
°C. After the coating, the gelatin solution was washed away with the EGM2 medium and
400 μL medium was added to each well. Thereafter, cell-free baseline measurements were
taken. After approximately 30 minutes, measurements were paused and 1 × 105 HUVECs
in suspension (200 μL) were added to the wells by mixing the cell suspension with medium
in the wells. The measuring was then resumed for at least 30 hours. For both baseline and
experiment timepoints, impedance was measured at multiple frequencies every 5 minutes.
Measurements at 4000 Hz were used for data analysis, because impendence is contributed
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mainly from cell junction resistance at this frequency.
3.2.9 Permeability of 3D Endothelial Culture
HUVECs with or without SEMA3F knockdown were seeded in gelatin coated microvas-
cular channels of custom-made gradient design OrganoPlate R○ (Mimetas, Leiden, the Nether-
lands) with 4 mg/mL type 1 collagen (Trevigen; Gaithersburg, United States) in the extra-
cellular matrix channel. After allowing the cells to adhere for 1 hour, culture medium was
replace by a mix of Endothelial Cell Growth Medium MV2 (PromoCell, Heidelberg, Ger-
many) and Pericyte Growth Medium (Angio-Proteomie, Boston, MA, USA) in a ratio of
1:1. The device was placed on a rocker platform with 7° angle of motion and eight minutes
timed operation to allow continuous flow of medium in the microvessels. After 24 hours, the
medium was refreshed and the HUVECs were cultured for 3-4 more days. To measure vessel
permeability, the culture medium in the extracellular matrix (ECM) channels was replaced
by HBSS+ buffers and the culture medium of the microvascular channels were replaced with
HBSS+ buffer containing 125 μg/mL Albumin-Alexa 555 (Life Technologies, Eugene, OR,
USA). Following this, the OrganoPlate R○ was placed in the environmental chamber (37 °C;
5% CO2) of a fluorescent microscope system (Nikon Eclipse Ti) and time-lapse images were
captured. The permeability coefficient was calculated by determining the fluorescent inten-
sities in the microvascular channel and in the ECM channel of the capture images. The
fluorescent intensity of the ECM channel was normalized with the fluorescent intensities in
the microvascular channel of each measured time point. This showed the change in intensity
ratio inside the gel channel as a function of time. The scatter plot was fitted with a linear












where Ip is the intensity in the microvascular channel, Ig is the intensity in the ECM
channel, Ag(480 · 10−6cm2) is the area of the ECM channel and is the length of the vessel
wall that separates between ECM and microvascular region. All data analysis was done with




Chemotaxis of THP-1 monocytes was measured using 24-well Transwell culture inserts
with a 5 μm pore size filter (Corning, 734-1573, Kennebunk, ME, USA), either coated with
10 μg/mL Fibronectin (Sigma, F4759, St. Louis, MO, USA) or containing an endothelial
monolayer. For transendothelial migration experiments, ECs were seeded at density of 4
× 104 cells/cm2 on the Transwell insert one day before the experiments and then kept in
EGM2 (100 μL in the top chamber and 500 μL in the bottom chamber). Two hours before
migration, EGM2 was replaced by migration medium (RPMI 1640 with 0.25% BSA) to
let ECs adapt to the new medium. When indicated, 15 h before the experiment, THP-1
cells were treated with 2 ng/mL TNFα. Before the experiment, THP-1 cells were washed
with migration medium and resuspended to a concentration of 1 × 107 per mL. Calcein
AM (ThermoFisher, C3100MP, 1:1000, Eugene, OR, USA) was added so that THP-1 cells
would carry green fluorescence. After labeling, THP-1 cells were washed twice in migration
medium and resuspended to a concentration of 1 × 106/mL. For SEMA3F pretreatment, 500
ng/mL SEMA3F (gift from Dr. Nakayama and Prof. Briscoe, Boston Children’s Hospital
and Harvard Medical School, Boston, MA, USA) was added to the suspension and cells
were incubated for 30 minutes. After 30 minutes, THP-1 cells were added to Transwell
inserts and the inserts were placed on wells with 500 μL migration medium supplemented
with 10 nM MCP1 (R&D Systems, 279-MC, Minneapolis, MN, USA) with or without 500
ng/mL SEMA3F. The cells were allowed to migration for 2 hours. Thereafter, the cells
in the bottom chambers (containing migrated THP-1 cells) were pelleted and lysed by 1%
TritonX-100. Fluorescent signal of Calcein AM was measured by a colorimetric analyzer
(excitation: 480 nm; emission: 525 nm), representing the number of THP-1 cells migrated.
3.3 Results
3.3.1 Semaphorin 3F Is the Highest Expressed Class III Semaphorin in Endothelial
Cells
We set off by studying the expression of Class III SEMAs in ECs using available tran-
scriptomics data on GPL570 platform, a commonly used human transcriptome microarray
platform. Of the Class III SEMAs, SEMA3A, SEMA3C and SEMA3G are abundantly ex-
pressed by some of the ECs (Figure 1A). High abundance of SEMA3F transcripts was
detected in all types of ECs profiled to date. The SEMA3F levels were in several types of
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ECs comparable to that of vascular endothelial cadherin (VE-cadherin, CDH5), the main
component of adherent junctions. Epithelial cadherin (E-cadherin, CDH1) was taken along
as negative control. Endothelial cells from larger arteries, such as aortic ECs, coronary artery
ECs, iliac artery ECs and umbilical artery ECs, showed higher expression of SEMA3F, com-
pared to microvascular ECs. In order to compare SEMA3F expression level of the ECs to
other cell types, all 369 cell types that were profiled on GPL570 platforms were ranked by ex-
pression of SEMA3F. The top 10 cell types consist of five EC types and five epithelial-related
cell types (Figure 1B).
Figure 1. High expression of SEMA3F in various types of endothelial cells
(A) Heatmap of Class III semaphorin expression of all types of human endothelial cells profiled on
Affymetrix Human Genome U133 Plus 2.0 Array platform (GEO accession: GPL570). Numbers
indicate normalized microarray signals on log2 scale. Black color: lower expression and green color:
higher expression. Expression signals of CDH5 and CDH1 were included as references. (B) SEMA3F
expression in 10 human cell types with highest SEMA3F expression. Data is presented as Mean ±
SEM; n = 3.
3.3.2 Expression of SEMA3F Is Regulated by Inflammatory Cytokines and Shear
Stress
Given the high expression of SEMA3F in ECs, we next assessed if inflammatory and
hemodynamic conditions affected the expression of SEMA3F. For this we used human umbil-
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Figure 2. Confirmation of SEMA3F expression in human umbilical vein endothelial
cells (HUVECs) and its response to inflammatory factors
(A) Quantification of expression of Class III semaphorins with qPCR in HUVECs. Results are
presented as copy numbers per GAPDH, Mean ± SEM, n = 3. (B) SEMA3F expression in HUVECs
stimulated with the inflammatory factors, TNFα (10 ng/mL) or IL1β (20 ng/mL). RNA was harvested
3, 6 and 24 h after stimulation started. Results are presented as copy numbers per GAPDH, Mean
± SEM, n = 3, * p < 0.05.
ical vein endothelial cells (HUVECs), in which we confirmed the expression of Class III SE-
MAs by qPCR (Figure 2A). Treatment with inflammatory cytokines decreased the expres-
sion of SEMA3F (Figure 2B). HUVECs treated with tumor necrosis factor alpha (TNFα)
had a decrease in expression by 50% after 6 hours and the effect persist until at least 24
hours. Similar observations were made for treatment with interleukin 1 beta (IL1β) after 6
hours, while the expression of SEMA3F was restored after 24 hours of IL1β treatment. The
expression of SEMA3A and SEMA3G were changed upon inflammatory cytokine stimula-
tion, however only IL1β reduced SEMA3A expression, while IL1β increased SEMA3G levels,
as did TNFα for SEMA3A expression upon 24 h stimulation (Figure S1A). To study the
regulation of SEMA3F expression by shear stress, ECs were cultured under laminar flow or
oscillatory flow (10 dyn/cm2) for 1 day or 7 days and gene expression to static cultured ECs
was compared. As expected, laminar shear stress induced the expression of shear-dependent
transcription factor Kruppel Like Factor 2 (KLF2) after 1 day and further after 7 days, while
oscillatory shear stress failed to do so (Figure 3A). Quantitative PCR revealed that mRNA
expression of SEMA3F was also augmented by a shear dependent mechanism, for SEMA3A
and SEMA3G this was not observed (Figure S1B). The expression of SEMA3F followed a
similar pattern as KLF2 with a significant 2.4-fold increased expression after 7 days (Figure
3B). Moreover, immunoblot analysis of control (static) and 7 days sheared ECs revealed an
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evident increase in SEMA3F protein expression, as well as known shear responsive NOS3
(Figure 3C). Interestingly, presence of SEMA3F dimers could only be detected in the con-
ditioned medium from ECs cultured under laminar flow, but not in the static condition
(Figure 3C). This implied that shear stress not only increased the transcription and trans-
lation of SEMA3F, but also the secretion of SEMA3F protein. Immunofluorescence staining
of SEMA3F revealed colocalization with heparan sulfate on the surface of the cells (Figure
3D–F). Treatment with heparanase reduced the presence of SEMA3F on the flow cultured
ECs (Figure 3D–F), indicating binding of SEMA3F to the endothelial glycocalyx, a net-
work of membrane-bound proteoglycans and glycoproteins. To assess if SEMA3F expression
can be mediated by the shear induced transcription factor KLF2, we overexpressed KLF2
in ECs (Figure 4A). Overexpression of KLF2 resulted in increased expression of SEMA3F
mRNA and protein in static cultured cells (Figure 4B,C). To confirm the KLF2-dependent
regulation of SEMA3F under laminar shear stress we silenced KLF2 in ECs using shRNA
vectors, and cultured these cells for 7 days under flow (Figure 4D). Knockdown of KLF2 in
endothelial cells suppressed the induction of SEMA3F by laminar flow (Figure 4E). NOS3
detection was used to validate functional overexpression or knock down of KLF2 (Figure
4C,F).
3.3.3 Loss of SEMA3F Impairs Endothelial Barrier Function
In order to study the functional importance of SEMA3F for ECs, SEMA3F expres-
sion in ECs was silenced using lentiviral shRNA vectors targeting the SEMA3F mRNA. A
non-SEMA3F targeting scrambled shRNA was used as a control. Repression of SEMA3F
(SEMA3F KD) was validated using qPCR (Figure 5A). Endothelial cells with reduced levels
of SEMA3F showed a more spindle-like and elongated morphology compared to scrambled
shRNA transduced cells (Figure 5B,C). Immunostaining of CDH5 revealed striped dis-
continuous adherens junctions (Figure 5C,D), which is often caused by excessive pulling
force from cytoskeleton to the junction [15]. Indeed, staining for filamented actin (F-actin)
showed a surfeit of stress fiber (Figure 5C,E). The morphological change strongly indicates
the possibility of impaired endothelial barrier function after reduction of SEMA3F expres-
sion. To test this postulation we assessed the effect of SEMA3F KD on endothelial barrier
function through the use of electric cell–substrate impedance sensing (ECIS) [16] and the
more physiological 3D-endothelial tube in a microfluidics platform [17]. With each method
we found that targeted reduction of SEMA3F in ECs resulted in impaired barrier function
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Figure 3. Regulation of SEMA3F expression and secretion by shear stress
(A-B) Quantitative qPCR analysis of KLF2 (A) and SEMA3F (B) mRNA isolated from HUVECs
cultured under laminar or oscillatory flow conditions (10 dyn/cm2) for 1 or 7 days compared to static
culture conditions. Results are presented relative to static cultured cells, set as 1, dotted line. Mean
± SEM of n = 3, * p < 0.05. (C) Immunoblot analysis of SEMA3F protein dimer in the supernatant
and NOS3 or GAPDH in cell lysates. Representative of n = 2–3. (D–F) Immunofluorescence staining
of SEMA3F (red), Heparan sulfate (green) and nuclei (blue) in HUVECs cultured under laminar flow
conditions for 7 days and treated with or without heparanase (1.5 μg/mL) for 2 hours at the end
of the 7 days culture. Scale bar = 40 μm. Quantification of mean fluorescence intensity of heparan
sulfate (E) and SEMA3F (F) of 3 independent experiments. Mean ± SEM, * p < 0.05.
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Figure 4. SEMA3F is induced by KLF2
(A-B) Quantitative qPCR analysis of KLF2 (A) and SEMA3F (B) mRNA isolated from HUVECs
transduced with mock or KLF2 overexpressing lentivirus. Results are presented relative to cells
transduced with mock virus, set as 1. Mean ± SEM of n = 3; * p < 0.05. (C) Representative
immunoblot analysis of NOS3, SEMA3F or GAPDH in protein lysates of HUVEC transduced with
mock or KLF2 overexpressing lentivirus. (D-F) KLF2 (D), SEMA3F (E) and NOS3 (F) mRNA
expression in HUVECs after transduction with lentiviral anti-KLF2 shRNA (KLF2 KD) or scrambled
shRNA (scrambled) and cultured under laminar flow conditions (10 dyn/cm2) for 7 days compared
to static culture conditions. Results are presented relative to scrambled, set as 1. Mean ± SEM of
n = 3, * p < 0.05.
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(Figure 6A–C). The impaired barrier function of cells with SEMA3F KD could be im-
proved by treating the endothelial cells with supernatant of non-transduced endothelial cells
cultured under laminar flow, indicated by more localization of CDH5 at cell–cell contacts
and increased impedance measurement (Figure 6D,E). Next, we assessed whether loss of
barrier function upon SEMA3F knock down alters monocyte transendothelial migration with
monocyte chemotaxis over Transwell filters containing endothelial monolayers with SEMA3F
knock down or control cells. Consistent with the reduced barrier function, we found that
loss of SEMA3F led to increased monocyte transendothelial migration (Figure 6F).
3.3.4 SEMA3F Itself Works as an Inhibitor of Migration for Activated Monocytes
Since SEMA3A can inhibit directional migration of monocytes [18], we investigated
whether SEMA3F could also affect monocyte migration by directly acting on monocytes.
For this, we started by looking at the expression of SEMA3F receptors, namely PLXNA1
and PLXNA3, and the co-receptor NRP2, by näıve monocytes and inflammatory stimulated
monocytes. We found that monocytes express all these receptors, and their expression levels
are induced upon stimulation with TNFα (Figure 7A). Next, SEMA3F was either used
to pretreat the monocytes or it was added to the Transwell migration system, either in the
bottom or in both compartments. Consistent with our receptor expression data, we observed
that the migration of TNFα-stimulated monocytes was inhibited by either pretreatment of
SEMA3F or addition of SEMA3F to the monocytes during the migration experiment. Having
SEMA3F only in the bottom compartment of the Transwell system did not affect migration
(Figure 7B,C). Together these observations have demonstrated that SEMA3F does have
an inhibitory effect on migration inflammatory stimulated monocyte, but not a repellent
effect.
3.4 Discussion
In this study, we confirmed the high expression of SEMA3F in ECs found with gene
expression meta-analysis of omni datasets. We revealed a KLF2-dependent regulation of
SEMA3F under laminar shear stress. Using an shRNA knock down model, we pinpointed
an essential role for SEMA3F in maintaining the endothelial barrier function and inhibiting
the mobility of monocytes. Collectively, these results support that SEMA3F expressed by
ECs can serve as a mediator of quiescent ECs. The function of Class III SEMAs in EC
biology has received a good amount of attention with SEMA3A being the most thoroughly
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Figure 5. Reduction of SEMA3F expression in endothelial cells leads to disrupted en-
dothelial adherens junctions
(A) SEMA3F mRNA expression after transduction with lentiviral anti-SEMA3F shRNA (SEMA3F
KD) or scrambled shRNA (Scrambled). Mean ± SEM of n = 3, * p < 0.05. (B) Bright field mi-
croscope images from HUVECs transduced with anti-SEMA3F shRNA (SEMA3F KD) or scrambled
shRNA (scrambled). Scale bar = 40 μm. (C–E) Immunofluorescence staining of CDH5 (green), F-
actin (red) and nuclei (blue) in SEMA3F KD or scrambled HUVECs. Scale bar = 10 μm (D,E) Bar
graphs show the quantification of percentage of stable adherens junctions (D) and F-actin staining
(E). Mean ± SEM of n = 3, * p < 0.05.
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Figure 6. Reduction of SEMA3F expression impairs barrier function of the endothelial mono-
layer
(A-B) HUVECs transduced with anti-SEMA3F shRNA (SEMA3F KD) or scrambled shRNA (scrambled)
were seeded in the vertical channel of a microfluidic device with collagen in the horizontal channel. At the
start of the measurement the fluorescently labeled albumin were infused in the vessel lumen and after 30
minutes albumin leakage outside the vessel channel was visualized and quantified. Dotted box indicates
region of quantification. Bar graph (B) shows quantification of permeability presented as Mean ± SEM of
n = 3, * p < 0.05. (C) Transendothelial electrical resistance of HUVECs transduced with anti-SEMA3F
shRNA (SEMA3F KD) or scrambled shRNA (scrambled) and seeded on electric cell–substrate impedance
sensing (ECIS) electrodes. Data are from one experiment representative of five independent experiments
(Mean ± SD of triplicate samples). (D) HUVECs transduced with anti-SEMA3F shRNA (SEMA3F KD) or
scrambled shRNA (scrambled) were seeded and cultured on ECIS electrodes in the presence of supernatant
of non-transduced endothelial cells cultured under static or laminar flow (7 days, 10 dyn/cm2). Results
are presented as percentage difference in impedance of the cells treated for 42 hours with supernatant
from flow compared with static endothelial cultures. Data are Mean ± SD of n = 2–3, * p < 0.05. (E)
Immunofluorescence staining of CDH5 (green), F-actin (red) and nuclei (blue) in SEMA3F KD HUVECs
cultured in the presence of supernatant of non-transduced endothelial cells cultured under static or laminar
flow (7 days, 10 dyn/cm2) for 24 h. Scale bar = 50 μm. (F) Migration of THP-1 cells across SEMA3F KD
or scrambled HUVEC-coated filters towards MCP1 (10 μM). Data are Mean ± SEM of n = 3, * p < 0.05.
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Figure 7. SEMA3F inhibits migration of TNFα stimulated monocytes
(A) Quantitative qPCR analysis of NRP2, PLXNA1 and PLXNA3 mRNA in THP-1 cells stimulated
for 15 h with TNFα (2 ng/mL), presented relative to mRNA in unstimulated cells (control), set as 1.
Mean ± SEM of n = 3, * p < 0.05. (B,C) Migration of THP1 cells unstimulated (B) or stimulated
for 15 h with TNFα (2 ng/mL, C) and with or without pretreatment with SEMA3F (500 ng/mL) or
exposure to SEMA3F (500 ng/mL) in the bottom or in the whole Transwell system towards MCP1
(10 μM). Results are presented relative to cells not exposed to SEMA3F, set as 1. Mean ± SEM of
n = 3, * p < 0.05.
investigated. SEMA3A binds to PLXNA2 (instead of PLXNA1 and PLXNA3 in the case
of SEMA3F), which activates the Rho-family small GTPase Rnd1 and induces a collapse of
the cytoskeleton [11, 19]. The ligand–receptor interaction was shown to inhibit stress fiber
formation and collapse of the ECs cell membrane [20]. SEMA3A was also shown to cause
internalization of CDH5, thus affecting the integrity of adherens junctions [21]. Via these
mechanisms, SEMA3A increased permeability of the endothelium in several situations [21-
24]. Compared to the effect of SEMA3A on endothelium permeability, available evidences
for a role of SEMA3F are rather ambiguous. High doses of exogenous SEMA3F were shown
to collapse the EC membrane and cytoskeleton, but it did not affect EC permeability [20].
Peritoneal injection of SEMA3F in mice caused elevation of leukocyte numbers in the peri-
toneal cavity, which may be explained by the disturbance of the endothelial or epithelial
cell function by SEMA3F [25]. Instead of using exogenous SEMA3F, we studied the effect
of reduced level of SEMA3F on EC barrier function, which should be more physiologically
relevant. In line with SEMA3F being shown to inhibit stress fiber formation [26, 27], after
the knockdown of SEMA3F, we observed excessive amounts of F-actin, especially at the
cortical regions of HUVECs. The end of stress fibers connects components of adherens junc-
tions. Excessive amounts of stress fibers can apply a pulling force on endothelial adherens
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junctions, resulting in disrupted integrity of these junctions and increased permeability [28,
29]. Indeed, our results show the disruption of adherens junctions with CDH5 immunoflu-
orescence staining. The fact that SEMA3F is a shear inducible protein, it is possible that
SEMA3F works as a shear-dependent auto- or paracrine regulator of endothelial cortical F-
actin via PLXN-small GTPase signaling, thus stabilizing the adherens junctions. Knowledge
on the exact small GTPase governing the downstream signaling is still lacking and requires
further research. One of the most common reasons for endothelial dysfunction is an adverse
hemodynamic environment, evidenced by the fact that more atherosclerotic plaques can be
found at bifurcations of vessels and regions with low vessel wall shear stress [30, 31]. The
underlying mechanism is that high (and laminar) shear stress provokes quiescence of ECs via
mechano-sensing proteins and downstream shear-dependent transcription factors, including
KLF2 and KLF4. Quiescent ECs have a good bioavailability of nitric oxide, better barrier
function and little inflammatory responses. Low shear stress or disturbed flow (also called
turbulence) stimulates EC proliferation, apoptosis and inflammation [32]. Adaption and
alteration of EC function under adverse hemodynamic environments involves and induces
changes in gene expression and is consequently the driver of functionalities changes [33].
For SEMA3A it has been shown, in vitro and in vivo, that its expression is decreased by
ECs at regions of disturbed flow and upon inflammatory stimulations [18]. For SEMA3F, in
line with the findings in our prolonged flow culture and KLF2 overexpression experiments,
upregulation has been reported in a microarray of ECs overexpressing the flow-responsive
transcription factor KLF2 [34]. Next to an increased SEMA3F expression upon laminar
flow we observed a decrease in expression upon inflammatory stimulations in the ECs. In
tumor cells it has been shown that the transcription repressors zinc finger E-box binding
homeobox (ZEB)-1 and inhibitors of DNA binding/differentiation 2 (Id2) proteins can de-
crease the expression of SEMA3F [35, 36]. In tumor cells these transcription factors can
be activated by inflammation [37, 38], and similar pathways might be at play in ECs in
regulating SEMA3F expression. Interestingly, we could not detect the SEMA3F protein in
the medium of ECs cultured under static conditions, whereas the SEMA3F protein could be
detected in the conditioned medium of ECs cultured under prolonged laminar flow. These
observations indicated that shear stress not only coordinated induction of SEMA3F gene
expression, but also stimulated secretion of SEMA3F, confirming the concept that induc-
tion of SEMA3F expression is at least a concomitant event in endothelial maturation and
quiescence. One key aspect of endothelial function is the ability to synthesize and maintain
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a network of membrane-bound proteoglycans and glycoproteins at the endothelium lumen,
called the glycocalyx [39]. This glycocalyx contains heparan sulfate proteoglycans providing
binding for endothelium- and plasma-derived soluble molecules facilitating protein–receptor
interactions and the formation of surface gradients of chemokines and growth factors [40].
While heparan sulfates are shown to be essential for the development of the nervous system
and specifically can affect several neuronal guidance cues [41], a role for these heparan sulfate
in SEMA-mediated function is barely described. A role for heparan sulfate proteoglycans in
SEMA function is suggested from the phenotypic similarities between central nervous sys-
tem development in mice defective in secreted SEMA signaling and mice lacking the heparan
sulfate elongation gene 1 (Ext1) [41]. For SEMA5A, an interaction with axonally expressed
heparan sulfate proteoglycans has been shown [42]. In addition, De Wit et al. have shown
that heparan sulfates can effectively compete SEMA3A from neuronal cells [43]. We have
found that treatment with heparanase reduces the presence of SEMA3F on ECs, proving
an interaction of SEMA3F with the endothelial glycocalyx probably mediated by heparan
sulfate. In this way, SEMA3F might be presented to leukocytes in the circulation and/or
be beneficial for a tight endothelial barrier by competing for VEGF on the glycocalyx. In
regard to leukocyte guidance, several members of the Class III SEMAs have been studied
in the context of inflammation and leukocyte recruitment. Studies have revealed that these
Class III SEMAs can dampen inflammation or mediate resolution of inflammation [44-48].
SEMA3A has been shown to inhibit migration of monocytes [18, 47] and for SEMA3E it has
been shown that it can inhibit the migration of macrophages [49] and neutrophils [48]. Only
for mature dendritic cells there have been reports that SEMA3A, -C and -F can promote
their migration [50]. For SEMA3F the functional effect on leukocyte migration had not been
fully studied. In our experiments, we showed that SEMA3F could affect monocyte migration
via both modulating EC adherens junction stability and acting directly on monocytes. In-
triguingly, in a recent study, Reichert et al. showed that SEMA3F promotes transmigration
of peripheral blood mononuclear cells via increasing PECAM1 at cellular junctions [25]. Sim-
ilarly, we observed reduction of PECAM1 with reduction of SEMA3F (unpublished data).
In both cases, the presence of PECAM1 in endothelial adherens junction was positively cor-
related with SEMA3F expression. PECAM1 is essential in maintaining endothelial barrier
function and promoting monocyte diapedesis through junctions of ECs [51-53]. When en-
dothelial junctions are intact, PECAM1 concentrates at the junctions, binds homophilically
to leukocyte expressed PECAM1 and facilitates transmigration of these cells [54]. When
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endothelial junctions are disrupted, junctional PECAM1 disappears and transmigration of
leukocytes is then independent of PECAM1. The above mechanism could explain why an in-
crease of monocyte migration through the EC monolayer is observed both with the SEMA3F
treatment or SEMA3F KD [25]. We also investigated whether SEMA3F could directly act
on monocyte migration. To our surprise, SEMA3F did not regulate the migration of resting
THP-1 cells. However, we saw that monocyte expression of SEMA3F receptors, namely
NRP2, PLXNA1 and PLXNA3, were induced by stimulation with TNFα. Similar observa-
tions have been made in DCs and natural killer cells (NKs), in which SEMA receptors were
upregulated upon cell activation [44, 50]. We next demonstrated that migration of TNFα-
stimulated monocytes was reduced by pretreatment with SEMA3F, or by having SEMA3F
in the migration system, but not by having SEMA3F only in the bottom chamber of the
Transwell system. Therefore, we concluded from our studies that SEMA3F acts as a general
inhibitor of monocyte migration, as observed before for SEMA3A [18]. Moreover, we revealed
that TNFα could sensitize monocytes by inducing the expression of SEMA3F receptors. In
conclusion, we demonstrated a novel function of SEMA3F in endothelial quiescence. As a
shear-inducible secretory factor, SEMA3F is essential for the endothelial barrier function and
is able to regulate monocyte migration. Together these studies provide novel insight into the
role of endothelial expressed SEMA3F as a mediator of endothelial homeostasis contributing
to vascular health.
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Endothelial Netrin-4 prevents endothelial cell senescence and
promotes endothelial cell survival
Zhang, H., Vreeken, D., Leuning, D. G., Bruikman, C. S., Junaid, A., Stem, W., deBruin,
R. G., Sol, W. M. P. J., Rabelink, T. J., van den Berg, B. M., van Zonneveld, A. J. and van
Gils, J. M.




Netrin-4, recognized in neural and vascular development, is highly expressed by mature
endothelial cells. The function of this netrin-4 in vascular biology after development has re-
mained unclear. We found that the expression of netrin-4 is highly regulated in endothelial
cells and is important for quiescent healthy endothelium. Netrin-4 expression is upregulated
in endothelial cells cultured under laminar flow conditions, while endothelial cells stimulated
with tumor necrosis factor alpha resulted in decreased netrin-4 expression. Targeted reduc-
tion of netrin-4 in endothelial cells resulted in increased expression of vascular cell adhesion
molecule 1 and intercellular adhesion molecule 1. Besides, these endothelial cells were more
prone to monocyte adhesion and showed impaired barrier function, measured in electric cell-
substrate impedance sensing system, as well as in an ‘organ-on-a-chip’ microfluidic system.
Importantly, endothelial cells with reduced levels of netrin-4 showed increased expression of
the senescence-associated markers cyclin-dependent kinase inhibitor-1 and -2A, an increased
cell size and decreased ability to proliferate. Consistent with the gene expression profile,
netrin-4 reduction was accompanied with more senescent associated β-galactosidase activity,
which could be rescued by adding netrin-4 protein. Finally, using human decellularized kid-
ney extracellular matrix scaffolds, we found that pre-treatment of the scaffolds with netrin-4
increased numbers of endothelial cells adhering to the matrix, showing a pro-survival effect
of netrin-4. Taken together, netrin-4 acts as an anti-senescence and anti-inflammation fac-
tor in endothelial cell function and our results provide insights as to maintain endothelial
homeostasis and supporting vascular health.
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Endothelium is the interior surface lining of blood vessels. It is involved in physiolog-
ical regulation of vascular barrier function, hemostasis and controlling of vascular tone. In
disease conditions, the endothelium can undergo functional adaptions and plays a role in
inflammatory response. Recent studies have identified novel roles of netrin class proteins in
these processes[1-4]. Netrin class proteins belong to the broader families of neuronal guid-
ance cues, which were originally identified in the nervous system for their role in directing
axon growth, but were later found to have expression and functions in many other tissues
[5]. Among netrin family proteins, we and others found netrin-4 (NTN4) to be the most
abundantly expressed in endothelial cells[6-8]. NTN4 is a special member of the netrin family
in several ways. Firstly, N-terminal domains of NTN4 are homologous to laminin β chain,
whereas those of other secreted netrins are homologous to laminin γ chain [5]. Secondly,
NTN4 has low binding affinity to the canonical netrin receptors, UNC5B, NEO1 and DCC
[9]. Instead, NTN4 has the property to bind to laminin γ chain in a way that could dis-
assemble the laminin network [9, 10]. Through this mechanism, high levels of exogenous
NTN4 were shown to disrupt branching of the epithelium in submandibular gland explants
and to decrease capillary development in a chick chorioallantoic membrane assay[9, 10]. The
involvement of NTN4 in endothelial cell biology is most studied in the context of angiogen-
esis, though consistency of evidence is still lacking. NTN4 was found to either increase[11,
12] or inhibit[7, 13, 14] endothelial cell migration and tube formation. However, the role
of endothelial NTN4 in physiology remains unclear. In this study, we confirmed the high
expression of NTN4 in endothelial cells and demonstrated its modulation by inflammation
and hemodynamic factors. State-of-art assays were used to further investigate the func-
tional importance of NTN4. We observed a premature cellular senescent phenotype with
inflammation and barrier loss upon reduced expression levels of NTN4 by endothelial cells.
Furthermore, we found that addition of NTN4 to extracellular matrix favored the survival
of endothelial cells.
4.2 Materials and Methods
4.2.1 Access to curated online gene expression datasets
Curated online gene expression datasets from all anatomical types on the microarray
platform “Affymetrix Human Genome U133 Plus 2.0 Array” (abbreviation: HG-U133 Plus 2;
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accession: GPL570) were obtained using Genevestigator software [15]. Average expression
of selected genes from endothelial types of cells and the standard deviation was extracted.
A heatmap illustrating the expression values was created with R package ggplot2[16].
4.2.2 Cell culture
Human umbilical vein endothelial cells (HUVECs) were isolated in house from human
umbilical cords as described previously [17] and cultured in endothelial growth medium-2
(EGM2, Lonza, CC-3162) supplemented with antibiotics, unless indicated otherwise. Human
pulmonary microvascular endothelial cells (MVECs) were a kind gift from Prof. M.J.T.H.
Goumans, Leiden University Medical Center, Leiden, the Netherlands. MVECs were culture
in microvascular endothelial cell medium-2 (EGM-2-MV, Lonza). Primary human periph-
eral blood monocytes were isolated as described previously [18] and cultured in RPMI1640
medium (Gibco, 21875034) supplemented with 10% FBS (v/v) and antibiotics. HEK293T
cells were purchased from ATCC and cultured in DMEM medium (Gibco, 41965039) sup-
plemented with 10% FBS and antibiotics. All cells were kept at 37 °C with 5% CO2.
4.2.3 Human tissue
Human transplant grade kidneys that were discarded for surgical reasons were used
after research consent was given. Procedures of kidney biopsies and decellularization were
adapted from Ott et al.[19] and were previously described by Leuning et al. [20]. In brief,
the renal artery was cannulated with a Luer-lock connector (Cole-Parmer, Barendrecht,
the Netherlands) and the kidney was perfused with 1% SDS in PBS containing antibiotics,
antimycotics, and DNAse, under a constant pressure of maximal 75 mm Hg for 5 days.
Afterwards the kidneys were perfused with dH2O with antibiotics, antimycotics, and DNAse
overnight. Then the kidneys were flushed with 1% (v/v) Triton-X 100 (Sigma) for one day
and afterwards flushed with PBS with antibiotics and antimycotics for at least 5 days, all
under a constant pressure of max. 75 mm Hg. Kidneys were stored at 4 °C in PBS until
further use. Biopsies of ≈ 1 cm3 were taken and either snap frozen in liquid nitrogen or fixed
overnight in 4% formaldehyde (Klinipath, Duiven, the Netherlands), stored in 70% ethanol,
embedded in paraffin and cut in 4 μm thick sections. Coronary atherosclerotic plaques were
retrieved from the archives of the Department of Pathology, Academic Medical Center, the
Netherlands. Materials were obtained after research consent and paraffin embedding.
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4.2.4 Quantitative PCR analysis for gene expression
For gene expression analysis, cells were lysed in Trizol (Invitrogen, 15596026). Total
RNA was extracted using RNeasy Mini Kit (Qiagen, 74106) according to the manufacture’s
manual. Genomic DNA was removed using RNase-Free DNase Set (Qiagen, 79254). First
strand complementary DNA was synthesized with equal amount of RNA input using M-
MLV Reverse Transcriptase (Promega, M1701) with OligodT primers (Promega, C1101).
Quantitative PCR (qPCR) analysis was performed with SYBR Green Master Mix (Applied
Biosystems, A25777). List of primers used can be found in Supplemental table 1.
4.2.5 Immunohistochemistry or immunofluorescence staining
For immunofluorescence staining of snap frozen human (decellularized) kidney sections,
sections were fixed in 4% paraformaldehyde (w/w in PBS) for 10 min at room temperature.
The samples were then washed three times with PBS and blocked with Serum-Free Protein
Block (Dako, X090930-2) for 30 minutes at room temperature. Primary antibodies were pre-
pared in 1% BSA (w/w in PBS). Incubation of primary antibodies was set at 4 °C overnight.
After the incubation, samples were washed three times with PBS again and incubated with
Alexa fluorochrome conjugated secondary antibody mix prepared in 1% BSA (w/w in PBS
supplemented with Hoechst (1:1000, Invitrogen, 11534886). Sections were then washed three
times with PBS and mounted with Prolong Gold (Invitrogen, P36930). For immunohisto-
chemistry staining of human coronary arteries, slides were deparaffinized in 100% xylene and
rehydrated in ethanol. Heat-induced epitope retrieval was performed in tris-EDTA buffer
(pH 9.0) for 20 minutes at 98°C. Next, nonspecific antigens were blocked with 1% BSA in
TBS for 30 minutes, followed by incubation with primary antibody overnight. After wash-
ing in TBS slides were incubated with HRP-labeled secondary antibody for one hour and
counterstained with Bright DAB substrate kit (BS04-110, Vector laboratories, Burlingame,
CA, USA). Slides were covered with glycergel (C0563, Agilent, Glostrup, Denmark) and a
glass coverslip. For immunofluorescence staining of HUVECs, cells were washed with Hank’s
Balanced Salt Solution with calcium and magnesium (HBSS+, Gibco, 14025092) and fixed
with 4% formaldehyde (v/v in HBSS+) for 10 minutes at room temperature. The cells were
then permeabilized with 0.1% Triton X-100 (w/w in HBSS) for two minutes, washed with
HBSS and incubated with 5% BSA (w/w in HBSS+) to reduce non-specific antibody bind-
ing. Primary antibody prepared in 0.5% BSA (w/w in HBSS+) was used to incubate the
cells overnight at 4 °C: The cells were washed three times. Alexa fluorochrome conjugated
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secondary antibody mix was prepared in 0.5% BSA (w/w in HBSS+) supplemented with
Hoechst 33528 (1:1000, Invitrogen, 11534886). After incubation with the mix for one hour
at room temperature, cells were washed again three times with HBSS+. Fluorescent images
were captured using Leica TCS SP5 confocal microscopy system (pinhole 1 airy; imaged 7-8
μm z-distance with step size of about 0.5 μm) and analyzed using ImageJ software. List of
antibodies used can be found in Supplemental table 2.
4.2.6 Lentiviral vectors, lentiviral particle production and transduction
Four different shRNA constructs targeting human QKI, and four different shRNA con-
structs targeting human NTN4 were obtained from the Mission Library (Sigma Aldrich),
and tested for their efficiency to knockdown QKI or NTN4, respectively. The best shRNAs
for targeting QKI or NTN4 were selected to perform all experiments. As a control, a non-
targeting shRNA (scramble) was used. Lentiviral particles were produced as described by
the Sigma Library protocol using HEK293T cells. Selection of transduced cells was achieved
using puromycin (2 μg/mL).
4.2.7 RNA immunoprecipitation
RNA-immunoprecipitation was performed with MVECs using Millipore’s validated RI-
PAb+ QKI-5 kit according to manufacture instructions.
4.2.8 Immunoblot analysis
Endothelial cells were washed with cold PBS and lysed in cold RIPA buffer (Cell signal-
ing, 9806). After centrifugation of the samples at 14000rpm for 10 minutes at 4 °C, protein
concentration in the supernatant was measured using the Pierce BCA Protein Assay Kit
(Thermo Scientific, 23255). Equal amounts of protein sample were denatured using DTT
and heating at 95 °C for 10 minutes followed by size separation on a 10% Mini-PROTEAN
gel (Biorad, 4561033). Proteins were transferred to PVDF membranes (Biorad, 1704156)
using the Trans-Blot Turbo system (Biorad), after which membranes were blocked in either
TBST-5% BSA (Sigma, A2058) for phosphorylated proteins or TBST-5% milk. Overnight
incubation was performed with primary antibodies. Incubation with HRP-conjugated sec-
ondary antibodies (1:5000, Dako) and Western lightning ECL (PerkinElmer, NEL103001EA)
or SuperSignal Western Blot Enhancer (ThermoFisher, 46640) enabled us to visualize pro-
tein bands with the ChemiDoc Touch Imaging System (Biorad). Expression was quantified
using ImageLab software (Biorad) and ImageJ software (http://rsbweb.nih.gov/ij/). List of
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antibodies used can be found in Supplemental table 2.
4.2.9 Proliferation assay
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), a yellow tetra-
zole, can be reduced to purple formazan by living cells. Thus, the number of viable cells can
be quantified in colorimetric manner. HUVECs were seeded in 24-well plates in subconflu-
ent density to allow space to proliferate (10,000 cells per well). At day one, three and five
after seeding, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution
(0.5 μg/mL in PBS) was added to designated wells after a wash with PBS. The cells were
incubated for 30 minutes at 37 °C. After the incubation, MTT solution was removed and
150 μL acidified isopropanol (0.04 M hydrochloride acid in isopropanol) solution was added
to lyse the cells. The lysate was transferred to a 96-well plate. Colorimetric reading was
done at 562 nm.
4.2.10 Senescence associated β-galactosidase staining
Senescence associated β-galactosidase staining was done using Senescence Cell Histo-
chemical Staining Kit (Sigma, CS0030) according to the manufacturer’s protocol. Briefly,
HUVECs were seeded in subconfluent density (10,000 per cm2) in μ8 slides (IBIDI, 80826).
After overnight culture, cells were washed twice with PBS and fixed with 1x Fixation Buffer
for six minutes. After fixation, cells were washed three times with PBS. The staining mixture
(200 μL) was added to each well and allowed to incubate overnight at 37 °C. After staining,
the number of positively stained cells (blue) and total cells were counted per field of view.
Percentage of positively stained cells was calculated for each condition.
4.2.11 Adhesion assay of primary monocytes to endothelial cell monolayer
HUVECs were seeded at confluent density (40,000 per cm2) one day before the ex-
periment in 96-well plates. Peripheral blood was obtained after informed consent (Ethical
Approval Number BTL 10.090) and peripheral mononuclear cells were isolated by density
gradient separation using Ficoll. CD14 Microbeads (Miltenyi Biotec, 130-050-201) and LS
columns (Miltenyi Biotec, 130-042-401) were used for magnetic separation of CD14 positive
monocytes. Freshly isolated monocytes were labelled with 5 μg/mL Calcein AM (Molecular
Probes Life Technologies, C3100MP) and incubated on top of a monolayer of HUVECs for
30 minutes at 37 °C. Non-adhering cells were washed away by multiple washing steps with
PBS, after which images were made. Cells were then lysed in Triton-X 1% for 10 minutes.
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Fluorescence was measured at λex 485 nm and λem 514 nm.
4.2.12 Electric cell-substrate impedance sensing
Electric Cell-substrate Impedance Sensing (ECIS) assays were done using the ECIS
Ztheta device (Applied BioPhysics) with standard 8-well arrays (Applied BioPhysics, 8W10E).
The 8-well arrays had gold electrodes fixed onto the bottom of the wells, enabling real time
measurement of impedance, which represents endothelial barrier function. Prior to the ex-
periment, electrodes were pretreated using 10 mM L-cysteine for 10 minutes. The wells
were washed twice using water and coated with 0.5% gelatin (w/w in water) for 10 minutes.
Gelatin solution was then replaced by 400 uL EGM2 medium and cell free baseline mea-
surements were taken for approximately 30 minutes. Meanwhile, HUVECs were trypsinized
and resuspended at a concentration of 1e6 per 200 μL. The measurements were paused, 1e6
HUVECs were added to each well in the volume of 200 μL. The measurements were then
resumed for at least 24 hours. Measurements were taken at multiple frequencies every five
minutes. Readings at 4000 Hz were used for data analysis and illustration, because at this
frequency the impendence measurement is mainly contributed by cell-cell junction resistance.
4.2.13 Permeability of 3D endothelial culture
HUVECs with or without NTN4 knockdown were seeded in gelatin coated microvascular
channels of custom-made gradient design OrganoPlate R○ (Mimetas) with 4 mg/mL type 1
collagen (Trevigen) in the extracellular matrix channel. After allowing the cells to adhere
for one hour, culture medium was replaced by a mix of Endothelial Cell Growth Medium
MV2 (PromoCell) and Pericyte Growth Medium (Angio-Proteomie) in a ratio of 1:1. The
device was placed on a rocker platform with 7° angle of motion and eight minutes timed
operation to allow continuous flow of medium in the microvessels. After 24 hours, the
medium was refreshed and the HUVECs were cultured for 3-4 more days. To measure
vessel permeability, the culture medium in the microvascular channels was replaced with
culture medium containing 125 μg/mL Albumin-Alexa 555 (Life Technologies). Following
this, the OrganoPlate R○ was placed in the environmental chamber (37 °C; 5% CO2) of
a fluorescent microscope system (Nikon Eclipse Ti) and time-lapse images were captured.
The permeability coefficient was calculated by determining the fluorescent intensities in the
microvascular channel and in the extracellular matrix channel. The fluorescent intensity
of the extracellular matrix channel was normalized with the fluorescent intensities in the
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microvascular channel of each measured time point. This showed the change in intensity
ratio inside the gel channel as a function of time. The scatter plot was fitted with a linear












where Ip is the intensity in the microvascular channel, Ig is the intensity in the ECM
channel, Ag(480 · 10−6cm2) is the area of the ECM channel and is the length of the vessel
wall that separates between ECM and microvascular region. All data analysis was done with
ImageJ (http://rsbweb.nih.gov/ij/, NIH, United States) and Matlab (MathWorks).
4.2.14 Decellularized human kidneys
For pretreatment of NTN4 on decellularized kidney sections, the snap frozen sections
of decellularized kidneys were prepared on coverslips, placed in 24 wells plate and incubated
with recombinant human NTN4 (1 μg/mL in 200 uL PBS, R&D systems, 1254-N4-025)
overnight at 4 °C. Incubation using only PBS served as a control. The next day, NTN4
solution was removed and, when indicated, 5e4 HUVECs were seeded into the wells to
allow the interaction between HUVECs and the kidney extracellular matrix. The cells were
cultured for 24 hours at 37 °C, before being fixed with 4% paraformaldehyde (w/w in PBS)
for one hour at room temperature. Immunofluorescent staining of laminin, NTN4 and CD31
was performed as described in the immunofluorescent staining section.
4.2.15 Statistical analyses
The difference between two group means was analyzed by Student’s t-test. Comparison
of three group means was analyzed by one-way ANOVA with Dunnett’s post hoc analysis
for the paired comparison to the control group. Mix effects of two conditions were analyzed
by two-way ANOVA with the interaction term. P values of less than 0.05 were considered
significant for all types of statistical analyses.
4.3 Results
4.3.1 NTN4 is the highest expressed Netrin in endothelial cells
We set off by studying the expression of NTN4 in various kinds of endothelial cells
using available transcriptomics data on the GPL570 platform, a commonly used human
transcriptome microarray platform. The average expression values of netrin family genes are
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presented in a heatmap, and expression of cadherin 5 (CDH5, vascular endothelial cadherin)
and cadherin 1 (CDH1, epithelial cadherin) were taken along as references of genes with
high or low expression (Figure 1A). NTN4 is the highest expressed netrin family gene
in all endothelial cell types, except for bone marrow endothelial progenitor cells. In some
endothelial cell types, NTN4 expression is comparable to that of CDH5, which encodes one
of the main components of endothelial adherens junctions. We also compared the NTN4
expression of endothelial cell types to that of other cell types by ranking all cell types by
NTN4 expression. The ranking resulted in seven endothelial cells types and the capillary-
rich structure of glomerulus in the top-10 list, confirming higher expression of NTN4 in
endothelial cells relative to other cell types (Figure 1B). The high expression of NTN4
in HUVECs was confirmed by qPCR (Figure 2A). In accordance to the gene expression
data, protein expression of NTN4 was observed in the endothelium of human coronary artery
(Figure 2B), and in the glomeruli and peritubular micro-vessels of human kidney (Figure
2C). Consistent with the fact that NTN4 is secreted to endothelial basement membrane,
staining of NTN4 co-localized with laminin signal at areas of vascular structures (Figure
2C).
4.3.2 Inflammation reduces and laminar shear stress induces NTN4 expression in
endothelial cells
Given the high expression of NTN4 in endothelial cells, we next assessed if inflammatory
and hemodynamic conditions could affect the expression of NTN4. Stimulation of HUVECs
with the inflammatory cytokines tumor necrosis factor (TNFα) and interleukin 1β (IL1β)
decreased the expression of NTN4 (Figure 3A), while culturing the cells under prolonged
laminar flow conditions upregulated expression of NTN4 (Figure 3B, C, Supplementary
Figure 1). Using confocal microscopy, NTN4 staining was found to be apparent in vesi-
cles, consistent with NTN4 being a secreted protein (Figure 3C and Supplementary
Figure 1). In addition, we observed no clear NTN4 staining at the extracellular base-
ment membrane itself (Supplementary Figure 1). As the RNA-binding protein Quaking
(QKI), discovered as post-transcriptional regulator and important for the development of
central nervous system[21, 22], is also regulated in the same manner by flow conditions [17]
(Figure 3D), we investigated the role of QKI in regulating NTN4 expression. Knockdown
of QKI (Supplementary Figure 2A) suppressed the expression of NTN4 in endothelial
cells (Figure 3E). We next sought to determine whether QKI can directly bind to mRNA
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Figure 1. High expression of NTN4 in various types of endothelial cells
(A) Heatmap of netrin family expression in all types of human endothelial cells profiled on Affymetrix
Human Genome U133 Plus 2.0 Array platform (GEO accession: GPL570). Numbers indicate nor-
malized microarray signals on log2 scale. Black color: lower expression and green color: higher
expression. Expression signals of CDH5 and CDH1 were included as references. (B) NTN4 expres-
sion in 10 human cell types with highest NTN4 expression. Data is presented as Mean ± SEM; n ≥
3.
Figure 2. Confirmation of NTN4 expression in endothelial cells
(A) Quantification of expression of the netrin family with qPCR in HUVECs. Results are presented
as copy numbers per GAPDH, Mean ± SEM, n = 5. (B) Immunohistochemistry of NTN4 (brown) in
human coronary artery. Scale bar = 50 μm. (C) Immunofluorescent staining of NTN4 (red), laminin
(green) and DNA (blue) in human kidney sections. Scale bars: 100 μm
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of NTN4 using an RNA-immunoprecipitation experiment. Indeed, mRNA of NTN4 was
highly enriched in the QKI-antibody precipitated RNA fraction (Figure 3F, G), indicating
binding of QKI to NTN4 mRNA.
4.3.3 Reducing NTN4 promotes an inflammatory phenotype in endothelial cells
In order to study the functional importance of NTN4 for endothelial cells, NTN4 expres-
sion in endothelial cells was silenced using lentiviral shRNA vectors targeting NTN4 mRNA.
A non-NTN4 targeting scrambled shRNA was used as a control. Repression of NTN4 was
validated using qPCR and immunofluorescence staining (Supplementary Figure 2B, C).
Staining of endothelial cells with reduced levels of NTN4 compared to endothelial cells trans-
duced with scrambled shRNA showed less aligned adherens junctions, made visible by Cad-
herin 5 staining. Using antibodies binding to an epitope of the integrin β1 that is exposed
constitutively or only exposed upon activation, respectively[23, 24],we showed that endothe-
lial cells with reduced levels of NTN4 have more total and activated integrin β1 (Figure
4A, B, Supplementary Figure 3). As increased integrin activity levels can be induced
by inhibition of protein kinase B (PKB, also known as Akt)[25, 26], we investigated Akt
phosphorylation levels using western blot. Reducing NTN4 in endothelial cells resulted in
less P-Akt (Figure 4C).
In addition, we investigated whether loss of NTN4 induces vascular leakage, since the
morphological change with less aligned adherens junctions strongly indicates the possibility
of reduced endothelial barrier function. In both electric cell–substrate impedance sensing
(ECIS) system [27] and the more physiological 3D-endothelial tube in a microfluidics platform
[28], we found that targeted reduction of NTN4 in endothelial cells resulted in impaired bar-
rier function (Figure 5A, B). Since reduction in endothelial barrier function is often caused
by an inflammatory phenotype, we examined whether the NTN4 knockdown endothelial
cells are more inflammatory-like. Endothelial cells with NTN4 KD indeed showed more ad-
hesion of primary monocytes (Figure 5C) and exhibited elevated expression of ICAM1 and
VCAM1 both at mRNA and protein levels (Figure 5D, E).
4.3.4 Reducing NTN4 induces endothelial cell senescence
Next to the inflammatory phenotype, we observed enlarged cell bodies at the same seed-
ing density (Figure 6A) and reduced capacity to proliferate (Figure 6B) in endothelial
cells with reduced expression of NTN4. These observations prompted us to assess cell senes-
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Figure 3. Regulation of NTN4 expression level in HUVECs
(A-B) qPCR analysis of NTN4 mRNA isolated from (A) HUVECs stimulated with the inflammatory
factors, TNFα (10 ng/mL) or IL1β (20 ng/mL) for 24 hours, or (B) HUVECs cultured under static
conditions or laminar flow (10 dynes/cm2) conditions for seven days. Results are expressed as fold
change of untreated cells (A) or static cultured cells (B), set to 1, Mean ± SEM, n = 3; * p <
0.05. (C) Immunofluorescence staining of NTN4 (red) and DNA (blue) in HUVECs cultured under
static conditions or laminar flow (10 dynes/cm2). Maximum intensity z -projection images from
a series of confocal images. Scale bars = 20 μm (D) qPCR analysis of QKI mRNA isolated from
HUVECs cultured under static or laminar flow conditions. Results are presented relative to static
cultured cells. Mean ± SEM of n = 4. * p < 0.05. (E) qPCR analysis of NTN4 mRNA isolated
from HUVECs transduced with anti-Qki shRNA (shQKI) or control shRNA (shCtrl). Results are
presented relative to shCtrl. Mean ± SEM of n = 5. * p < 0.05. (F, G) RNA-immunoprecipitation
in HUVEC using an IgG control or QKI-5 antibody. (F) Immunoblot of QKI confirming immunopre-
cipitation of QKI protein from endothelial cell lysates. (G) NTN4 and GAPDH mRNA abundance
in the immune-precipitated fraction was determined by qPCR. Results are presented relative to IgG
immunoprecipitation. Mean ± SEM of n = 4. * p < 0.05.
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Figure 4. Reduction of NTN4 expression in endothelial cells reduces CDH5 junction
localization and increases integrin β1 activity
(A) Immunofluorescence staining of CDH5, integrin β1 or activated integrin β1 (green) and DNA
(blue) in HUVECs transduced with anti-NTN4 shRNA (sh-NTN4) or scrambled shRNA (sh-Ctrl).
Representative images of n = 2-3. Maximum intensity z -projection images from series of confocal
images. Scale bar = 50 μm. (B) Quantification of fraction of stable adherens junctions. Mean ±
SEM of n = 3; * p < 0.05. (C) Immunoblots and quantification of phospho- and total Akt in sh-Ctrl
and sh-NTN4 treated cells. Levels are expressed as ratio P-Akt/total Akt, Mean ± SEM of n = 3.
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Figure 5. Reduction of NTN4 expression in endothelial cells diminishes endothelial
barrier function and promotes an inflammatory phenotype
(A) Left graph shows transendothelial electrical resistance of scrambled shRNA (sh-Ctrl) or anti-
NTN4 shRNA (sh-NTN4) transduced HUVECs seeded on electric cell–substrate impedance sensing
(ECIS) electrodes (Mean ± SD of technical triplicates, representative of three independent experi-
ments). Right graph shows the relative trans-endothelial electrical resistance of sh-Ctrl or sh-NTN4
HUVEC stable monolayer, sh-Ctrl set to 1. Mean ± SEM of n = 3. (B) HUVECs transduced with
sh-Ctrl or sh-NTN4 were seeded in the vertical channel of a microfluidic device with collagen in the
horizontal channel. At the start of the measurement, fluorescently labeled albumin was infused in
the vessel lumen and after 10 minutes albumin leakage outside the vessel channel was visualized and
quantified. Dotted box indicates the region used in quantification. Bar graph shows the permeability
coefficient presented as Mean ± SEM of n = 3; * p < 0.05. (C) Quantification of adhesion of primary
human monocytes to sh-Ctrl or sh-NTN4 transduced HUVECs. Mean ± SEM of n = 3; * p < 0.05
(D) ICAM1 and VCAM1 mRNA expression in sh-Ctrl or sh-NTN4 transduced HUVECs. Results
are presented relative to sh-Ctrl. Mean ± SEM of n = 3; * p < 0.05. (E) Immunoblots of ICAM1,
VCAM1 and GAPDH (housekeeping) in sh-Ctrl and sh-NTN4 treated cells. n=4.
89
Chapter 4
cence by investigating expression levels of senescence- associated transcription factors. Up-
regulation of senescence-associated transcription factors, CDKN1A and CDKN2A (encoding
p21Waf1/Cip1 and p16Ink4a, respectively), but not CDKN1B (encoding p27Kip1), was observed
in endothelial cells with NTN4 knockdown (Figure 6C). For CDKN1A, the most abundantly
expressed of these three genes, we performed immunofluorescence staining to look into pro-
tein expression, and observed also at protein level increased expression of the senescence
marker CDKN1A upon NTN4 knockdown (Figure 6D). Furthermore, senescence-associated
β-galactosidase (SA-β-gal) staining revealed a higher percentage of positively stained cells
in NTN4 sh-RNA treated endothelial cells compared to scrambled sh-RNA (Figure 6E).
To confirm the hypothesis that loss of NTN4 induced the endothelial senescence, we per-
formed rescue experiment with human NTN4 protein. Indeed, NTN4 knockdown endothelial
cells cultured on human NTN4 coating no longer showed increased β-galactosidase staining
compared to control cells (Figure 6E).
4.3.5 NTN4 promotes endothelial cell survival
As introduced previously, NTN4 can interact with laminin gamma chain in the basement
membrane[9, 10]. To study the consequence for endothelial cells of NTN4 interacting with
extracellular matrix, we utilized sections of decellularized human kidney. Immunostaining
confirmed NTN4 presence on the extracellular matrix, which could be increased by addition
of NTN4 protein (Figure 7A). Next, we added endothelial cells to the kidney scaffold with
or without extra loading of NTN4. We observed that more endothelial cells adhered to the
kidney scaffolds loaded with NTN4, as quantified by CD31 staining and nucleus counting
(Figure 7B and 7C).
4.4 Discussion
Shear stress, or the in vivo hemodynamic environment, is one of the most profound reg-
ulators of endothelial cell biology. Low shear stress or disturbed flow explains the increased
vulnerability of certain vascular regions (bifurcations or inner wall of aorta) to pathophysi-
ological changes, such as endothelial senescence, vascular wall inflammation and atheroscle-
rosis [29]. In the current study, we found that the expression of NTN4 could be induced
by prolonged laminar shear stress. Making use of NTN4 knockdown endothelial cells, we
showed that a reduction of NTN4 resulted in a more inflammatory phenotype with impaired
barrier function as well as increased monocyte adhesion due to increased expression of ad-
90
Chapter 4
Figure 6. Loss of NTN4 results in endothelial cell senescence
(A) Cell surface area of scramble shRNA treated endothelial cells (sh-Ctrl) or endothelial cells treated
with shRNA against NTN4 (sh-NTN4) cultured into confluent monolayer. Mean ± SEM of n = 3; *
p < 0.05. (B) Proliferation of sh-Ctrl and sh-NTN4 endothelial cells. Results are expressed as fold
change to day 0, sh-Ctrl. Mean ± SEM of n = 3; * p < 0.05. (C) CDKN1A, CDKN1B and CDKN2A
mRNA expression in sh-Ctrl or sh-NTN4 endothelial cells. Results are presented relative to sh-Ctrl
set to 1. Mean ± SEM of n = 3; * p < 0.05. (D) Immunofluorescence staining of CDKN1A (green)
and DNA (blue) in HUVECs transduced with anti-NTN4 shRNA (sh-NTN4) or scrambled shRNA
(sh-Ctrl). Representative images of n = 2. Maximum intensity z -projection images from series of
confocal images. Scale bar = 50 μm. (E) Representative images of SA-β-gal staining of sh-Ctrl or
sh-NTN4 cells cultured in wells pre-treated with PBS or NTN4. Bar graph shows the fraction of
positively stained cells. Mean ± SEM of n = 3; * p < 0.05 for effect of shNTN4, #p < 0.05 for
interaction effect of shNTN4 and NTN4 coating.
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Figure 7. NTN4 on extracellular matrix supports endothelial survival
(A) Immunofluorescence staining of NTN4 (green) and laminin (white) of human kidney and decel-
lularized kidney with and without preincubation of NTN4 protein. Representative images of n = 3.
Scale bar = 100 μm. (B-C) Number of nuclei (B) or CD31+ area of human decellularized kidneys
without (Ctrl) and with preincubation of NTN4 protein (NTN4) on which endothelial cells were
added and cultured. Results are expressed as (B) fold change to Ctrl or (C) CD31+/laminin ratio.
Mean ± SEM of n = 3; * p < 0.05. (D) Immunofluorescence staining of CD31 (green) and laminin
(red) of human decellularized kidney with and without preincubation of NTN4 on which endothelial
cells were added and cultured. Representative images of n = 3. Scale bar = 100 μm.
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hesion molecules. Loss of NTN4 also led to a senescent endothelial phenotype, which can
explain the inflammatory nature of these cells. Using decellularized human kidneys, we
were able to illustrate the effect of NTN4 addition in promoting endothelial adhesion and
survival to extracellular matrix. Collectively, these results indicate an important role for
NTN4 in maintaining endothelial cell function. Cellular senescence can be induced by two
mechanisms, namely replicative senescence and stress-induced senescence. Via these mech-
anisms, senescence of endothelial cells was shown to occur under circumstances of repetitive
injuries (due to atherosclerosis or artificial injuries) or oxidative stress (reviewed in [30]).
Replicative senescence results from shortening of telomeres during division of primary cells
[31], while stress-induced senescence can be caused by reasons including DNA damage [32]
and oxidative stress [33]. We saw senescent phenotypes of endothelial cells upon knockdown
of NTN4 expression, which fits in the theoretical framework of stress-induced cellular senes-
cence, since the replicative potential of the HUVECs was not exhausted. Work done by Li
et al. showed that NTN4 was implicated in protection of glioblastoma cell line U251MG
from senescence in an ITGB4-dependent manner [34]. Further investigations are needed to
clarify the dependency of protective effect of NTN4 from senescence on integrin activity in
endothelial cells. The presence of NTN4 has been shown to increase activity of Akt and
ERK1/2[11, 35]. Increased levels of Akt phosphorylation result in decreased integrin activ-
ity[25, 26] and are associated with increased survival of endothelial cells [36]. In line with
this, our NTN4 knockdown cells showed decreased Akt phosphorylation, increased integrin
activity and decreased endothelial survival. In addition, integrin activity and binding to
extracellular matrix also modulate endothelial cell cytoskeletal contractility and cell shape,
thereby also affecting endothelial barrier function[37, 38]. ITGB1 gene inactivation impairs
proper localization of VE-cadherin and thereby endothelial junction integrity [39]. In con-
trast, addition of NTN4 has been shown to be able to bind to and activate endothelial
integrin alpha 6 beta 1[40]. As NTN4 is structurally homologous to laminin β chain and has
been known as a guidance cue in extracellular matrix, it is able to regulate the structure
of the laminin network in cellular basement membrane[9, 10]. We suggest that the local
concentration of NTN4 is of much relevance. NTN4 has been shown to disassemble laminin
networks and to disrupt endothelial basement membrane functions when given exogenously
[9]. Here, we demonstrate for the first time that reduction of NTN4 expression from its
normal level induces an inflammatory and senescent phenotype. In addition, reintroducing
NTN4 can rescue the senescent phenotype and increase adhesion of endothelial cells to the
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extracellular matrix. This suggests that modification of the matrix by NTN4 adapts the
extracellular matrix properties in a more beneficial way, giving an essential role for NTN4
to regulate endothelial extracellular matrix properties under physiological condition. The
relevance of such a modification in vivo is yet to be revealed. Together we identified NTN4 as
an anti-senescence and anti-inflammatory protein. NTN4 is important in prevention of en-
dothelial cells from pathophysiological consequences, such as decreased regeneration capacity
and endothelial dysfunction.
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Antibody Company Catalogue number
Rabbit anti-human Akt Cell Signaling 4691
Rabbit anti-human P-Akt Cell Signaling 4060
Mouse anti-human CD31 BD Biosciences 555446
Mouse anti-human CDH5 BD Biosciences 555661
Goat anti-human CDKN1A Santa Cruz Biotechnology sc-397
Rabbit anti-human GAPDH Cell Signaling 5174
Rabbit anti-goat HRP Dako P0160
Donkey anti-goat alexa-488 Invitrogen A-11055
Donkey anti-goat alexa-568 Invitrogen A-11057
Donkey anti-goat alexa-647 Invitrogen A-21447
Rabbit anti-human ICAM1 Cell signaling 4915
Mouse anti-activated integrin β1 Merck-Millipore MAB2079Z
Mouse anti-integrin β1 Santa Cruz Biotechnology sc-53711
Rabbit anti-human laminin Sigma Aldrich L9393
Goat anti-mouse alexa-488 Invitrogen A-11001
Goat anti-human NTN4 R&D Systems AF1254
Mouse anti-panQKI NeuroMab clone N147/6
Goat anti-rabbit HRP Dako P0448
Donkey anti-rabbit alexa-568 Invitrogen A-11011
Rabbit anti-human VCAM1 Abcam ab134047
Supplemental table 2. List of antibodies used
100
Chapter 4
Supplementary Figure 1. Immunofluorescent images at different z plane of staining of NTN4
(red) and DNA (blue) in HUVECs cultured under static conditions or laminar flow (10 dynes/cm2).
Scale bar = 20 μm.
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Supplementary Figure 2. (A) qPCR analysis of QKI mRNA isolated from HUVECs transduced
with anti-Qki shRNA (sh-QKI) or control shRNA (sh-Ctrl). Results are presented relative to sh-Ctrl.
Mean ± SEM of n = 5. * p < 0.05. (B) NTN4 mRNA expression in sh-RNA treated endothelial cells
(sh-Ctrl) or endothelial cells treated with sh-RNA against NTN4 (sh-NTN4). Results are presented
relative to scrambled. Mean ± SEM of n = 3; * p < 0.05. (C) Immunofluorescence staining of NTN4
(red) and DNA (blue) in HUVECs transduced with anti-NTN4 shRNA (sh-NTN4) or scrambled
shRNA (sh-Ctrl).
Supplementary Figure 3. Immunofluorescent images at different z plane of staining of CDH5,
integrin β1 or activated integrin β1 (green) and DNA (blue) in HUVECs transduced with anti-NTN4




Comprehensive analysis of neuronal guidance cue expression
regulation during monocyte to macrophage differentiation re-
veals post-transcriptional regulatory hotspot in Semaphorin7A
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In response to inflammatory cytokines and chemokines, monocytes differentiate into
macrophages. Recent research on neuronal guidance cues (NGCs) has expanded their func-
tion in the field of immunology. Nonetheless, a comprehensive analysis of gene expression
regulation of NGC ligands and receptors in the monocyte to macrophage differentiation pro-
cess was not available yet. We performed transcriptome profiling in both human primary
periphery blood monocytes (PBMCs)/PBMC-derived macrophages and THP-1 cells/THP1-
macrophages using microarray or RNAsequencing methods. Pathway analysis showed that
the axonal guidance pathway is significantly regulated upon monocyte differentiation. We
confirmed NGC ligands and receptors which were consistently regulated, including SEMA4D,
SEMA7A, NRP1, NRP2, PLXNA1, PLXNA3. The involvement of RNA-binding protein
quaking (QKI) in the regulation of NGC expression was investigated using monocytes and
macrophages from a QKI haplo-insufficient patient and her healthy sibling. This revealed a
positive correlation of SEMA7A expression with QKI expression. In silico analysis of 3’UTRs
of NGCs proposed the competitive binding of QKI to proximal microRNA targeting sites as
the mechanism of QKI-dependent regulation of SEMA7A. RNA-immunoprecipitation con-
firmed an interaction of QKI with the 3’UTR of SEMA7A. In addition, loss of SEMA7A
resulted in monocyte differentiation towards a more anti-inflammatory macrophage. All
taken together, the axonal guidance pathway is regulated during monocyte to macrophage
differentiation and the regulation is in line with the necessary functional adaption for the
specialized role of macrophages.
Keywords




Monocytes, with their ability to phagocytose, present antigens and produce cytokines,
play important roles in immune surveillance. In response to inflammatory cytokines and
chemokines, they are able to extravasate through endothelium and differentiate into macrophages,
which are more specialized in phagocytosis and play a significant role in innate immunity [1].
Besides their important roles in various physiological processes, macrophages are responsible
for the pathophysiology of various inflammatory diseases, including atherosclerosis, Crohn’s
disease, and various neurodegenerative diseases [2]. Upon monocyte to macrophage differ-
entiation, the cells change their functionalities in multifaceted ways, which can partly be re-
flected by altered gene expressions in biological pathways. A comprehensive understanding of
biological pathway regulations during monocyte/macrophage differentiation give insights to
their functions in health and disease. Neuronal guidance cues (NGCs) are ligands in the axon
guidance pathway that trigger downstream signaling by binding to their receptors. They con-
sist of 4 classes, namely semaphorin (SEMA), netrin (NTN), ephrin (EFN) and slit (SLIT),
with their receptors being plexin/neuropilin (PLXN/NRP), UNC5/DCC/NEO1, EPH and
ROBO, respectively. Functionally, these guidance cues affect adhesion, migration and acti-
vation of cells. In recent years, we have come to the understanding that neuronal guidance
cues play an important role in immunology and are also specifically shown to be involved in
monocyte-macrophage biology. For example, SEMA7A was shown to stimulate production
of pro-inflammatory cytokines in monocytes and potentially promote differentiation of mono-
cytes to macrophages [3]. NTN1 and SEMA3A were found to inhibit migration of monocyte-
like cell lines and adhesion of leukocytes to capillary endothelium [4]. In ApoE knockout mice
fed a high fat diet, NTN1 inhibited emigration of macrophages from atherosclerotic lesions
[5]. To better interpret the involvement of NGCs in monocyte-to-macrophage differentiation,
we sought out to give an overall image of the expression of guidance cues and their regulations
during monocyte-to-macrophage differentiation using multiple commonly used experimental
models. Quaking (QKI), an RNA binding protein (RBP), has been identified as a central
regulator of gene expression changes in the monocyte-to-macrophage differentiation process
[6]. One of the mechanisms through which QKI performs its regulatory functions is that
QKI binds to quaking response element (QRE) motif in mRNA stabilizing mRNA transcript
[7, 8]. The QRE motif consists of the core sequence “ACUAA”, often followed by a half site
“UAAY” [7]. Despite the central role of QKI in monocyte-to-macrophage differentiation,
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involvement of QKI in the regulation of NGCs is yet to be studied. In the current study,
we found significant regulation of genes in the axonal guidance pathway during monocyte
to macrophage differentiation by pathway analysis. Consistent regulation of gene expression
was identified among multiple experimental models. In addition, we explored the involve-
ment of QKI in the regulation of NGC ligands and receptors [6]. Using material from a QKI
haplodeficient patient, we demonstrated the possibility that regulation of SEMA7A was de-
pendent on the competitive binding of QKI to a microRNA (miRNA) targeting cluster in
3’UTR of SEMA7A.
5.2 Materials and Methods
5.2.1 Culture of human monocytes and THP-1 cells
THP-1 cells were obtained from ATCC (TIB202) and were cultured in RPMI 1640
medium with 10% fetal bovine serum (FBS) supplemented with 0.01 μg/mLL-glutamine,
penicillin and streptomycin and 0.05 mM 2-mercaptoethanol. For differentiation of THP-1
cells to THP-1 macrophages, 100 nM of Phorbol 12-Myristate 13-Acetate (PMA, Sigma-
Aldrich) was added to the medium. After 3 days, the PMA-containing medium was replaced
by normal growth medium and the cells were cultured for another 5 days. Primary human
monocytes were isolated from whole blood donated by the QKI haplo-deficiency patient and
her sibling. Peripheral blood mononuclear cells were isolated by gradient centrifugation in
Ficoll-Paque (Sigma-Aldrich). Monocyte fraction were then labeled with anti-CD14 antibody
conjugated to magnetic beads (Miltenyi) and separated on a MACS magnetic column, ac-
cording to manufacturer’s instruction. The purity of the isolated monocytes was around 95%
(Supplementary Figure 1). Isolated monocytes were either subjected directly to RNA iso-
lation procedure or differentiated to pro-inflammatory macrophage in RPMI 1640 medium
with 10% FBS supplemented with 5 ng/mLrecombinant human granulocyte-macrophage
colony-stimulating factor (GM-CSF, Biosource). The medium was refreshed every 2 days
until day 7. Ethics issues regarding utilization of patient-derived samples were described
previously [6]. Briefly, informed consents were obtained prior to the experiments and the
proposals were approved by relevant ethics committees in Maastricht University Medical
Center, the Netherlands, and Leuven University Hospital, Belgium.
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5.2.2 Omics data access
Transcriptome (GSE9820 [9], last downloaded on Jan 15, 2015) and miRNA (GSE52986,
last downloaded on Oct 01, 2018 [10]) profiling data of human monocytes were obtained
from Gene Expression Omnibus (GEO) repository using “GEOquery” package from R bio-
conductor, according the developer’s manual [11]. QKI eCLIP data were downloaded from
ENCODE website (ENCSR366YOG, last downloaded on Sept 23, 2018) [12]. A summary
of in-house and online data used in this article is provided in Supplementary table 1.
5.2.3 Gene expression microarrays
Detailed method has been described before by de Bruin et al [6]. THP-1 cells and THP-
1 macrophages were lysed in Trizol (Thermo Fisher Scientific). RNA was isolated using the
RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. Complementary
DNA synthesis was done with the WT Expression Kit (Affymetrics). Fragmentation and
terminal labeling were done using the WT Terminal Labeling Kit (Affymetrics). The library
was then hybridized to HJAY Chips (Affymetrix 540091). Chips were scanned using the
Affymetrix Gene ChIP Scanner 3000 7G (Affymetrix). Probe intensity data were analyzed
using the standard Affymetrix pipeline according to manufacturer’s instructions. Data was
deposited in GEO under the accession number GSE74887.
5.2.4 RNA sequencing
RNA sequencing analysis (RNAseq) was performed as previously described [6]. Briefly,
ribosomal RNA was removed using Ribo-Zero rRNA Removal Kit (Illumina). Sequence
libraries for mRNA were generated using TruSeq RNA Library Prep Kit (Illumina). The
cDNA fragments of 300 bp in size were isolated and purified using 2% E-gel SizeSelect
gels (Invitrogen). The libraries were then pair-end sequenced on Illumina HiSEQ platform
to a depth of 41-70 million reads per sample. The sequencing results were mapped using
Tophat2 software to GRCh37/UCSC-hg19 genome assembly with the gene model provided
by “hg19 UCSC Known Genes” [13]. Guidance cues with non-zero counts were included for
subsequent analyses.
5.2.5 Pathway analysis
Pathway analysis was done using annotation of Kyoto Encyclopedia of Genes and
Genomes (KEGG) [14] with R package “gage” [15]. Gene symbols are converted to En-
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trez ID using data base provided in R package “org.Hs.eg.db”. Pathway “Axon guidance”
(KEGG accession: hsa04360) was tested under the null hypothesis that this pathway is not
significantly regulated. A p-value of less than 0.05 was considered enough for rejecting the
null hypothesis. The analysis was visualized using R package “pathview”.
5.2.6 Quantitative polymerase chain reaction
RNA isolation was done as described for the gene expression microarray method. Briefly,
RNA isolation was done using the miRNeasy Mini Kit (Qiagen), while random hexamers
served as primers for first strand cDNA synthesis. The polymerase chain reaction (PCR) was
run on a CFX384 Real-Time PCR Detection System and SYBRgreen (Applied Biosystems)
was used to detect amplification of the PCR product. A list of primer sequences can be found
in Table 1. We analyzed 4 housekeeping genes in the THP-1 monocytes and macrophages.
Three out of four were unchanged by differentiation (Supplementary Figure 2A). From
this GAPDH was chosen for the analysis of primary monocytes differentiated to macrophages.
Comparing different donors, showed that GAPDH mRNA did not change upon differentiation
(Supplementary Figure 2B). Therefore, the presented change in mRNA expression was
calculated by the comparative copies per GAPDH.
5.2.7 Mapping of “ACUAA” 5mer and miRNA target sites in 3’UTR of transcripts
Genome coordinates of 3’UTRs of NGC transcripts were retrieved from Ensembl an-
notation “EnsDb.Hsapiens.v75” [16] using R package “GenomicFeatures” [17]. Sequences of
3’UTRs were obtained using R package “ensembldb” [18]. Motif “ACUAA” was matched
against 3’ UTR sequence using R package “Biostrings” [19]. Counts of the 5mer were stored
and related to the regulation of NGCs. Genome coordinates of QRE motifs were also stored
for subsequent analysis. To examine the possibility that QKI could protect 3’UTRs of NGCs
from targeting of miRNA, we collected genomic coordinates of miRNA target sites from
“miRbase.org” [20] and of QRE 5mers from the previous mapping. The miRNA target sites
were filtered by the miRNA expression levels given from the monocyte miRNA microarray
(GSE52986 [10]; Supplementary table 1 Dataset 4; expression level in top 50%) and by
miRNA targeting strength score (miRsvr score ¡ -1). QRE mappings were cross-validated
by experimentally confirmed interaction of QKI and target mRNA using eCLIP-seq method
(ENCSR366YOG [12]) by overlaying genomic range of narrow peak signals to QRE map-
pings. Next, we scanned for proximity of validated QRE and filtered miRNA targeting sites
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SEMA7A 3’UTR GGCATCGATGACCCAAGACT TGGGAGCATCGCTGCATTTA
TNFA CCTCTCTCTAATCAGCCCTCTG GAGGACCTGGGAGTAGATGAG
Table 1. List of primers used
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using R package “GenomicRanges” [17]. We considered a physical distance of less than 20
nucleotide as proximity. Final results were visualized with R package “Gviz” [21].
5.2.8 RNA immunoprecipitation
HEK293T cells were transfected with a human QKI5 and human SEMA7A 3’UTR-
reporter plasmid (SwitchGear Genomics) through the use of polyethylenimine (3 μg/1μg
DNA; Polysciences Inc). Twenty-four hours after transfection RNA-immunoprecipitation
was performed using Millipore’s validated RIPAb+QKI-5 kit according to manufacture in-
structions.
5.2.9 Immunoblot analysis
Suspended cells were collected, spun down, washed with cold PBS and lysed in 100ul of
Novex Tris-Glycine SDS sample buffer (ThermoFisher, LC2676). Adhered cells were washed
with cold PBS, lysed in another 100 μL of sample buffer, collected and combined with
lysates from suspended cells. After sonication, samples were centrifuged at 14000 rpm for
10 minutes at 4°C. Equal amounts of protein samples, measured with Nanodrop (Thermo
Fisher), were denatured using DTT and heating at 95°C for 10 minutes, followed by size
separation on a 10% Mini-PROTEAN gel (Biorad, 4561033). Proteins were transferred
to PVDF membranes (Biorad, 1074156) using the Trans-Blot Turbo system (Biorad) after
which membranes were blocked in TBST-5% Milk. Membranes were incubated with human
SEMA7A antibody (1:10000, AF 2068, R&D systems) or GAPDH antibody (1:1000, 5174,
Cell signaling Technology) in blocking buffer overnight at 4°C. Thereafter membranes were
shortly washed and incubated with HRP-labeled secondary antibodies (1:5000, Dako) for
1 hour at room temperature. After thorough washing with TBST, protein bands were
visualized using Western lightning ECL (PerkinElmer, NEL1030001EA) and the ChemiDoc
Touch Imaging System (Biorad).
5.2.10 Statistical analysis
Comparison between 2 means were done with 2-tailed unpaired Student’s t-test. A




5.3.1 Axonal guidance pathway is significantly altered in monocyte to macrophage
differentiation
In order to assess the relevance of the axon guidance pathway in monocyte to macrophage
differentiation, we extracted transcriptome profiling data of human peripheral blood mono-
cytes and monocyte-derived macrophages (Supplementary Table 1 Dataset 1) and of
THP-1 cells and THP-1 macrophages (Supplementary Table 1 Dataset 2). KEGG
pathway analysis on the 2 datasets (Supplementary Figure 3 and 4) showed significant
(p=0.016 and 0.007 respectively) regulation of gene expression in the axon guidance path-
way (KEGG: hsa04360) during monocyte-to-macrophage differentiation (Table 2). Since
downstream signaling in the axon guidance pathway is initiated by binding of guidance cues
and their receptors on the cell surface, we next focused on the regulation of NGC ligands
and their receptors during monocyte-to-macrophage differentiation.
Pathway Accession Biological Process P value
Axon guidance KEGG: hsa04360 Human monocyte-macrophage 0.016
Axon guidance KEGG: hsa04360 THP1-THP1 macrophage 0.007
Table 2. Pathway analysis of the transcriptome change in experimental monocyte-
macrophage differentiation
5.3.2 Detectable expression of NGCs in monocytes and macrophages
To gain insight in the genes with significant expression, we summarized the transcrip-
tome data obtained from both microarray and RNAseq methods. Significant expression of
NGCs from different classes was detected in primary human monocytes and macrophages
(Figure 1A, Supplementary table 1 Dataset 1) and in THP1 cells and THP1 macrophages
(Supplementary Figure 5, Supplementary table 1 Dataset 2). To examine the com-
parability between observations of the 2 methods, we plotted the relative probe signal inten-
sity representing expression of NGCs in descending order and differentially labeled the ones
that were detectable in RNAseq data (Figure 1B and 1C). As we have n = 3 in microar-
ray method, the signals from microarray methods gives good overview of the expression of
NGCs and its variation. The RNAseq experiment, as a method with better sensitivity and
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larger dynamic range, provides extra information on the likelihood of whether NGCs with
borderline expression are actually expressed. Several NGCs, including SEMA4D, SEMA7A,
NRP1, NRP2, PLXNA1, PLXNA3 and NTN1 that are known to be involved in monocyte-
macrophage physiology, could be detected with both the micro array and RNAseq. However,
some NGCs like EPHA4 and UNC5B were detected with RNAseq but have a low expression
in the microarray. This might be due to the intrinsic character of a higher dynamic range
of RNAseq. Overall it can be concluded that numerous NGCs are expressed by monocytes
and macrophages.
5.3.3 Regulation of NGCs in monocyte to macrophage differentiation
Next we assessed the changes in expression of NGCs in monocyte-to-macrophage differ-
entiation in vitro in 3 datasets (Mono-macro RNAseq, Mono-macro microarray and THP-1
microarray). Fold changes in NGC expression in macrophages relative to monocytes are
depicted in a heatmap and shown in Figure 2A. Around half of all NGCs were detectable
with RNAseq (36/74, Figure 2B). Of the detected NGCs, 12.2% were upregulated (9/74),
while 10.8% were downregulated (8/74) in at least 2 of the 3 datasets (Figure 2A and
2B). Regulation of NGC expression was confirmed by qPCR (Figure 3 and Supplemen-
tary Figure 6). The list of regulated genes is shown in Table 3 and a brief annotation of
the known relevant functions are also provided. Overall can be concluded that the results
obtained from different methods had good agreement with each other.
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Figure 1. Expression of NGCs in human monocytes/macrophages
(A) Heatmap of mRNA expression of NGCs in human monocytes/macrophages detected by mi-
croarray expressed in log2 scale. (Lighter blue indicates higher expression; n=12; * p < 0.05) (B, C)
Average expression levels of mRNA NGCs in human monocytes (B) or macrophage (C) detected by
microarray ranked by expression in monocytes from high to low. RED: detectable in RNAseq. Data














NTNG2 Down Down* - ++ Netrin Function unknown
ADORA2B Up - Up* ++
Netrin
Receptor
ADORA2B has a pro-
inflammatory role through
production of cAMP. [22]
EPHA1 Down Down* Down* ++
Ephrin
Receptor
EPHA1 is a receptor for EFNA1,
which promotes monocyte adhe-
sion. [23]
EPHB3 Down Down* - +/-
Ephrin
Receptor
EPHB3 is a receptor for EFNB2,
which promotes monocyte adhe-
sion. [24]
EPHB4 Down Down* Down* +
Ephrin
Receptor
EPHB4 is a receptor for EFNB2,
which promotes monocyte adhe-
sion. [24]
SEMA3C Up - Up* +++ Semaphorin
SEMA3C enhances deformability
of DCs, promoting migration of
DCs. [25]
SEMA4A Down Down Down ++++ Semaphorin
SEMA4A promotes expression of
VEGFA in monocytes. [26]
SEMA4B Down Down* - +++ Semaphorin Function unknown
SEMA4D Down Down* Down* ++++ Semaphorin
AntiSEMA4D treatment augments
pro-inflammatory function of mφ
[27]; SEMA4D itself also promote
differentiation of monocyte to al-
ternatively activated mφ [28].
SEMA4F Up Up* Up* - Semaphorin Function unknown
SEMA6A Down - Down* + Semaphorin
SEMA6A signals via PLXNA4
leading to repulsion of cell migra-
tion. [29]
SEMA7A Up Up* Up* +/- Semaphorin
SEMA7A works as a stimulator of
monocytes, promoting the produc-
tion of GM-CSF. [3]
NRP1 Up Up* Up* ++ Neuropilin
NRP1 is a co-receptor of Class III
semaphorins, which are repellents
for monocyte adhesion and migra-
tion.[4] NRP1+ mφ migrate to-
wards SEMA3A expressed in hy-
poxic niches of tumors. [30]
NRP2 Up Up* Up* ++ Neuropilin
NRP2 is a co-receptor of Class III
semaphorins, which are repellents
for monocyte adhesion and migra-
tion. [4] NRP2 is required for
phagocytosis of mφ. [31]
PLXNA1 Up Up* Up* ++ Plexin
PLXNA1 is a receptor of Class III
semaphorins, which are repellents
for monocyte adhesion and migra-
tion. [4] PLXNA1 facilitates mi-
gration of tumor associated mφ
into hypoxic niche. [30]
PLXNA3 Up Up* Up* + Plexin
PLXNA3 is a receptor of Class III
semaphorins, which are repellents
for monocyte adhesion and migra-
tion. [4]
PLXND1 - Up* Up* +++ Plexin
SEMA3E-PLXND1 axis promotes
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Table 3. Overview of regulated genes and their known relevant function
Annotation of functions of the NGCs that showed consistent changes in at least 2 of the 3 monocyte-to-
macrophage differentiation datasets. (* p < 0.05; mφ: macrophages)
Figure 2. Change of NGC expression during monocyte to macrophage differentiation
(A) Heatmap of fold change of NGC expression in log2 scale (GREEN: upregulation; RED: downreg-
ulation). (Mono-macro RNAseq n=1; mono-macro microarray n=12; THP-1 microarray n=3) (B)
Summary of NGC expression regulation during monocyte/macrophage differentiation.
5.3.4 Quaking contributes to the regulation of NGCs
Next we investigated the role of the RNA-binding protein QKI in the regulation of NGC
expression. Similar to NGCs, QKI was originally identified for its function in the central
and peripheral nervous system, while further studies revealed that QKI was ubiquitously
expressed [8]. In addition, QKI is known as one of the key master regulators controlling gene
expression change during monocyte-to-macrophage differentiation [6]. QKI is upregulated
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Figure 3. Confirmation of regulation of NGC expression
Quantitative PCR analysis of NGCs mRNA isolated from human monocytes or macrophages. Gene
expression is expressed as copies per GAPDH in a log2 scale. Data Mean ± SEM; n=3; * p < 0.05).
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in pro-inflammatory macro-phages, modulating the expression of various genes that have
important functions in macrophage biology. To gain insight into whether QKI is implicated
in regulating NGC expression in monocyte-to-macrophage differentiation, we exploited ma-
terial from a patient with a haplo-deficiency of QKI (patient) and her unaffected sibling. The
haplo-deficiency is caused by chromosomal translocation that occurred in the intron of the
QKI gene. The transcription of a complete QKI gene is disrupted leading to reduced QKI
expression. Transcriptome profiling was done using RNAseq method in both freshly isolated
peripheral blood monocytes and monocyte-derived macrophages (Figure 4A, Supplemen-
tary table 1 Dataset 3). Due to the limitation of numbers of samples by nature, we could
only examine change of NGC expression by putting an arbitrary threshold (±log¬20.4¬).
Fold changes of NGC expression comparing the patient and her sibling showed SEMA7A to
be consistently regulated in monocytes and monocyte-derived macrophages (Figure 4B).
Expression of SEMA7A was decreased in both patient monocytes and macrophages compared
to monocytes and macrophages from her sibling. To extend results obtained with the QKI
haploinsufficient patient, we reduced QKI expression in primary human monocytes harvested
from healthy controls using GapmeR antisense oligonucleotides that either targeted QKI for
degradation or are scrambled as a control [6]. The GapmeR antisense oligonucleotides were
present during the differentiation of the primary monocytes to macrophages. Although the
GapmeR-mediated reduction in QKI expression varied a lot per donor, it nonetheless en-
abled us to validate a positive correlation between QKI and SEMA7A expression (Figure
4C).
5.3.5 QKI binds to cluster of miRNA target sites in SEMA7A 3’UTR
One of the well-defined mechanisms by which QKI affects gene expression is to stabilize
gene transcripts by binding to quaking response element (QRE) motifs on their 3’ UTRs
[7, 8]. A QRE consists of a core sequence “ACUAA” and a half site “UAAY” [7]. We
therefore explored the fold change of NGC expression between the patient and her sibling
in relation to the number of “ACUAA” core sequences in 3’UTRs of NGCs (Figure 5A,
B). Surprisingly, the analysis revealed no clear correlations between the fold change of the
NGCs and QRE counts, so that existence of QRE sequence alone did not explain the effect
of QKI to enhance expression of SEMA7A. We then explored the possibility whether binding
of QKI to 3’ UTRs of mRNAs might mask the sites for microRNA (miRNA) interactions by
scanning proximal pairs of miRNA targeting sites and QRE motifs in 3’UTRs of NGC genes.
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Figure 4. Regulation of NGC expression by QKI
(A) Heatmap of expression of NGCs in monocytes and macrophages determined by RNAseq from
QKI patient and sibling in log2 scale (Lighter blue indicates higher expression; n=1). (B) Fold
change of NGC expression comparing QKI patient’s monocyte and macrophage to her sibling’s.
(C) In macrophages treated with GapmeR antisense oligonucleotides, there is a significant positive
correlation between QKI and SEMA7A expression, measures by quantitative PCR analysis. Gene
expression is expressed as copies per GAPDH.
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The scanning results revealed that only in the 3’UTR of the SEMA7A gene such proximity
between QREs and miRNA targeting sites was present (Figure 6). The QRE at the very
end of SEMA7A’s 3’UTR overlaps with QKI-DNA interactions sites from both duplicates
from eCLIP-seq, increasing the confidence that this QRE is actively used. In proximity
of the QRE, a targeting site of a cluster of miRNAs exists. It is therefore probable that
QKI and miRNAs antagonistically regulate expression of SEMA7A in a proposed broader
concept of RBP-miRNA interaction. Moreover, the QRE was experimentally verified with
CLIP-seq methods in the K562 myeloid cell line (Figure 6, Supplementary table 1
Dataset 5). This observation further supported our theory that QKI enhances SEMA7A
transcript stability by competing with the binding of miRNAs in the 3’UTR of SEMA7A. We
next sought to determine whether QKI can directly bind to 3’UTR of SEMA7A using RNA-
immunoprecipitation experiment. For this we used Hek293T cells in which we overexpressed
both QKI and a construct containing the 3’UTR of SEMA7A. QKI is known to bind RNA
of QKI itself, which we also observed (Figure 7A). When analyzing the SEMA7A 3’ UTR
indeed, RNA of SEMA7A 3’UTR was highly enriched in the QKI-antibody precipitated RNA
fraction (Figure 7B), indicating binding of QKI to the 3’ UTR of SEMA7A.
5.3.6 SEMA7A induced monocyte differentiation to pro-inflammatory macrophage
Before further exploring the functional important of SEMA7A for macrophages, we
validated the increase of SEMA7A upon monocyte into macrophage differentiation seen at
mRNA level at protein level (Figure 8A-B). To gain insight into the function of SEMA7A
in monocyte differentiation into macrophage we silenced SEMA7A expression in mono-
cytes using lentiviral shRNA vectors targeting the SEMA7A mRNA and non-SEMA7A tar-
geting control shRNA. These monocytes were differentiated into macrophages. Targeted
reduction of SEMA7A in monocytes did not seems to affect the capacity of the mono-
cytes to differentiate into macrophages, but did show more elongated anti-inflammatory
macrophage morphology (Figure 8C). To confirm the hypothesis that loss of SEMA7A in-
duced a more anti-inflammatory phenotype, we investigated expression levels of TNFα (pro-
inflammatory macrophage cytokine) and IL-10 (anti-inflammatory macrophage cytokine).
Indeed, SEMA7A knockdown macrophages showed a ratio that was more anti-inflammatory
compared to control macrophages (Figure 8D).
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Figure 5. QKI response elements in NGC transcripts
(A-C) Scatter plots of QRE motif counts in the 3’UTRs of NGCs against log2 fold change of NGC
expression in monocytes and macrophages. In A monocytes and macrophages combined. In B
and C monocyte shown separately with individual NGCs. Existence of quaking response element




Figure 6. Visualization of genomic annotations in 3’UTR region of SEMA7A gene
The region in 3’UTR region of SEMA7A in the human genome (hg19 Chromosome 15 q24.1, bp
74,701,500 – 74,703,000) is annotated with aspects of miRNA binding sites, QKI targeting sites
(experimental evidence based), QKI response element (QRE, in silico alignment of “ACUAA motif”)
and SEMA7A exon. The microRNA binding information was extracted from “miRbase” and was
filtered by expression in monocytes/macrophages and miRNA interaction score. Interactions between
RNA binding proteins (RBPs) to genomic DNA were obtained from technique duplicates of eCLIP-
seq in the myelogenous K562 cells.
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Figure 7. RNA-immunoprecipitation showing quaking protein binding to the 3’UTR
of SEMA7A
(A) RNA-immunoprecipitation in Hek293T cells overexpression QKI5 using an IgG control or QKI5
antibody. QKI5 and GAPDH mRNA abundance in immune-precipitated fraction was determined
by qPCR. Results are presented relative to IgG immunoprecipitation. Data Mean ± SEM; n = 5;
* p < 0.05. (B) RNA-immunoprecipitation in Hek293T cells overexpression QKI5 and 3’UTR of
SEMA7A using an IgG control or QKI5 antibody. SEMA7A 3’UTR and GAPDH mRNA abundance
in immune-precipitated fraction was determined by qPCR. Results are presented relative to IgG
immunoprecipitation. Data Mean ± SEM; n=3; * p < 0.05.
5.4 Discussion
In this study, we identified the axon guidance pathway as a novel pathway regulated
in the monocyte-macrophage differentiation process. We illustrated the regulation of NGCs
and annotated the shift in functionality contributed by the regulation of axon guidance
pathway based on the currently available knowledge from the literature. We also investi-
gated the involvement of QKI in regulation of SEMA7A in a miRNA dependent manner.
The different platforms analyzed to detect NGC gene expression in human monocytes and
macrophage showed numerous NGCs expressed. NTN1 was low, but significant expressed,
it was detectable with the RNAseq method and had a signal above background in the mi-
croarray. The relevance of NTN1 secreted from macrophages has been shown to inhibit
their emigration in autocrine or paracrine manner [5]. NGCs like EPHA4 and UNC5B were
detected with RNAseq but had low expression in microarray. This could be due to the in-
trinsic character of RNAseq that it has a larger dynamic range. We found many members
of the semaphorin family expressed by monocytes and macrophages, both ligands and re-
ceptors. For example SEMA4D (CD100), an immune semaphorin, was identified with both
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Figure 8. Role for SEMA7A in monocyte differentiation into pro-inflammatory
macrophages
(A) Bright field microscope images from THP1 monocytes and macrophages. (B) Representative im-
munoblot analysis of SEMA7A or ACTB (loading control) in protein lysates THP1 monocytes and
macrophages. (C) Bright field microscope images from THP1 macrophages transduced with anti-
SEMA7A shRNA (sh-SEMA7A) or scrambled shRNA (sh-Ctrl). Elongated phenotype indicated by
#. (D) Ratio of TNF-α and IL-10 mRNA expression of sh-SEMA7A or sh-Ctrl THP1 macrophages.
Data Mean ± SEM; n=4; * p < 0.05.
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methods and has been shown to mediate monocyte adhesion and differentiation [28, 33].
Expression of the SEMA7A-PLXNC1 ligand-receptor pair, which was recently shown to be
involved in atherogenesis [34], was also detected. During the differentiation of both human
primary monocytes to macrophages and THP-1 cells to THP-1 macrophages, upregulation
of receptors for Class III semaphorins, namely NRP1, NRP2, PLXNA1 and PLXNA3, was
observed. Previous studies have shown that activation of the SEMA3-PLXNA-NRP axis
is reduced in monocyte-endothelium interactions, although SEMA3A-NRP1 binding could
sustain directed migration of macrophages under hypoxic condition in tumor tissues [4, 30].
Upregulation of these receptors could sensitize the response of macrophages to the guid-
ance signals provided by Class III semaphorins. In addition, we observed downregulation
of membrane bound Class IV semaphorins, namely SEMA4A, SEMA4B and SEMA4D in
macrophages compared to monocytes. SEMA4D is known to promote differentiation of alter-
natively activated macrophages, while anti-SEMA4D treatment increases the population of
classically activated macrophages in mammary carcinoma tissue and induces the production
of inflammatory cytokines [27, 28]. This is in line with our finding of SEMA4D downregula-
tion in macrophages, considering GM-CSF stimulation is a model of monocyte-to-classical-
macrophage differentiation. In contrast to SEMA4D, SEMA7A expression was increased in
monocyte to macrophage differentiation. Our studies indicate that SEMA7A itself serves as
a stimulator for monocytes to differentiated into a pro-inflammatory macrophage. These ob-
servation are in line with the findings of Holmes et al, that SEMA7A results in an increased
production of inflammatory cytokines and GM-CSF, which could be a potential positive
feedback mechanism for monocyte activation and differentiation [3]. Indeed, neutralization
of SEMA7A using an antibody reduced the number of pro-inflammatory macrophages in a
murine viral myocarditis model [35]. QKI was shown to be a critical regulator of monocyte
to macrophage differentiation [6]. During the differentiation, expression of QKI increases,
triggering a range of effects, including transcript stabilization and alternative splicing. We
investigated whether regulation of some NGCs could be mediated by QKI by comparing
the NGC expression in monocytes and macrophages of the QKI haplodeficient patient and
her sibling. As described previously, SEMA7A was upregulated in monocyte-to-macrophage
differentiation. The comparison of the patient and her sibling revealed that SEMA7A was
decreased in both monocytes and macrophages. QRE motifs were found in 3’UTR of the
SEMA7A transcript, which are necessary for the transcript stabilization effect of QKI. How-
ever, counts of QRE motifs alone could not explain the regulation of SEMA7A expression
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by QKI activity, indicating that extra factors are involved in the regulation of SEMA7A by
QKI. It has been proposed that QKI could stabilize transcripts of miRNAs thereby regulat-
ing gene expression [36]. However, such mechanism is unlikely to be applicable in our case,
since SEMA7A would have been upregulated in patients if any miRNA targeting SEMA7A
was stabilized by QKI. Therefore, we explored the QRE motif region and found a cluster of
miRNA target sites in proximity of QRE. This observation pointed to the possibility that the
competitive binding of QKI to miRNA targeting sites is the underlying mechanism for regu-
lation of SEMA7A by QKI. Such a concept has been reported for other RBPs before [37, 38],
but not yet for QKI. We now show that QKI binds to the 3’UTR of SEMA7A. Further stud-
ies are needed to confirm the competitive access of QKI and miRNA to 3’UTR of SEMA7A
to be responsible for the observed changes in SEMA7A expression. In summary, during
monocyte-to-macrophage differentiation, axonal guidance pathway was significantly regu-
lated with changes in expression of several NGC ligands and receptors. Regulation of NGCs
in monocyte-to-macrophage differentiation fits the functional adaption that is necessary for
the specialized role of macrophages. So far, a role for SEMA7A in regulating macrophage
polarization into an pro-inflammatory macrophage. In the future, the changes in gene expres-
sion can be further studied in the context of diseases where monocyte-macrophage biology
plays a role.
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No. Material Description Type
1 Human monocyte Patients with atherosclerosis and healthy controls online
2 THP-1 cell line THP-1 cells and THP-1 macrophage in house
3 Human monocyte QKI haploinsufficiency patient and her sibling in house
4 Human monocyte Healthy controls online
5 K562 cell line Isogenic duplicates of QKI eCLIP-seq in K562 cells online
No. Accession Differentiation Method Profiling Method
1 GSE9820 20h Plastic Culture Microarray (mRNA)
2 GSE74887 PMA (100 nM) for 8 days Microarray (mRNA)
3 GSE74978 GM-CSF (5 ng/ml) for 7 days RNAseq (mRNA)
4 GSE52986 NA Microarray (miRNA)
5 ENCSR366YOG NA eCLIP-seq
Supplementary table 1. Summary of the data accessions used in relation to the exper-




Assessing purity of monocyte isolation. A sample of peripheral blood mononuclear cells (top), of
which the CD14-positive selected cells (middle) where isolated and the non-selected cells (bottom)
were incubated with anti-human CD14 (APC, 1:200, Clone Mφ P9, cat no. 345787, BD), measured
by flow cytometry LSR-II (BD Biosciences, Vianen, The Netherlands), and analyzed using FlowJo




Assessing multiple housekeeping genes. Quantitative PCR analysis of different housekeeping mRNA
isolated from THP1-monocytes or -macrophages (A) or primary monocytes or macrophages (B).
Gene expression is expressed Ct values. (A) each color is different housekeeping gene measured in
3 independent THP1 monocytes and 3 independent THP1 macrophages samples. (B) each color




Visualization of the axon guidance pathway and the gene expression changes during human
monocyte-to-macrophage differentiation. The gene expression in monocytes and macrophages was
obtained from GEO database (Accession: GSE9820, Supplementary table 1 Dataset 1). Data from




Visualization of the axon guidance pathway and the gene expression change during THP-1 cell
to THP-1 macrophage differentiation. The changes in gene expression in THP-1 cells to THP-
1 macrophages were profiled in on the “Affymetrix GeneChip Human HJAY Array” (Accession:





Expression of NGCs in human monocyte/macrophage cell line. Heatmap of expression of NGCs
in THP1 cells/THP1 macrophages in a log2 scale. Light blue: higher expression; dark blue: lower




Confirmation of regulation of NGC expression. Quantitative PCR analysis of NGCs mRNA isolated
from THP1-monocytes or -macrophages. Gene expression is expressed as copies per GAPDH in a





Prediction power on cardiovascular disease of neuroimmune
guidance cues expression by peripheral blood monocytes de-
termined by machine learning methods
Zhang, H., Bredewold, E. O. W., Vreeken, D., Duijs, J., de Boer, H. C., Kraaijeveld,A. O.,
Jukema, J. W., Pijls, N. H., Waltenberger, J., Biessen, E. A. L., van der Veer,E. P., van
Zonneveld, A. J. and van Gils, J. M.




Atherosclerosis is the underlying pathology in a major part of cardiovascular disease,
the leading cause of mortality in developed countries. The infiltration of monocytes into the
vessel walls of large arteries is a key denominator of atherogenesis, making monocytes ac-
countable for the development of atherosclerosis. With the development of high-throughput
transcriptome profiling platforms and cytometric methods for circulating cells, it is now fea-
sible to study in-depth the predicted functional change of circulating monocytes reflected by
changes of gene expression in certain pathways and correlate the changes to disease outcome.
Neuroimmune guidance cues comprise a group of circulating- and cell membrane-associated
signaling proteins that are progressively involved in monocyte functions. Here, we employed
the CIRCULATING CELLS study cohort to classify cardiovascular disease patients and
healthy individuals in relation to their expression of neuroimmune guidance cues in circu-
lating monocytes. To cope with the complexity of human datasets featured by noisy data,
nonlinearity and multidimensionality, we assessed various machine-learning methods. Of
these, the linear discriminant analysis, Näıve Bayesian model and stochastic gradient boost
model yielded perfect or near-perfect sensibility and specificity and revealed that expression
levels of the neuroimmune guidance cues SEMA6B, SEMA6D and EPHA2 in circulating
monocytes were of predictive values for cardiovascular disease outcome.
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Cardiovascular diseases (CVD) remain a leading cause of death in the more economi-
cally developed countries, despite improvements in surgical and drug treatments. Much of
the CVD-related mortality and morbidity is attributable to atherosclerosis [1]. Atherosclero-
sis is a systemic chronic inflammatory and immune disease [2,3]. Monocytes and their derived
macrophages play a key role in the development of atherosclerosis. Under conditions of dys-
lipidemia and chronic systemic inflammation, circulating monocytes and the endothelium
become activated, resulting in monocyte infiltration and differentiation into macrophages in
the vessel wall. Upon the excessive uptake of lipids, these macrophages become foam cells
and participate decisively in the development and exacerbation of atherosclerosis, coronary
stenosis and its clinical sequela, such as acute myocardial infarctions [3-7]. Neuroimmune
guidance cues (NGCs) comprise the netrin, semaphorin, ephrin and slit families of proteins of
ligands and receptors, which were originally characterized to direct cell and axon migration
during neural development. In the last two decades, it has become increasingly clear that
these proteins can also play a major role in (pathological) immune responses by directly
regulating leukocyte trafficking and directly impacting the pathogenesis of atherosclerosis
[8-10]. Indeed, numerous studies using murine atherosclerosis models have found multi-
faceted roles of NGCs in the development of atherosclerosis [11-15]. In addition, several
observations also support a role for NGCs in human CVD. For instance, three NGC genes
are located on human chromosome 1, in the locus that has been identified as the premature
myocardial infarction susceptibility locus [16]. In addition, the axonal guidance pathway
is found enriched with genetic variants that have significant associations with CVD, and
several novel genetic risk loci for CVD contain NGCs genes [17,18]. However, whether the
monocytic expression of NGCs is informative for human CVD has not been described yet.
Transcriptomics can reveal key alterations in biological processes causing human diseases,
thereby present novel instruments that are not only useful for the understanding of the
disease mechanisms but, also, for molecular diagnosis and clinical therapy [19]. Since mono-
cytes are among the culprit cells of atherosclerosis development, monocytic expression levels
of NGCs could provide insights into the underlying mechanisms in atherosclerosis develop-
ment and can be used to improve the evidence-based treatment of CVD to reduce the global
burden of this disease. The CIRCULATING CELLS study was designed to study the role
of several cellular mediators of atherosclerosis as biomarkers of CVD to predict the suscep-
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tibility of patients to the progression of CVD [20]. By applying different machine-learning
methods (also known as predictive modeling methods) on the gene expression data of pe-
ripheral monocytes from the CIRCULATING CELLS study cohort, we investigated whether
monocytic NGC expression is informative to distinguish between healthy individuals and
CVD patients. As machine-learning methods are developed to explore complex relationships
between predictors and outcomes, they are suitable tools to tackle the difficulties due to the
complexity of human datasets featured by noisy data, nonlinearity and multidimensionality.
Some machine-learning methods take simplistic approaches and work with linear relation-
ships between features and outcomes, while other methods are more complex and are able
to capture nonlinear patterns and to tolerate a low information-noise ratio, owing to the
difference of their pre-assumptions and learning logics. We compared the performance of
multiple modeling methods to explore the best predicting potential of our dataset. In our
study, we included commonly used models like logistic regression and linear discriminant
analysis, as well as more complex nonlinear models and tree-based models. Linear models,
like partial least square, have supervised dimension reduction functionality, which benefits
model performances in the case of high between-feature correlations. Nonlinear models, like
Näıve Bayesian, make probabilistic calls based on the information provided by the features
independently, possibly performing better in situations when between-feature correlations
are low. In addition to modeling of the data itself, stochastic gradient boost also models
the residuals, thereby increasing the learning ability when the information-noise ratio is low.
We compared the results of the different modeling methods to gain insights on the nature of
the dataset. Altogether, this allowed us to give a proof of concept that the expression of a
small set of functional genes can be a prediction value for complex diseases like CVD.
6.2 Materials and Methods
6.2.1 Study Population
The study population consists of a subgroup of 369 patients from the CIRCULATING
CELLS study cohort [20] (Figure 1). In brief, CIRCULATING CELLS was a prospective
multicenter study in which patients scheduled for coronary angiography due to CVD were
included. For this subgroup, extensive clinical characteristics were recorded (Table 1), and
the transcriptomes of purified circulating CD14+ monocytes were profiled. To minimize the
potential influence of the presence of profound acute myocardial ischemia on monocytic gene
expression profiles, patients with ST-elevation myocardial infarction (STEMI) were excluded.
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Figure 1. Flowchart of predictive modeling using neuroimmune guidance cues (NGCs)
Subjects in the CIRCULATING CELLS cohort were recruited based on inclusion criteria. The
clinical characteristics were collected, peripheral blooded CD14-positive monocytes were isolated,
and their transcriptomes were profiled. The expression of neuronal guidance cues was subset. The
individuals were randomly assigned to the Training Set or Test Set for external assessment of the
model performance. Classification models that were built on the Training Set data and model
performance were internally assessed with cross-validation. Finally, we made comparisons between
the models and gained insights on the choice of model and features.
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Clinical Characteristics All CVD Healthy
Demographic data
Number (male/female) 368 (273/95) 356 (264/92) 12 (9/3)
Age 61.8 (±10.4) 62.2 (±10.3) 49.2 (±6.3)
BMI 27.3 (±4.3) 27.4 (±4.3) 23.7 (±2.3)
Coronary risk factors
Hypertension 231 (63%) 231 (0.65) 0 (0)
Hypercholesterolemia 70 (19%) 65 (0.18) 5 (0.42)
Diabetes 77 (21%) 77 (0.22) 0 (0)
Current smoker 73 (20%) 73 (0.21) 0 (0)
Family MI history 141 (39%) 137 (0.39) 4 (0.33)
Previous MI 112 (30%) 112 (0.31) 0 (0)
Positive family history 157 (43%) 152 (0.43) 5 (0.42)
Therapeutic decision
PTCA 130 (35%) 130 (0.37) 0 (0)
CABG 32 (9%) 32 (0.09) 0 (0)
NYHA Classification
NYHA Class I 248 (67%) 236 (0.66) 12 (1)
NYHA Class II 78 (21%) 78 (0.22) 0 (0)
NYHA Class III 26 (7%) 26 (0.07) 0 (0)
NYHA Class IV 16 (4%) 16 (0.04) 0 (0)
Current medication
β-blocker 228 (69%) 228 (0.72) 0 (0)
Ca-antagonist 95 (29%) 95 (0.30) 0 (0)
Aspirin 260 (79%) 260 (0.82) 0 (0)
Vitamin K antagonist 29 (9%) 29 (0.09) 0 (0)
Low molecular weight heparin 10 (3%) 10 (0.03) 0 (0)
ADP receptor blocker 168 (51%) 168 (0.53) 0 (0)
ACE inhibitor 116 (35%) 116 (0.36) 0 (0)
ATII receptor blocker 71 (22%) 71 (0.22) 0 (0)
Diuretic 76 (23%) 76 (0.24) 0 (0)
Statins 252 (77%) 252 (0.79) 0 (0)
Table 1. Clinical characteristics of the CTMM patient cohort
Values are N ± SD or N (%). Abbreviations: BMI—body mass index, MI—myocardial infarction,
PTCA—percutaneous transluminal coronary angioplasty, CABG—coronary artery bypass graft,
NYHA—New York Heart Association, and CVD—cardiovascular disease.
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Additional exclusion criteria were age ¡ 18 years, inability to give informed consent, suspected
drug or alcohol abuse, serious concomitant disease, serious recent infectious disease in the
last 6 weeks or suspected elevated state of the immune system and noncooperativeness.
The study was approved by the medical ethical committees of the participating centers and
conformed to the Declaration of Helsinki. All patients received oral and written information
about the objectives of the study and provided written informed consent.
6.2.2 Isolation of Peripheral Blood CD14-Positive Monocytes
The full procedures for the isolation of peripheral blood CD14-positive monocytes were
described previously [20]. Briefly, 60 mLof EDTA blood was collected from patients via
the arterial sheath catheter. Peripheral blood mononuclear cells (PBMCs) were isolated by
density gradient centrifugation over Ficollpaque Plus (GE Healthcare, Diegem, the Nether-
lands). For further purification of monocytes, the PBMC fraction was incubated with mag-
netic beads coated with anti-CD14 antibodies (BD Biosciences, Breda, the Netherlands), and
monocytes were purified with a MACS separation system according to the manufacturer’s
instructions (BD Biosciences, Breda, the Netherlands). Cells in CD14-positive fraction were
resuspended, lysed in Trizol and aliquoted. The aliquots were stored at -80 °C for RNA
isolation.
6.2.3 RNA Isolation and Microarray Analysis
Monocyte samples were shipped to Eurofins Genomics for semiautomated extraction of
RNA using RNeasy 96-well plates (Qiagen). RNA samples were quantified using a Beckman
Coulter DTX880 system, and only samples that displayed RIN values > 9 (Agilent Bioana-
lyzer) were included. Labeled RNA was prepared and used on the array for hybridization.
Hybridized chips were scanned by Illumina BeadStation (Illumina, Inc., San Diego, CA,
USA). Raw image analysis and signal extraction was performed with Illumina Beadstudio
Gene Expression software with default settings (no background subtraction). Data were
exported as text files. The gene expression profiling data were integrated and archived using
the self-developed software “Circucel” [20]. The expressions of NGC ligands and receptors
were extracted along with the phenotypic profiles of the patients. We excluded patient
records without the required outcome parameter—in this case, a “confirmed diagnosis”. For





Univariate correlation of NGC expressions (or other continuous variables) with a cat-
egorical variable was tested by 2 mean Student’s t-tests. p-values were obtained from t-
statistics. Univariate correlation of NGC expressions (or other continuous variables) with
a continuous variable was tested with linear regression. p-values were obtained from the
t-statistic of the coefficient of the variable. Correlation of 2 categorical variables was tested
using Pearson’s chi-squared test of the cross-tabulation. p-values were obtained from the
chi-square statistics. For all the tests, a p-value of less than 0.05 was considered significant.
6.2.5 Model Fitting and Assessment of Model Performance
We used R package “caret” and its multiple dependencies (summarized in Table 2) for
modeling the predicting power of NGCs to the disease status of patients [33]. Performance
statistics for binary classification models were calculated, including accuracy, Cohen’s kappa




which indicates the performance gain from the modeling over random guessing (the higher,
the better). Since this data set features a smaller number of healthy individuals, we set the
models to aim for picking up healthy individuals as events. The sensitivity (true positive
prediction) and specificity (true negative prediction) values were also calculated in accord
to this principle. For the external assessment of model performance, data partitions were
created to have a training set (90% of the dataset) and a test set (10% of the dataset).
This was done using the “createDataPartition” function in the “caret” package to ensure
proportional and representative coverage of individuals in both the training and test sets.
Data in the training set were used for model building, and the data in the test set were
held out in the training process and were used to determine the model performance pseudo-
externally by comparing the prediction on the test set with the actual outcome of the test
set. The distributions of NGC expressions in the training set and test set were illustrated
in Figure S3. For the internal assessment of model performance and stability, 10-fold
cross-validations were done, which means 10% of the training data were kept out of each
iteration to evaluate the model generated by the other 90% training data over 10 iterations.
Similar performance statistics were calculated at each iteration. The average values and
standard deviations of the parameters were summarized to assess the model performance and
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stability, respectively. Some models were tuned in ranges of tuning parameters to control
their complexity and adaptivity (Table 2). Tuning parameters giving the best performance
statistics in the cross-validation were chosen as optimal tuning of the model, and a final
model was built using these parameters on the complete training data.
6.3 Results
6.3.1 NGC Expressions in Monocytes and Feature Selections
We made use of the CIRCULATING CELLS study cohort [20] to address the question of
whether NGC expression profiles of circulating blood cells can be related to cardiovascular
health. From 368 subjects out of this cohort (CVD patients and healthy controls), the
transcriptomes of their CD14-positive monocytes were profiled (Figure 1). The individuals
received different treatments and medications, and some of them suffered from other diseases,
resembling the reality of complexity of most human cohorts (Table 1). Next, we aimed
to classify CVD patients and healthy individuals using the differential expression of the
NGC transcripts. To that end, we first sought to include NGCs with high expression levels
and good univariate correlation with the outcome. Figure 2A shows the expression of
NGCs in the cohort. Based on the detection threshold of the profiling platform, NGCs
with signals higher than 6.75 (log2 scale unless specified otherwise) were unconditionally
included in the modeling as potential features. To validate the microarray analysis, we
compared the monocytic NGC expression profile obtained by microarray to that obtained
by real-time PCR. Both methods showed a similar expression profile, with the exception of
SEMA3E (Figure S1). To gain understanding of univariate correlation of the features to
the outcome, violin plots of the NGC expressions were created to compare the distribution
of NGC expression levels in both the CVD group and healthy group (Figure 2B and
Table S1). The ranges of expressions showed overlaps in both groups, suggesting that the
univariate prediction power will be minimal. In addition, with the ranges being widespread,
the information to noise ratio is relatively low in this dataset. To quantify the univariate
correlation of NGC expressions to the disease status, we calculated the p-value with two
mean t-tests between the CVD group and healthy group. A volcano plot was created to
observe the t-test p-value in relation to the fold change (Figure 3A). We identified several
NGC ligands and receptors to be significantly different between CVD patients and healthy
individuals, although with small fold changes. Among the significantly different genes, 10 had
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“gbm”, “plyr”
C5.0 Tree C5 Tree/Rule-based NA “C50”, “plyr”
Table 2. Summary of model names, types and tuning parameters
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their low expression levels. In total, 35 NGC genes were further to be used as features in
subsequent modeling. Finally, to avoid instability caused by between-feature collinearity in
some models, we calculated between-feature correlations of the expressions of selected NGCs
(Figure 3B). No pairwise correlations of NGC expressions exceeded the threshold of 0.75,
suggesting that there would be a minimal influence of collinearity. Therefore, none of the
selected NGCs were eliminated based on between-feature correlations.
6.3.2 Gender and Age are Unlikely to be Confounding Factors in the Current Study
Gender and age are conventional confounding factors in clinical situations when reveal-
ing relationships between measurements of phenotypes and diseases. For machine learning,
if age or gender affect both the features and the outcome, they would be confounding factors
by definition. Firstly, we examined the relationship of age to NGC expressions and disease
outcome. NGC expressions plotted against age in scatterplots with linear fittings showed no
significant correlation between age and the NGC expressions (Figure 4A). The age ranges
of both groups overlap, although the younger age dominates in the healthy group (Figure
4B). These observations suggested that age would add an additional prediction power in
our modeling but would not be a confounding factor, as it does not link directly to NGC
expressions. Next, we examined the relationship of sex to NGC expressions and disease out-
comes. Using violin plots, we compared the distribution of NGC expressions in both sexes
(Figure 5A). The distribution of NGC expressions was barely affected by sex, including the
X-linked PLXNA3, PLXNB3 and EFNB1 genes (Figure 5A). There were six NGCs with
significantly different expressions comparing males to females, albeit with a very small fold
change relative to the variations (Figure 5B). Cross-tabulations of sex and disease outcomes
were made, and the frequency distribution of both genders was similar among CVD patients
and healthy individuals (Figure 5C). Therefore, sex was also unlikely to be a confounding
factor in this study. Regardless, sex and age were included in our modeling process, as it is
common practice to control for these conventional confounding factors.
6.3.3 Performance of Different Models
Different machine-learning methods were applied, and optimal tuning was obtained for
each model listed in Table 2. The performance statistics for each of the models was cal-
culated and summarized in Figure 6. As measurements for model stability, we examined
standard deviations of the cross-validations for accuracies and Cohen’s Kappa. Model per-
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Figure 2. NGC expressions in patients and healthy subjects
(a) Box plots with quartiles were created using NGC expressions from all individuals. Baseline signal
of the platform (6.75) was indicated with the dashed line. (b) Violin plots of all NGC expressions
were created for cardiovascular disease (CVD) patients and healthy individuals. The violin shapes
represent the density distribution of NGC expressions in the groups. The NGC expressions of CVD
patients overlap with those of healthy individuals. Due to the small number of healthy individuals,
their NGC expressions were sometimes not normally distributed.
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Figure 3. Univariate correlation of NGC expressions with disease phenotypes and pair-
wise correlations of NGC expressions
(a) Volcano plot showing the fold changes and the significance of difference in the 2 mean Student’s
t-tests between NGC expressions in CVD patients and healthy individuals. NGCs with significant
differences (p < 0.05) are labeled with gene names and red color. For most NGCs, the univariate
correlation determined by the 2 mean Student’s t-tests with the outcomes is minimal. (b) Pairwise
covariances of NGC expressions were illustrated in the heatmap to examine the between-feature
correlations. Blue color indicates a positive correlation, whereas red color indicates a negative cor-




Figure 4. Influence of age as a potential confounding factor
(a) Scatter plots of expressions of selected NGCs in relation to age were made to show the influence
of age on NGC expressions. Linear regressions were done with age being the dependent variable
providing the fitted trend line (blue line), the 95% confidence interval of the trend (gray area) and
the regression R-squared. Correlations of NGC expressions and age are minimal, as indicated by the
R-squared values. (b) Boxplot of age distribution in CVD patients and healthy individuals. Young
age dominates in the healthy individuals.
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Figure 5. Inspection of the influence of sex as a potential confounding factor
(a) Violin plots to show the distribution of expressions of selected NGCs in males and females. To
be noticed is that distributions of selected NGC expressions are similar between sexes. (b) A volcano
plot was made showing the fold change and the significance of differences in a 2 mean Student’s
t-tests between NGC expressions in males and females. NGCs with significant differences (p < 0.05)
were labeled with gene names and red color. (c) Contingency table showing that the ratio of sexes
is not biased in relation to the outcomes.
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formance could be categorized in four groups (Figure 6A-D). (1) Partial least squares,
support vector machine and nearest shrunken centroids models failed entirely to model the
informative part of the gene expression data, as was revealed by having bottom-line accuracy
(not better than predicting all the individuals to be CVD) and zero Cohen’s Kappa value in
the cross-validation, training set and test set. (2) Most models—namely, logistic regression,
k-nearest neighbors, mixture discriminant analysis, flexible discriminant analysis, bagged
CART (classification and regression tree), random forest and single C5.0 tree—suffered from
overfitting, as was characterized by far better performances of models in the training set
than in the test set. This can be explained by the modeling process trying to polish these
models to perfectly predict the outcome based on the information in the training dataset.
However, the modeling for the training set could not be generalized to the test set data. (3)
K-nearest neighbors and flexible discriminant models had overall better prediction powers
over random guesses but were still not up to standard. (4) Linear discriminant analysis,
Näıve Bayesian and stochastic gradient boosting models performed best compared with the
other models, within both the training set and test set at an accuracy of more than 0.98
and Cohen’s Kappa more than 0.75 in the test set. These results indicate that the linear
discriminant analysis, Näıve Bayesian and stochastic gradient boosting models were able
to translate the informative part of NGC expression data into disease outcome. The three
best-performing models all reached a sensitivity of 1 in the test set, meaning that they were
able to discriminate healthy individuals from CVD patients (Figure 6C). Cohen’s kappa (κ)
values were 0.79, 0.79 and 1 for the linear discriminant analysis, Näıve Bayesian model and
stochastic gradient boost model, respectively (Figure 6B). The lower Cohen’s kappa (κ) for
the former two models were due to the misclassification of one healthy individual as a CVD
patient (Table 3). In the prediction of the training set, the linear discriminant analysis had
lower sensitivity in the training set due to the misclassification of three healthy individuals
to the CVD group (Table 3). Interestingly, the three misclassified healthy individuals still
had higher modeled probability to be healthy than all but one misclassified CVD patient,
suggesting that the sensitivity problem can be solved by an alternative cutoff value of the
classification probability. When the cutoff value was altered from the original 0.5 to 0.28,
the linear discriminant analysis achieved the same ideal sensitivity as the Näıve Bayesian
model (Figure S2A,B). However, to prove the external efficiency of the alternative cutoff,




Figure 6. Model performance
(a-d) Model performance metrics—namely, accuracy (a), Cohen’s Kappa (b), sensitivity (c) and
specificity (d)—were illustrated in cross-validations (green dots and error bars), Training Set (black
dots) and Test Set (red dots) for all models. Models are categorized into 4 groups based on their
performances.
Training Reference Test Reference
Model Prediction CVD Healthy Prediction CVD Healthy
Linear Discriminant CVD 284 3 CVD 70 0
Analysis Healthy 1 7 Healthy 1 2
Naive Bayesian CVD 285 0 CVD 70 0
Healthy 0 10 Healthy 1 2
Stochastic Gradient CVD 285 0 CVD 71 0
Boosting Healthy 0 10 Healthy 0 2
Table 3. Confusion matrices of the linear discriminant analysis, Naive Bayesian and
stochastic gradient boosting models
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6.3.4 Features with the Most Importance in the Models
Apart from age, the most important three features determined by the linear discrimi-
nant analysis and Näıve Bayesian model were PLXNC1, DSCAM and DCC, while the most
important three features determined by stochastic gradient boost were SEMA6B, SEMA6D
and EPHA2 (Figure 7A-C). As we noted before, age was determined to be important con-
tributor to the model but was hardly a confounding factor, considering the weak correlation
of age with NGC expressions (Figure 7A-C). The functional relevance of the top features
will be discussed in the Discussion section.
Figure 7. Variable importance of the models
(a-c) Variable importance measured in the linear discriminant analysis (a), Näıve Bayesian model
(b) and stochastic gradient boost model (c). The importance of the most important feature was
scaled to 100.
6.4 Discussion
In this study, we used NGC expressions of peripheral blood monocytes for the predic-
tion of CVD. To reveal the true prediction power of monocytic NGC expression profiles, we
performed cross-validation and validation using a pseudo-external test set with conventional
confounding factors controlled. Of the models, Näıve Bayesian model and stochastic gradient
model had satisfactory discrimination in both the training test and test set. The stochastic
gradient model with a residual modeling mechanism was able to achieve 100% accuracy.
Therefore, we have established the proof of concept that a small set of functional genes,
NGCs, is of sufficient prediction power for the classification of CVD patients and healthy
individuals. There are several challenging factors in the prediction of CVDs using mono-
cytic NGC expressions. Firstly, nonlinearity is common in the biological effect of proteins.
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Taking NTN1 as an example, the repellent effect of NTN1 on monocyte and macrophage
migration has an optimal concentration of around 250 ng/ml; higher or lower concentrations
are both less effective [3,14]. The biological effect also depends on its target, as NTN1 also
has opposite roles acting on smooth muscle cells or macrophages [15]. Secondly, concomitant
physiological processes in certain disease conditions can systemically cancel out the change
of average gene expressions if they alter the gene expression in the opposite direction. In
our case, CVD patients experience changes in the monocyte subpopulations, with increased
lipopolysaccharide receptors and the low-affinity FC γ receptor-positive monocytes, referred
to as intermediate monocytes [21,22]. These intermediate monocytes have been shown to
predict cardiovascular events in subjects referred for elective coronary angiography [23]. At
the same time, there is increased mobilization of lipopolysaccharide receptor-positive and
low-affinity FC γ receptor-negative näıve classical monocytes from bone marrow, a pro-
cess termed monocytosis. For any changes induced by monocyte activation/differentiation,
monocytosis will cancel out the change because of the added näıve classical monocyte popu-
lation. Moreover, human measurements in general can be very heterogenic by nature. Even
proved biomarkers suffer from false positives and false negatives because of large variations
in human measurements. In this study, we sought to tackle these problems by applying
multiple modeling methods, each of which incorporates special features in the aspects of the
linearity requirements or the learning mechanisms. Machine-learning methods are different
from each other in various ways, including learning mechanisms and the assumptions made
on the features. For a given dataset, choosing a model with suitable learning mechanisms
and proper assumptions of the features can benefit the performance of modeling. In the cur-
rent dataset, the linear discriminant analysis and the Näıve Bayesian model both adopted
the same features, with identical weights on each feature, but the Näıve Bayesian model
had better performance (Figure 6 and 7A,B). As both models are based on multivariate
probability densities, the difference of the model performance should result from the differ-
ent intrinsic assumptions and learning mechanisms of the models. The linear discriminant
analysis assumes a multidimensional Gaussian distribution of the feature data, while the
Näıve Bayesian model works with a more flexible distribution. Instead, the Näıve Bayesian
model makes a strong assumption that all features are independent, so that the conditional
probability of one class will be simply the product of the probability densities of all features.
In addition, Näıve Bayesian could model nonlinear relationships between features and the
outcome. Due to smaller numbers of individuals in the healthy group, distributions were
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sometimes non-normal (Figure 2B). As previously described, the features in this dataset
have relatively low pairwise covariance (Figure 3B), so that the independent-feature as-
sumption required by the Näıve Bayesian model is very likely to be acceptable. Taken
together, the structure in the current dataset favors the Näıve Bayesian model, which ex-
plains its better performance. The top 10 important NGCs chosen in the linear discriminant
analysis and Näıve Bayesian models were all significantly differently expressed in the two
mean t-tests, except NTNG1 (Figure 3A and 7A,B). This suggests that these two models
favored features that have primarily different values in CVD and healthy groups, while the
inclusion of NTNG1 served as a supplement to address the remaining variations that had
not been explained by the other factors. Stochastic gradient boosting got the ideal classifi-
cation of CVD and healthy individuals in both the training set and test set with a superior
discrimination of CVD and healthy probability than the linear discriminant analysis and
Näıve Bayesian model (Figure 6 and Table 2). The stochastic gradient boosting model
is a classification tree-based model that incorporates functionalities that allows iterations
over different choices of features and the modeling of residuals at costs until the residual is
smaller than a certain threshold. From our modeling practice, the complexity of the stochas-
tic gradient boosting paid off in comparison to the other two tree-based models—namely,
the bagged CART model and the random forest model (Figure 6 and Figure S2C-E). The
bagged CART model, which does not iterate among different sets of features, suffered from
a larger variation of predicted probabilities (Figure S2C,D), suggesting that randomized
feature selection did benefit the modeling stability. On the other hand, the random forest
model had the ability to produce probability predictions with less variation but failed to de-
liver a probability above the cutoff in the test set, confirming the extra learning ability made
possible by the gradient boosting process (Figure S2C,E). Notably, the stochastic gradient
boosting model picked considerably different NGCs as features. The most important three
features in this model, SEMA6B, SEMA6D and EPHA2, are not included in the top 10 fea-
tures in the linear discriminant analysis and Näıve Bayesian models (Figure 7). The most
important feature, SEMA6B, was not even significant in the two mean t-tests (Figure 3A).
Variable importance in the stochastic gradient boosting model took both the importance of
a variable in the building of a decision tree and the subsequent modeling of residuals into
account. It is likely that SEMA6B performed well in the modeling of the residual, since the
univariate prediction power of SEMA6B should be minimal. The modeling of residuals often
improves datasets with lower information-to-noise ratios, which is the case in the current
156
Chapter 6
dataset. The importance of a feature in certain models could sometimes inform us with the
relevance of the feature to the outcome. In the current setup, the importance of an NGC in
the prediction models might suggest the functional importance of NGC in the development of
CVD via monocytes. The linear discriminant analysis and Näıve Bayesian model picked up
PLXNC1 as the most important feature. PLXNC1 mediates monocyte migration, adhesion
and differentiation in response to its ligand SEMA7A [24]. At regions experiencing disturbed
blood flow (atheroprone), an increase of SEMA7A in endothelial cells exacerbates inflamma-
tion and atherosclerotic plaque size [12]. SEMA6D and EPHA2 were chosen as the second
and third most important features in the stochastic gradient boost model. SEMA6D has a
role in immunology as being costimulatory molecule-expressed by dendritic cells [25]. The
function of SEMA6D in monocytes is not known yet. EPHA2 promotes the adhesion and
differentiation of monocytes [26,27]. In an apolipoprotein E knockout murine atherosclerosis
model, the knockdown of EPHA2 using adenovirus-carrying short hairpin RNA resulted in
the attenuation of atherosclerotic lesion development [28]. However, the amount of con-
tribution from EPHA2 knockdown on monocytes could not be distinguished from that of
endothelial cells. A limitation of this study is that the number of individuals is small in the
healthy group, meaning the models were less trained by features of individuals with a healthy
phenotype. This also led to some degree of instability of the models in the cross-validation.
Another limitation is that the healthy individuals were younger than patients in the CVD
group. Although, the ranges of ages in the two groups overlapped, it is to be determined
whether the model could discriminate between the two phenotypes when the age range in
the healthy group is extended. Future studies should recruit more age-matched individu-
als. To fully reveal the prediction power of NGC expressions, future works should focus on
whether NGC expressions could discriminate between classes with more subtle differences,
e.g. between stable and unstable angina. It should also be noted that the pathogenesis of
CVD is rather complex. In this article, we focused on the association of NGC expressions
to CVD, although multiple pathways are involved, leading to the identification of an incom-
plete risk gene set. The complex pathogenesis also dampens our ability to draw conclusions
on causality, since it is possible that mechanisms that are implicated in CVD also alter the
functional states of monocytes, reflected by monocytic gene expressions. In general, the
development of clinical risk prediction models often faces certain hurdles, which could lead
to less-defined results. Some studies only examined the univariate prediction value and ig-
nored the combined prediction value of all features [29], while other studies did examine the
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multivariate prediction value of features but used models that made strong assumptions on
the data structure and covariance between features [30,31]. It is also common that studies
have accessed the models in a descriptive way, but the external prediction potential is not
determined [29,31,32]. In our study, we have incorporated multiple NGCs as features based
on both statistical examinations and biological insights. We assessed the performances with
cross-validation in the training data and independent prediction in the held-out data, thereby
controlling the models on overfitting. Moreover, the models were shown to be not only a
descriptive tool to confirm the correlations between NGC expression and CVD outcome but,
also, a prediction method that can be applied to new datasets. In addition, we applied one
of the complex models, the stochastic gradient boosting, which makes little assumptions on
the characteristics of the data structure and returned a better performance. Taken together,
this study gave the proof of principle on how machine-learning methods could be applied
to the prediction of disease outcomes using the expression of a set of functional genes in
circulating cells and allowed us to identify SEMA6B, SEMA6D and EPHA2 as predictive
genes for CVD in the current cohort.
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7.1 Key findings in this thesis
This thesis aimed to provide evidence that supports a central role for NGCs in CVD
by studying the expression, regulation and function of neuronal guidance cues (NGCs) in
endothelial cells and monocytes, the 2 cells types that play main role in development of
atherosclerosis. The findings laid the foundation for future research of NGCs as novel tar-
gets for intervention of atherosclerosis. Following a short introduction in Chapter 1, in
Chapter 2, we started with an overall review of the expression profiles and known func-
tions of semaphorins and netrins in mature vascular endothelial cells. Average expression of
semaphorins and netrins were listed, based on the transcriptomic data on GPL570 platform.
Roles of semaphorins and netrins in survival, renewal potential, response to vessel wall shear
stress, barrier function and controlling of vascular tone were summarized. From the litera-
ture review and preliminary experiments, we spotted high expression of SEMA3F and NTN4
in almost all types of endothelial cells. However, less was known about the function of these
two guidance cues in mature and quiescent endothelial cells. There was also a lack of knowl-
edge of function of SEMA3F and NTN4 in physiological concentration range. Therefore, in
Chapter 3 and 4, functions of SEMA3F and NTN4 in endothelial cells were investigated
in a reductionist approach. In Chapter 3, we observed impaired barrier function, result-
ing from change of cytoskeleton arrangement, if expression of SEMA3F was reduced using
shRNA in human primary endothelial cells. The monocytic cell line THP-1 were shown to
express the SEMA3F receptors NRP2, PLXNA1 and PLXNA3. In the presence of SEMA3F,
monocyte migrations were inhibited. In Chapter 4, we made the observation that reduced
level of NTN4 led to a senescence phenotype in endothelial cells. Presence of NTN4 in ex-
tracellular matrix derived from decellularized human kidney increased ability of endothelial
cell to adhere to the matrix by promoting endothelial cell survival. These studies demon-
strate the necessity of the 2 NGCs in endothelial cell biology. In Chapter 5, we perform
a gene expression meta-analysis of NGCs during the monocyte to macrophage differentia-
tion process, which is the critical process that occurs during development of atherosclerosis.
Our pathway analysis confirmed the implication of axon guidance pathway in monocyte to
macrophage differentiation process. The change of NGC expression profile corresponds to the
function adaptions required for classically activated macrophages. Pro-inflammatory guid-
ance cues, like SEMA7A, are upregulated in macrophage, while anti-inflammatory guidance
cues, like SEMA4D, are downregulated. NGC receptors that were responsible for direction
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of cell migration were upregulated. We further investigated the regulation of NGCs by the
RNA-binding protein quaking (QKI) and found a regulatory hotspot in 3’UTR of SEMA7A
transcript. QKI and a cluster of microRNAs possibly antagonize each other’s effect by com-
petitive binding at this hotspot. Given the implication of NGCs in monocyte function, we
went one step further to validate the relevance of monocytic NGC expression in human using
a coronary artery disease patient cohort. In Chapter 6, we determined prediction power of
NGC expression of circulating CD14-positive monocytes. Using predictive modeling meth-
ods, we were able to find models, which correctly distinguished CVD patients from healthy
individual. Therefore, monocytic expression of NGCs contains sufficient information for the
disease status in our cohort. This gives the first link of between monocytic NGC expression
and clinical phenotype in CVD patients.
7.2 NGCs are among the mediators of endothelial functional adaption to
vessel wall shear stress
Atherosclerotic plaques profoundly develop at regions with disturbed flow or lower vas-
cular wall shear stress [1]. This evidence has led to recognition of unfavorable hemodynamic
environment as a key driver of endothelial dysfunction and subsequently atherogenesis. Ves-
sel wall shear stress is the coplanar force applied to the vascular endothelium by the blood
flow. Laminar shear stress (> 10 dyn/cm2) provokes endothelial quiescence, which denotes
the state of endothelial cells being mature and functional. Quiescence endothelial cells have
a good barrier function, less coagulant activity and higher eNOS function (higher bioavail-
ability of NO) and are anti-inflammatory. Therefore, laminar shear stress is believed to
be atheroprotective, while disturbed flow (turbulence, oscillatory flow) is believed to be
atherogenic. Genes that are regulated by shear stress are interesting, because they could be
potential mediators of functional adaption to shear stress in endothelial cells, which may sub-
sequently affect development of atherosclerosis. Previously it has been reported that NTN1,
SEMA3A and EFNB2 expression is regulated by different flow conditions in both aortic arch
of LDLR knockout mice and cell culture. With expression of NTN1 and SEMA3A being
higher in atheroprotective flow condition (outer curvature of aortic arch and laminar flow),
while expression of EFNB2 being higher in atherogenic flow condition (inner curvature of
aortic arch and oscillatory flow) [2]. In Chapter 3 and 4, we found that SEMA3F and
NTN4 were also upregulated by laminar shear stress, adding 2 more guidance cues that are
regulated by shear stress. As reviewed in Chapter 2, NTN1 could serve as repellents of
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monocyte migration and leukocyte adhesion, thus adding to the anti-inflammatory property
of quiescent endothelial cells [3]. Passacquale et al observed downregulation of endothelial
NTN1 in ApoE knockout mouse and showed that counteracting the downregulation with
aspirin resulted in reduced atherosclerotic plaque progression by reducing monocyte infiltra-
tion [4]. Serum levels of NTN1 have been found to correlate with grades of atherosclerosis
in human. In contrast to NTN1, EFNB2 could serve as monocyte attractant, so that low
expression of EFNB2 in quiescent endothelial cells is intuitive [2]. Despite various studies
confirming the involvement of SEMA3A and EFNB2 in cell types related to atherosclerosis,
no in vivo evidence showing direct role in atherogenic has been published. In Chapter 3, we
found SEMA3F was essential for stability of endothelial adherens junction and subsequently
endothelial barrier function. Like SEMA3A and NTN1, SEMA3F was found to inhibit mono-
cyte migration, although the inhibitory effect was not directional. Under baseline condition,
global knockout of SEMA3F in mice do not display atherosclerotic phenotype [5]. Evidence
of atheroprotective effect of SEMA3F in partial ligation mouse model is just emerging [6]
(unpublished data suggesting 48% increase of lesion size in SEMA3F knockout mice com-
pared to WT littermates following partial ligation procedure). In a Japanese population,
a polymorphism in SEMA3F was associated with decreased risk of myocardial infarction.
In Chapter 4, we demonstrated that NTN4 deficiency in endothelial cells lead to reduced
survival and senescence phenotype of endothelial cells. Our observation is in line with other
reports on the role of exogenous NTN4 in promoting endothelial cell survival via kinase
activation or activation of integrins [7]. In ApoE knockout mouse, increased endothelial
cell proliferation and turnover was observed in the aorta surface, especially in atheroprone
regions [8]. The increased turnover could be viewed as a repair response to damage of en-
dothelium. As reviewed in Chapter 2, proliferation of endothelial cells requires the cells
to deviate from the quiescent state, one the consequences of which is impaired endothelial
barrier function. It has long been known that leukocyte infiltration and endothelial cell
proliferation occurs concurrently in early atherosclerosis [9]. Together, these observations
provide theoretical possibility that factors, like NTN4, that promote endothelial cell survival
could counteract damage to the endothelium. However, the essence of NTN4 in such role in
vivo is still yet to be established. In summary, NGCs are among the mediators of functional
adaption to vessel wall shear stress of endothelial cells. Insights in functional importance of
NGCs are accumulating on cell level, but investigations of the in vivo functions of NGCs in
relation to atherosclerosis are largely lacking, except for well-studies ones like NTN1.
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7.3 In search for potential therapeutic targets in atherosclerosis: where
do NGCs fit in?
Different methodological approaches have been applied to discover new therapeutic
targets of atherosclerosis. Mechanisms involved in pathogenesis of atherosclerosis have been
extensively studied with various therapeutic targets unraveled. One of the earliest studies in
atherosclerosis established the importance of blood cholesterol in development of atheroscle-
rosis with high cholesterol diet fed rabbit being the first experimental animal models of
atherosclerosis [10, 11]. From that time onward, numerous efforts have been made to tackle
hypercholesterolemia, which is to date most effective strategy of atherosclerosis intervention
(reviewed in [12]). There were also early efforts made in epidemiological research to access
the risk factors for atherosclerosis, including alcohol consumption [13], diabetes [14], blood
pressure, body mass [15] and later also smoking [16]. These traditional risk factors were
later confirmed in different situations and are still primary targets of intervention. It was
later found that atherosclerosis is an inflammatory condition, caused by factors including
vessel wall shear stress, dyslipidemia and infection [17, 18]. In early stage of atherosclerosis,
these factors cause endothelial dysfunction. In Chapter 3 and 4 of the thesis, we discussed
the role of NTN4 and SEMA3F in endothelial cell function in the context of shear stress
and inflammation. In Chapter 5, we discussed the expression, regulation, and functional
relevance of NGCs in monocyte to macrophage differentiation. Our studies are part of con-
tinuing efforts to explore mechanisms involved in pathogenesis of atherosclerosis. In modern
times, advances in molecular biology, genetics, high-throughput nucleotide assays, establish-
ment of experimental atherosclerosis animal models and development of genetic engineering
tools have boosted the discoveries of new therapeutic targets. Targets are discovered both
by screening in population or high-risk families and by mining in the genes (or non-coding
elements) that can be possibly involved in pathogenesis of atherosclerosis. As a population
screening method, genome wide association studies (GWAS, GWA studies) are normally done
to screen the genomic regions that are relevant to cardiovascular disease traits [19]. Regions
with best association strength are picked to study further to narrow down to a causal gene
or regulatory segment. GWAS led to discoveries of genomic hot spots like chromosome 1p13
near CELSR2-PSRC1-SORT1 genes [19]. GWA studies have several advantages: discover-
ies are directly relevance in human situation; associations can be made regarding different
outcomes; findings are not limited to coding regions; results can be interpreted with future
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knowledge. The principle of GWAS dictates that genotype polymorphisms with reasonably
prevalence in the studied population can be found. On the other hand, rare variants with
high genetic penetrance have been found in patients with familial atherosclerosis. Early
studies in familial hypercholesterolemia identified causal mutations in LDLR and ApoB100
genes [20]. With the development next generation sequencing technology, whole exome se-
quencing can be performed now in familial premature atherosclerosis patients to reveal the
causal gene targets in a high-throughput manner [21]. An on-going research in our group
makes use of exome sequencing data from familial pre-mature atherosclerosis families with
normal blood cholesterol level (data not shown here because it is out of the scope of this
thesis). The sequencing identified several mutations in NGCs, which could potentially ex-
plain the phenotypes in these patients [22]. Such experimental setup is also beneficial in
discovering gene targets that are functioning independent of hyperlipidemia if the affected
individuals suffer from atherosclerosis despite having normal lipid profiles.
7.4 How can machine learning tools aid biomedical research and its appli-
cations?
Modern omics technologies like microarrays and next-generation sequencing have made
it possible to generate enormous number of features from biological samples. A traditional
way to combine information from different clinical features is to have an accumulative scoring
system based on the value of each measurements that can be calculated manually. However,
with the dimensions given by omics data, it is no longer possible to do it. Such situa-
tion prompted the need for better tools to deal with huge and complex biological features,
which in our and others’ opinion can be met with machine learning methods (or predictive
modeling). In Chapter 6, we gave the proof of concept that by using NGC expression in
circulating CD14-positive monocytes, one can distinguish between healthy individuals and
CVD patients. Biological omics data are by nature not necessarily independent (between
features) nor linear (the features themselves). Various predictive modeling methods were
developed to accommodate the complexity of data in these aspects (discussed in the book by
Max Kuhn [23]). By modeling the biological data to a certain disease outcome, associations
of the biological data and the disease outcome can be made, giving directions for further
causality studies. Machine learning methods can iterate in ranges of different parameters, the
optimal models chosen from the iterations have the possibility to come close to the maximum
prediction power of a certain dataset. Such ability makes decision making easier regarding
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whether the pool of the observations is relevant for the purpose of the study. Furthermore,
machine learning methods can build the link between functional genes/transcripts/proteins
and disease phenotypes prior to full elucidation, thus accelerating the translation of knowl-
edge to clinical situations.
7.5 NGCs as targets of atherosclerosis intervention: the challenges and
future perspectives
Despite a much better understandings of the functions of NGCs in cardiovascular sys-
tem, several challenges remain before successful interventions can be developed targeting
NGCs. The broad spectrum of functions of NGCs means targeting NGCs could lead to many
undesirable or unexpected effect. The problem is further complicated by the multi-to-multi
binding patterns of NGC ligands and receptors. Despite the descent amount of knowledge on
the functional importance of netrins and semaphorins in endothelial cell and monocyte biol-
ogy, insights in the downstream signaling pathways are relative scarce. Future work should
aim at comprehensive mapping of the downstream signaling pathways to pinpoint more spe-
cific druggable targets. Moreover, it is sometimes clear that a simple agonist/antagonist
approach is not feasible. For example, endothelial derived NTN1 is atheroprotective owning
to its ability to work as repellent for monocytes, whereas macrophage derived NTN1 decrease
inhibits macrophage emigration from atherosclerotic lesions and is therefore atherogenic [4,
24]. Tissue specific drug delivery strategy is necessary in such situation. The effects of NGCs
are often dose dependent. There are sometimes optimal concentrations for benefit effect of
NGCs. For example, repellent effect of NTN1 and SEMA3A on monocyte migration has
optimal concentration [2]. High concentration of exogenous SEMA3F was shown to cause
collapse of endothelial cytoskeleton, whereas we showed in Chapter 3 SEMA3F deficiency
in endothelial cells impaired stability of adherens junction via excessive activation of F-actin
[25]. If NGCs were developed as drug targets, it is important to know the optimal dose of
NGCs for the beneficial effect. It is, however, promising for NGCs to be biomarkers for CVD
patient stratification. Based on functional importance of NGCs in monocytes as described
in Chapter 5, we speculated that peripheral blood monocytes could carry information of
patients’ disease status. We confirmed the speculation by modeling the predictive power of
monocytic expression of NGCs in Chapter 6 in a preliminary setting. To further establish
NGC expression as features for patient stratification, a larger prospective cohort would be
needed. In addition, a better choice of the cell type to be profiled could theoretically im-
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prove the prediction power further. In summary, to prove therapeutic value of NGCs, deeper
understanding of the signaling pathways and the dosing is needed, among other challenges.
7.6 Conclusion
In the first half of my thesis, I started with reviewing the recent research regarding
functions of semaphrorins and netrins in mature endothelial cell biology. In the review, I
identified SEMA3F and NTN4 as two highly expressed NGCs, for which there was a lack of
knowledge of their function in mature endothelial cells. In the following chapters, their roles
in maintaining endothelial barrier function, inhibition of monocyte migration, prevention of
endothelial cell senescence and promotion of endothelial cell survival were revealed. In the
second half of my thesis, I focused on comprehensive analysis of regulation of NGC expression
in monocytes and macrophages. I then took a step forward found that regulation of NGC
expression in monocytes could be informative for prediction whether patients were currently
affected by CVD. Findings in the thesis add to the growing knowledge that NGCs are widely
involved in pathological processes underlying atherosclerosis.
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Ondanks aanzienlijke vooruitgang in de behandeling, blijven hart- en vaatziekten een
van de meest voorkomende doodsoorzaken. Atherosclerose, ook wel bekend als aderverkal-
king, is een proces dat centraal staat binnen de cardiovasculaire ziekten en is gekenmerkt
door excessieve ophoping van vetten en immuun cellen in de vaatwand (plaques). De be-
langrijkste strategie om mortaliteit door atherosclerose te verminderen is het corrigeren van
dyslipidemie (afwijkingen in de samenstelling van vetten, waaronder triglyceriden en cho-
lesterol, in het bloed). De meest succesvolle en meest gebruikte interventie is de remming
van de aanmaak van cholesterol door statines. Additionele behandeling met een antilichaam
tegen PCSK9 kan de cholesterol niveaus nog verder verlagen. Ondanks de mogelijkheid
tot het corrigeren van cholesterol levels, is er echter nog steeds een aanzienlijk risico op
cardiovasculaire ziekten.
Naast de cholesterolverlagende strategie, is er steeds meer onderzoek naar strategieën
die ingrijpen op de immunologische reacties, ontstekingsreacties, die plaatsvinden bij athe-
rosclerose. Behandeling met Canakinumab (een antilichaam tegen IL-1β) bleek hart- en
vaatziekten met 16% te verlagen. Ondanks een toename in het aantal (dodelijke) infecties
als gevolg van een verminderde afweer van de patiënt, toont deze studie het belang van
ontstekingsreacties bij atherosclerose. Verder is het bekend dat atherosclerotische plaques
zich vaak ontwikkelen in gebieden met onregelmatige bloedstroming, zoals bloedvat vertak-
kingen, terwijl het overige vatenstelsel relatief onaangedaan is. Dit duidt op een rol voor
endotheelcellen, cellen die de binnenwand van de bloedvaten bekleden, bij het ontstaan van
atherosclerose. Bovenstaande ontwikkelingen stimuleren onderzoeksinspanningen om die-
pere inzichten te verkrijgen in de bijdrage van endotheelcellen en ontstekingsreacties in de
pathogenese van atherosclerose om het resterende risico op hart- en vaatziekten verder aan
te pakken.
Neuronal guidance cues (NGC’s) zijn een verzameling van receptoren en liganden die een
belangrijke rol hebben bij de embryonale ontwikkeling van zowel het zenuw- als bloedvaten-
stelsel. Door een samenspel van aantrekkende en afstotende signalen naar cellen, regisseren
NGC’s de patroonvorming van deze stelsels. Afhankelijk van de context worden NGC’s ook
wel neuronal guidance eiwitten (naar hun moleculaire eigenschap), axonal guidance cues
(naar hun oorspronkelijke functie) of zelfs neuro-immune guidance cues (naar hun later ge-
vonden rol in de immunologie) genoemd. De NGC’s bestaan uit 4 families van liganden,
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namelijk netrin, semaphorin, slit en ephrin. Binding van deze liganden aan hun diverse
receptoren, met verschillende specificiteit en affiniteit, leidt tot een complexe stroom aan
signalen in de betrokken cellen. Een groot deel van deze signalen resulteert in veranderde
activiteit van GTPase enzymen, welke de organisatie van het cytoskelet van de cel reguleren
waarmee NGC’s hun aantrekkende en afstotende effect kunnen realiseren. Naast de rol van
NGC’s tijdens de ontwikkeling, zijn ook functies van NGC’s beschreven in zowel volwas-
sen endotheel- als immuun cellen, wat ook de focus van dit proefschrift is. Met de kennis
in dit proefschrift demonstreer ik de relevantie van NGC’s in de vasculaire biologie vanuit
fundamentele celbiologie tot aan hart- en vaatziekten patiënten.
In Hoofdstuk 2 wordt een gedetailleerd literatuuroverzicht gegeven van de functies
van semaphorin en netrin NGC’s in volwassen endotheelcellen. Op basis van transcriptomic
gegevens verkregen op het GPL570-platform, is de gemiddelde expressie van semaphorins en
netrins vermeld. Verder wordt in dit hoofdstuk de rol van semaphorin en netrin NGC’s in
verschillende functies van endotheelcellen, zoals barrièrefunctie en de controle van bloeddruk,
samengevat. Uit zowel het literatuuronderzoek als eigen experimenten viel op dat op bijna
alle verschillende soorten endotheelcellen een hoge expressie van SEMA3F en NTN4 hebben.
Er was echter minder bekend over de functie van deze twee specifieke NGC’s in volwassen
en gezonde endotheelcellen.
In Hoofdstuk 3 en 4 is dan ook de regulatie en functie van SEMA3F en NTN4 in
endotheelcellen onderzocht. De expressie niveaus van zowel SEMA3F als NTN4 worden ge-
reguleerd door ontstekingsfactoren en hemodynamische factoren. In Hoofdstuk 3 wordt
beschreven hoe vermindering van SEMA3F, door een verandering in het cytoskelet, de endo-
theel barrièrefunctie verminderd. Verder is aangetoond dat monocyten de SEMA3F recepto-
ren NRP2, PLXNA1 en PLXNA3 tot expressie brengen en dat aanwezigheid van SEMA3F
de migratie van monocyten remt. In Hoofdstuk 4 is beschreven dat dat verlaagde expressie
van NTN4 leidt tot een verouderd fenotype van endotheelcellen. Aanwezigheid van NTN4
in de extracellulaire matrix verhoogt het vermogen van endotheelcellen om aan de matrix te
hechten en bevordert de overleving van endotheelcellen. Beide studies tonen het belang van
de twee NGC’s in de endotheelcelbiologie aan.
NGC’s blijken ook een rol te spelen in de biologie van monocyten. Differentiatie van
monocyten naar macrofagen is een kritisch proces tijdens de ontwikkeling van atherosclerose.
Hoofdstuk 5 beschrijft dan ook een uitgebreide meta-analyse van NGC-genexpressie tijdens
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deze differentiatie. Onze analyse bevestigt de betrokkenheid van NGC’s in het differentiatie-
proces van monocyten tot macrofagen. De verandering van het NGC-expressieprofiel komt
overeen met de noodzakelijke functieaanpassingen voor klassiek geactiveerde macrofagen.
Onstekingsstimulerende NGC’s, zoals SEMA7A, worden verhoogd in macrofagen, terwijl
ontstekingsremmende NGC’s, zoals SEMA4D, worden verminderd. Daarnaast hebben we
geconstateerd dat de NGC-receptoren die verantwoordelijk zijn voor cel migratie meer tot
expressie worden gebracht door het differentiatie proces. Vervolgens hebben we de regu-
latie van NGC expressie niveaus door het RNA bindende eiwit quaking (QKI) onderzocht
en hebben we een regulerende hotspot in het 3’UTR van het SEMA7A-transcript gevonden.
Competitieve binding van een cluster van microRNA’s en QKI op deze hotspot reguleren mo-
gelijk de expressie van SEMA7A. De in silico-voorspelling dat SEMA7A wordt gereguleerd
door QKI wordt bevestigd met laboratoriumwaarnemingen.
Gezien de implicaties van NGC’s in monocyt functie, hebben we vervolgens de relevantie
van NGC expressie door monocyten gevalideerd met behulp van een cohort van patiënten met
coronaire vaatziekte. In Hoofdstuk 6 wordt de voorspellende kracht van NGC-expressie
van monocyten in het bloed bepaald. Met behulp van voorspellende modelleringsmethoden
waren we in staat om modellen te vinden die patiënten met hart- en vaatziekten correct
kunnen onderscheiden van gezonde individuen. Dit laat zien dat de NGC expressie van
monocyten voldoende informatie bevat voor de ziektestatus van de patiënten in dit cohort.
Dit geeft een duidelijke link tussen NGC expressie van monocyten en een klinisch fenotype
bij hart- en vaatziekten patiënten.
De resultaten beschreven in dit proefschrift over de expressie, regulatie en functie van
NGC’s in endotheelcellen en monocyten (de twee celtypen die een hoofdrol spelen bij de ont-
wikkeling van atherosclerose) leveren bewijs voor een centrale rol voor NGC’s in vasculaire
biologie en daarmee ook hart- en vaatziekten. Deze bevindingen vormen een basis voor toe-
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